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ABSTRACT
Agoraphobia Is the most pervasive and serious of all the phobic disorders, narks 
(1969) reported that agoraphobics represent between 505S-605S of all phobic clients seen 
by practicing mental health professionals. The syndrome Includes fears of leaving home, 
being in closed spaces, shopping, and traveling especially when alone. There 1s much fear 
generalization throughout the course of the disorder, and numerous other symptoms are 
commonly present, including panic attacks, tension, dizziness, frequent depression, 
depersonalizations and obsessions.
The purpose of the present investigation was to determine whether In vivo exposure 
treatment of agoraphobics could be made more efficient by Incorporating cognitive 
restructuring procedures Into the behavioral treatment. Thirty-two adult subjects, were 
recruited through the clientele of the outpatient department at the Foothills Hospital, 
Calgary, Alberta, and from announcements in local media of a program to treat agoraphobia. 
Subjects were randomly assigned to either the In vivo exposure group ( noncognitfve group; 
a= 12), the in vivo exposure + cognitive restructuring (cognitive group; a » 1 D o r the 
waiting list control group (a=  9). Subjects In the two therapy groups received 22 weekly 
group therapy sessions lasting approximately two hours each. The waiting list control 
group did not receive any treatment at this time.
A multifaceted assessment procedure Including, a) a measure of frequency of panic 
attacks, b) measures of general anxiety, c) measures of phobic anxiety, d) measures of
11
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phobic avoidance, including a behavioral avoidance test, e) a measure of global distress, f) a 
measure of treatment expectations, and g) a fear questionnaire, were administered to all 
three groups. These were administered before treatment began ( pretreatment assessment), 
after 11 weeks of treatment ( intermediate treatment assessment) and after the completion 
of treatment (posttreatment assessment)
Results of the present Investigation clearly suggest that in vivo treatment of 
agoraphobia could not be made more efficient by Incorporating cognitive restructuring Into 
the behavioral treatment. Multiple measures of change yielded no significant Improvement 
1n phobic symptomotology for subjects In the waiting list control group. The lack of change 
In the control group contrasted with the Improvement obtained In the two therapy groups. 
Both therapy groups were accompanied by marked and significant reduction In phobic 
symptomotology as measured on the following scales (a) Watson and Marks rating scale of 
phobic anxiety, ( b) Watson and Marks rating scale of avoidance and (c) Behavior avoidance 
test. The two therapy groups displayed a consistent but nonsignificant trend toward 
Improvement on ten of the remaining eleven measures. There was no evidence to Indicate 
that the noncognitive or cognitive groups differed significantly from one another on any of 
the dependent measures.
The results of the present study essentially corroborated the findings of Emmelkamp et 
al. (1986), Emmelkamp & Mersch (1982), Last et al. (1984), MavissakalIan et al 
(1983 ), and Williams and Rappoport (1983). Comparisons with relevant research, 
reasons for the lack of therapy differences, methodological concerns, theoretical 
implications and suggestions for future research were discusssed.
li i
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CHAPTER I 
INTRODUCTION
Agoraphobia Is the fear of experiencing overwhelming anxiety In various public 
places, e.g., elevators, airplanes, crowded stores, traveling, or busy streets. A central 
theme with agoraphobics Is that of feeling trapped where immediate escape from the feared 
situation is not thought to be possible. Agoraphobia is the most pervasive and serious of all 
the phobic responses and has been reported to be very difficult to treat ( Goldstein & 
Chambless, 1978). Although this problem has long been reported to be very resistant to 
treatment, Interventions which involve Interaction with the actual feared situation ( "in 
vivo exposure") have been reported to be effective (e.g., Emmelkamp & Wessels, 1975; 
Hafner & Marks, 1976).
Theorists and therapists (e.g., Beck & Emery, 1979) working in the field of 
agoraphobia, noting the debilitating thoughts and thinking styles of their clients, have 
suggested that cognitive therapy may be effective in changing such thinking patterns and 
subsequently succeed in reducing phobic behavior. Only two studies (Williams & 
Rappoport, 1983; Emmelkamp & Merch, 1982) have examined the integration of cognitive 
restructuring with in vivo exposure for agoraphobics and then examined the treatment' 
outcome. Both studies suggested an equivalence of treatment methods, however, both studies 
were methodologically flawed and deserve replication and extension with design
-  1 -
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Improvements. Despite the above two studies, there Is reason to think that such a combined 
approach may enable people to utilize more effectively cognitive Interventions.
The purpose of the present study was to determine whether in vivo exposure treatment of 
agoraphobia could be mads more efficient by incorporating cognitive modification techniques 
into the treatment. It Is hypothesized that In vivo exposure combined with cognitive 
restructuring w ill be superior to In vivo exposure In treating the debilitating problem of 
agoraphobia.
Initia lly, the agoraphobia syndrome w ill be described. Subsequent sections w ill 
examine the theories of acquisition of. phobias, behavioral and cognitive treatment 
approaches to phobias and to agoraphobia In particular. The rationale for the cognitive 
therapy procedures and a brief description of these techniques w ill be outlined. A statement 
of the purpose of this study and the hypotheses to be tested w ill conclude the Introductory 
chapter.
. Overview of Agoraphobia Syndrome 
The term "agoraphobia” was firs t coined by Westphal, a German psychiatrist, who, In 
1871, published a manuscript, Die Agoraphoble, which described the experiences of three 
males who had Intense anxiety when walking across open spaces or through empty streets. 
His account was cited by Errera (1962):
Impossibility of walking through certain streets or squares, or 
possibility of doing so only with resultant dread of anxiety... no loss of 
consciousness... vertigo was excluded by all patients... no hallucinations 
or delusions to cause this strange fear... agony was much Increased when 
the particular streets dreaded were deserted and the shops closed. The 
patients experienced great comfort from the companionship of men or 
even an Inanimate object, such as a vehicle or a cane. The use of beer or 
wine also allowed the patient to pass through the feared locality with
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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comparative comfort. One man even sought, without immoral motives, 
the companionship of a prostitute as far as his own door ... Some localities 
are more difficult of access than others; the patient walking far 1n order 
not to traverse them... Strange to say, In one Instance, the open country 
was less feared than sparsely housed streets In town. Case 3 also had a 
dislike for crossing a certain bridge. He feared he would fall 1n the water. 
In this case there was also apprehension of Impending Insanity.
In two cases, the onset of the disease had been sudden; In the third, 
the fear had been gradually Increasing for a number of years, (p. 332)
Today, over one hundred years later, agoraphobia remains the most disabling of 
phobias (Goldstein & Chambless, 1978). While agoraphobia Is often defined as a fear of 
open spaces, this 1s really a misnomer since agoraphobics typically exhibit a wide variety of 
avoidance behaviors Including an Inability to enter closed spaces, and of shopping, traveling, 
and entering social situations, especially when alone. There Is much fear generalization to 
additional stimuli throughout the course of the disorder, and numerous other symptoms are 
commonly present, Including panic attacks, tension, dizziness, frequent depression, 
depersonalization, and obsessions.
The Diagnostic and Statistical Manual, 3rd ed. (American Psychiatric Association,
1980) contains two categories, "Agoraphobia with Panic Attacks" and "Agoraphobia without 
Panic Attacks," both described as follows:
The essential feature Is a marked fear of being alone, or being In public 
places from which escape might be difficult or help not available In case 
of sudden Incapacitation. Normal activities are Increasingly constricted 
as the fears of avoidance behavior dominate the Individual's life. The most 
common situations avoided Involve being In a crowd, such as on a busy 
street or In crowded stores, or being In tunnels, on bridges, on elevators, 
or in public transportation. Often these Individuals Insist that a family 
member or friend accompany them whenever they leave home.
The disturbance is not due to a major depressive episode, Obsessive 
Compulsive Disorder, Paranoid Personality Disorder, or Schizophrenia. 
Often the initial phase of the disorder consists of recurrent panic attxks
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... The Individual develops anticipatory fear of having such an attack and 
becomes reluctant or refuses to enter a variety of situations that are 
associated with these attacks. ( p. 226)
The DSM-111 describes "panic attacks" as follows:
Panic attacks are manifested by the sudden onset of intense apprehension, 
fear, or terror, often associated with feelings of Impending doom. The 
most common symptoms experienced during an attack are dyspnea; 
palpitations; chest pain or discomfort; choking or smothering sensations; 
dizziness, vertigo, or unsteady feelings; feelings of unreality 
(depersonalization or dereallzatlon); paresthesias; hot and cold flashes; 
sweating, faintness; trembling or shaking; and fear of dying, going crazy, 
or doing something uncontrolled during the attack. Attacks usually last 
minutes; more rarely, hours.... panic (anxiety) attacks.... (may) occur 
at times unpredlctably, though certain situations, e.g., drivtng a car, may 
become associated with a panic attack. ( p. 230)
These panic attacks are typically accompanied by a sense of doom and fear that one Is 
dying of a heart attack or stroke, Is going crazy, or Is going to faint, or lose control In some 
way as to be publicly humiliated. Agoraphobics seek to flee when such attacks occur, and 
fear and avoid any place where flight to safety Is likely to be prevented. It is for this 
reason that a number of authors (Goldstein & Chambless, 1978; Weekes, 1976) have 
proposed that agoraphobia Is prim arily a "fear of fear", with the fear of places being 
secondary.
The prevalence of agoraphobia 1n the general community has been estimated at 
6.3/1000 (Agras, Sylvester & Ollveau, 1969). The proportion of psychiatric patients* 
who are diagnosed phobic is about 2 -3 £  (Terhune, 1961), and of these, the majority are 
agoraphobic. The majority of patients who present themselves for either psychiatric or 
psychological treatment for agoraphobia also suffer from panic attacks (Johnson, 1985).
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A prominent characteristic of this syndrome Is that approximately two-thirds of 
patients are women (Marks, 1970;Terhune, 1949). The majority are married and tend to 
marry at ages comparable to normal populations (Marks & Gelder, 1965). Most authors 
have claimed that agoraphobics are not unusual In Intelligence, education, religion, ethnic 
groups, socioeconomic status or occupation (Fensterhelnm &Beer, 1977; Marks, 1969; 
Weekes, 1976).
Agoraphobia normally begins In young adult life (18 -35  years). Marks (1970) and 
Bowen and Kohout (1979) report two peak ages of onset, at about 20 years and at about 
30-35 years. Most research reported Indicates that agoraphobics seek treatment In their 
thirties, although the time from onset to professional contact varies considerably (Marks,
1970). A more detailed description of the agoraphobic syndrome can be found In a number 
of excel lent reviews (Chamb1ess&Goldstein, 1982; Mathews, Gelder & Johnston, 1981).
Theories of the Acquisition of Phobias 
The discussion which follows briefly examines theories for the acquisition of phobias. 
These theories fall Into two broad classifications, learning theories and cognitive models.
1. Two factor theory: Classical and operant conditioning
The most influential p re -1970 formulation of phobias In learning theory terms Is the 
two-processor two-factor theory (Eysenck & Rachman, 1979; Mowrer, 1960), In which 
the two 'factors' Involved are classical and Instrumental conditioning prxedures. Central to 
two-factor theory Is the claim that avoidance behavior Is acquired and maintained "by the 
Intermediation of fear" (Mowrer, 1960, p. 25).
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Mowrer (1960) proposed that all fears are In itia lly acquired through Pavlovlan 
(classical conditioning) processes, and are maintained as a result of operant-conditioned 
learning. In the classical conditioning component, the phobic situation (or, more 
accurately, the environment In which phobic behavior 1s manifested) has acquired the 
potential to evoke anxiety, a conditioned reponse (CR), through pairing with a noxious 
unconditioned stimulus ( UCS). Reiss (1980) summarizes the concepts In this way.
Initia lly neutral stimuli become conditioned ellcltors of fear when 
experienced In temporal contiguity with such averslve events as conflict, 
trauma, pain, and confinement. A phobic stimulus Is regarded as a 
conditioned stimulus (CS), acquired fear Is regarded as a conditioned 
response (CR), and averslve events are regarded as reinforcing stimuli 
and as unconditioned stimuli (USs). ( p. 381)
The acquisition and maintenance of avoidance responses are attributed to negative 
reinforcement ( Instrumental) contingent upon avoidance of the feared object or situations. 
Escaping the CS, or phobic situation Is negatively reinforced by anxiety-reduction. Because 
of this, escaping becomes established as a habitual response to the phobic surroundings, and 
more Important the escape behavior curtails exposure to the CS. Brief exposure to the CS Is 
likely to be Insufficient to promote extinction of the CR, and, furthermore, 
anxiety-reduction becomes correlated with new environments that may assume the 
connotation of safety. Avoidance of the CS In the firs t place, another prominent feature of 
phobic behavior, equally protects the CR from extinction. SJdman (1966) summarizes the 
sequence of events as follows:
The literature on avoidance behavior consists largely of a series of 
variations on a single theme; The subject is firs t made anxious through a 
process of Pavlovlan conditioning; his avoidance behavior is reinforced 
when It terminates or reduced the conditioned anxiety state. ( p. 448)
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The most significant support for classically conditioned acquisition of fear generally Is 
derived from experiments with laboratory animals (see reviews by Broadhurst, 1960,
1972; and Wolpe, 1958). There have been a few reported Instances of conditioned fear 
responses In humans, however, It has been difficult to demonstrate this phenomenon In the 
laboratory ( Rachman, 1977). Supporters of the operant conditioning theory Justify their 
position by reporting on the successful use of learning schemes based on this theory with 
both animals and humans (e.g., Blackman, 1974). However, the success of techniques based 
on a particular theory do not necessarily demonstrate the validity of the theory. In fact, 
there are serious objections to the validity of both the Pavlovlan theory of fear acquisition 
and the operant conditioning theory of avoidance behavior.
A number of objections to Pavlovlan theory Include (8) the difficulty In demonstrating 
that the CS Is not a discriminative stimulus ( I.e., a signal that the UCS may occur) rather 
than a stimulus that has acquired response-evoking properties In Itself (e.g., Herrnsteln,
1969); ( b) the finding that extinguishing of fear responses does not necessarily occur, 8S 
predicted by the theory, upon repeated presentations of the CS in the absence of any 
externally-occurring traumatic events (e.g., repeated exposure to being away from home 
without harm has little  effect upon agoraphobics’ fears of such exposure); (c) the fact that 
the theory seems to require a concept of equfpotentially: that Is, that any stimuli coinciding 
with the elicitation of fear could become a CS and this clearly does not happen; (d) that 
patients with strong fears often deny that any traumatic event was associated with acquisition 
of the fear, and that some phobics have never been exposed to the situations they fear. A 
fuller discussion of the shortcomings of classical conditioning theory Is considered beyond the 
scope of this essay, but the Interested reader 1s directed to Rachman, 1977.
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A number of deflclences of the operant model of avoidance maintenance are that (a) 
people often choose to confront stimuli they fear rather than avoid them; ( b) avoidance 1s not 
necessarily associated with anxiety nor with reinforcement (Bolles, 1972; Rachman,
1976); (c) the theory does not explain nor predict behavior, since "Reinforcement" is 
defined as "those contingencies which modify behavior," and so the theory becomes 
tautological: A person avoids because reinforcement Is contingent upon the avoidance 
response; the contingency Is reinforcing because the person is observed to avoid. As 1n the 
case with Pavlovlan conditioning, a discussion of the inadequacies of the operant model is 
considered beyond the scope of this essay, however, the interested reader Is directed to 
Bolles, 1972.
2. Cognitive models
Other models have been suggested (Bandura, 1977; Bolles, 1972; Rachman, 1977; 
Reiss, 1980) for fear acquisition, that are purported to be more adequate theoretically.
These models have received some experimental support. Bolles (1972), Reiss (1980), 
Bandura (1977), and Rachman (1977) all stressed the cognitive aspects of fear acquisition 
and modification. Bandura (1969) has alread/ demonstrated that fears may be acquired 
vicariously through modeling and other symbolic means. Bolles (1972) proposed that 
processes underlying operant conditioning paradigms are more adequately described by an 
expectancy model, in which two kinds of expectancies are learned: that certain responses are 
likely to lead to certain consequences. Bolles (1972) suggested that avoidance responses to 
CSs are more adequately explained by considering the Informational value of the CS (that an 
unpleasant event Is likely to follow) than by theorizing that escape from the CS has become
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QInherently reinforcing.
Reiss (1980) extended the expectancy concept to Pavlovlan conditioning by pointing 
out the importance of the Informational value of the stimuli which become CSs, and suggested 
that subjects respond to the expected appearance of the UCS rather than to other properties 
acquired by the CS. Reiss (1980) proposed an expectancy model of phobias. Assumptions of 
this model are that, (a) classical conditioning is a form of stimulus-expectancy learning, 
and ( b) the laws governing the acquisition of expectancies and CRs are essential ly the same. 
There are, then, according to Reiss (1980) four processes In the acquisition of a phobia:
(1 ) The acquisition of "initiating (danger) expectancies". These 
expectancies of physical or social danger can result from cognitive 
learning, associative learning, covert conditioning, observations 
from models, or a combination of these factors.
(2 ) The acquisition of "anxiety expectancies" through In vivo or covert 
experiences.
(3 ) Initial avoidance, which at least sometimes occurs via negative 
reinforcement.
(4 ) The persistence of avoidance by means of self-regulatory processes.
Bandura (1977) has elaborated a cognitive model of behavior change which proposes 
that performance-based treatments for phobic disorders decreases fear and avoidance 
behavior by Increasing perceived self-efficacy. Self-efficacy may be defined as an 
Individual's expectations of personal effectiveness In dealing with the particular feared 
situation. The level of perceived self-efficacy, or expectations of personal effectiveness, 
may be derived from four major sources: (1 ) behavioral experience, (2 ) vicarious 
experience, (3 ) verbal persuasion and exhortation, and (4 ) level of physiological arousal 
(from which the individual judges his or her ability to deal with the situation). Bandura
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(1977) has Interpreted his and other research findings, with phobic subjects, as 
supporting the position that Information gathered from all four sources Including cognitive 
ones Is seen as contributing to the success of performance-based treatments. The 
self-efficacy model has received some empirical support from studies with snake phobics 
( Bandura & Adams, 1977), acrophoblcs (Bourque &l_adoucer, 1980), and agoraphobics 
(Bandura, Adams, Hardy & Howells, 1980), but further work 1s needed to provide adequate 
support for the theory.
To summarize, more recent theories proposed to explain acquisition, maintenance, and 
reduction of fear In humans have given strong emphasis to cognitive processes. Some of 
these theories have been briefly presented for the readers’ Interest. These more recent 
theories seem to have greater explanatory and predictive power than the older, two-factor 
theory, but experimental support for them Is Just beginning to be reported.
Pehpvlpr Theropy.fpr Phobia?
The discussion which follows examines some of the evidence regarding the therapeutic 
efficacy of behavior therapy, as It pertains to phobias In general, and as related to 
agoraphobia In particular.
Effectiveness of Behavior Therapy for Phobias
Since the early 60’s, a large body of literature has been devoted to the behavioral 
treatment of phobic disorders. Several critical reviews of the research have appeared that 
have attempted to unify the findings In this area, and It has been suggested that the 
therapeutic element common to successful treatments of phobias Is exposure to phobic 
(feared) situations (Marks, 1978; Mathews, 1978; MavlssakalIan & Barlow, 1981). The
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term "exposure treatments" has been proposed by Marks (1978) and utilized to signify all 
treatment strategies that Involves exposing the phobic client to the threatening real-life 
situation for extended periods of time.
Exposure treatments have been conducted In a variety of ways, over the years, 
differing, at least procedurally, on several Important dimensions. Marks (1978) has 
summarized the varieties of approach to the phobic stimulus In exposure treatments, and 
has concluded that some of the more common ways In which treatments vary Include, 
Imagined versus live ( in vivo) exposure, and therapist-assisted versus self-exposure. 
Different combinations of these variables have resulted In a number of different treatment 
strategies all of which have been shown to be relatively effective when Incorporating some 
form of exposure to fear-eliciting situations ( Mavlssakallan & Barlow, 1981).
The single common thread that unifies all of the above mentioned treatment strategies 
may be found in the concept of exposure. It appears clear that exposure of phobics to feared 
situations results In fear reduction, and there Is some indication that direct or live 
confrontation with phobic stimuli may be most effective In facilitating this goal.
Effectiveness of Behavior Therapy for Agoraphobics
The application of behavioral treatments with agoraphobics has been Investigated in a 
large number of studies with encouraging results overall. Among the behavioral procedures 
that have been studied with agoraphobics Include systematic desensitization (Gelder & 
Marks, 1966;Gelder, Marks&Wolff, 1967), ImagJnal flooding (Marks, Boulougour Is & 
Marset, 1971; Gelder, Bancroft, Gath, Johnston, Mathews & Shaw, 1973), successive 
approximation (Agras, Leltenberg & Barlow, 1968; Crowe, Marks, Agras & Leltenberg,
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1972). self-observation (Emmelkamp, 1974; Emmelkamp & Ultee, 1974), group In vivo 
flooding (Hand, Lamontagne & Marks, 1974; Stern & Marks, 1973; Teasdale, Walsh, 
Lanshlre & Mathews, 1977; Watson, Mullett & Plllay, 1973) and participant modeling 
(Bandura, Adams, Hardy & Howells, 1980). Each of the treatment procedures mentioned 
above Involve exposing the phobic Individual to the feared situations. The various 
treatments differ mainly 1n terms of certain parameters of exposure namely, mode of 
presentation (tmaglnal vs. In vivo), Intensity (graded vs. ungraded), and mode of 
facilitation (therapist aided, partner aided, or self-directed).
Taken together, the studies cited above provide overwhelming support for the efficacy 
of behavioral methods In treating those suffering from agoraphobia. With few exceptions 1n 
vivo exposure procedures have been demonstrated to be superior to Imagery-based therapy 
procedures (Chambless &. Goldstein, 1982; Mathews, Gelder & Johnston, 1981). In fact, 
Marks (1975) concluded that "real life exposure Is the most powerful therapeutic factor so 
far Identified" (p. 93).
A number of the studies cited above are particularly relevant to the use of In vivo 
exposure for agoraphobics. Five of these studies are worthy of more detailed review, as they 
Illustrate the usefulness of behavioral treatment and Indicate the type of methodology typical 
of research In the field
(1 ) One of the earliest studies to examine the efficacy of behavioral treatment for 
agoraphobics was conducted by Gelder, Marks, Wolff, and Clarke (1967). This study used 
agoraphobics, social phobics, and single-situation phobics to compare the outcome of three 
forms of treatment: Individual psychoanalytic psychotherapy, group psychoanalytic 
psychotherapy, and Individual behavior therapy. Treatment time parameters were 1 hour
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per week for 50 weeks, 1 112 hours per week for 80 weeks, and 1 hour per week for 36 
weeks, respectively. Approximately half of the subjects were agoraphobics. Subjects In the 
behavior therapy condition received systematic desensitization and graduated 1n vivo tasks to 
be carried out between sessions. Outcome was assessed using rating scales completed by 
patients, therapists, and assessors. After 6 months of treatment, patient ratings of 
improvement on "main phobia" were significantly better for the behavior therapy group 
than for the other two groups, and behavior therapy was better than group therapy on 
therapists' and assessors' ratings on "main phobia." These differences had disappeared by 
the 12th month assessment (at which the psychotherapy groups had received 3 months’ 
additional treatment compared to the behavior therapy group). By the end of treatment 
there was some Indication that the two Individual treatments were better than the group 
condition, but the Individual treatments were not distinguishable from one another. Since 
the behavior therapy group received less treatment than the psychotherapy patients (36 
hours versus 50 hours), the behavioral treatment was more cost effective.
(2 ) Crowe, Marks, Agras, and Leltenberg (1972) compared Imeglnal flooding, 
systematic desensitization and "shaping" or "reinforced practice" In a cross-over stud/ of 
fourteen phobics Including four agoraphobics. The shaping procedure required the subjects 
to approach the actual feared situation In graduated steps, with Instructions to turn back as 
soon as he/she became anxious. The therapist delivered social reinforcement In the form of 
praise for Improved performance. This Is the firs t report of a well conceived and executed 
In vivo procedure for agoraphobics. Each subject received one block of four sessions of each 
treatment In random order. Sessions were held twice weekly and the duration of exposure 
(real or fmagtnal) was 40 minutes per session. Both behavioral measures and symptom
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ratings were used In the assessments, which were made prior to treatment and after each 
treatment block.
On the behavioral test the shaping condition was found to be significantly better than 
systematic desensitization, while flooding was In an Intermediate position and did not differ 
significantly from either of the other two treatments. No differences were found among 
conditions on the rating scales. Comparing the agoraphobics to the slngle-sltuatlon phobics, 
no differences were found In response to the three conditions. For the agoraphobics the 
order of effectiveness of the treatments was the same on all measures 
(shaping— flooding--systematic desensitization), while for the single-situation phobics no 
consistent order was found. The authors Justifiably conclude that for agoraphobics, shaping 
seems to be especially worthy of further study.
(3 ) Emmelkamp and Wessels (1975) compared flooding In vivo versus flooding in 
imagination versus a combination of the two procedures with 19 agoraphobic subjects (18 
females and 1 male). Subjects were matched on duration of symptoms and amount of time 
they were able to walk around on the street alone. Three groups were generated. The firs t 
received four sessions of flooding In Imagination, and the third received four sessions of a 
combination of flooding in imagination and flooding in Yivo, and then each subject carried out 
eight sessions of in vivo exposure with minimal therapist contxt. Assessments were made 
at pretreatment, after the firs t four sessions, at post treatment, and at follow-up. Both 
behavioral tests and rating scales were used. Treatments were performed In subjxts* home, 
and the home was the starting point In the exposure conditions.
At the intermediate assessment subjxts in the two xnditions which Included In vivo 
exposure showed gains on the behavioral test and on most ratings of anxiety and avoidance,
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while subjects In the Imaginal treatment reported reduced anxiety but showed no change In 
avoidance behavior. The In vivo exposure condition was superior to the combined treatment 
on many variables, 8nd the combined treatment was superior to the imaginal-only condition 
on therapist ratings only. At posttest, after all groups had eight sessions of In vivo 
exposure, no differences were found between the groups, and all groups showed significant 
improvement on most measures. In vivo exposure was clearly shown to be superior to 
Imaginal flooding.
(4) Emmelkamp, Kuipers, and Eggerant (1978) used a cross-over design In which 
twenty-one agoraphobics were exposed to "cognitive restructuring" and prolonged real-life 
exposure. Each technique was implemented In a group context. Patients were randomly 
distributed among four groups, two of which received cognitive restructuring, and the 
remaining two of which had In vivo flooding; after five 2 hour sessions, exh group received 
the alternate treatment for the same number of sessions. Assessments were made 
pretreatment, at cross-over, posttreatment, and I month after treatment, and consisted of a 
behavioral test, self-report Inventories, and rating scales completed by the patient and an 
independent clinician.
in general, all four therapy groups showed improvement from pre- to posttest on 
almost all variables. Prolonged exposure produced significantly more improvement than 
cognitive restructuring on a behavioral test and on many self-report and rating scales. 
Results of the assessment at 1 -month follow-up were almost identical to those Immediately 
posttreatment. In vivo exposure was generally, consistently, and significantly superior to 
cognitive restructuring.
(5) McDonald, Sartory, Grey, Cobb, Stern and Marks (1979) provided support for
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the effectiveness of systematic exposure without the presence of a therapist. Nineteen 
agoraphobic outpatients were randomly assigned to a self-exposure homework condition or a 
nonexposure discussion condition. Subjects 1n both conditions met Individually for 20-30 
minutes on four different occasions over a six- week period. In the self-exposure condition, 
therapists helped subjects plan their self-exposure activities, while subjects In the 
non-exposure control participated In general discussions with the therapist on life 
difficulties. Results revealed a small but statistically significant superiority of the 
self-exposure condition on subjects' ratings of phobic severity and assessor’s ratings of 
target problems. The authors conclude that such self-exposure can be of benefit to 
agoraphobics.
The ultimate test of any treatment approach Is Its ability to Induce desired changes 
which endure over time. In regard to this ability, the great majority of studies that Include 
follow-up information after any form of treatment Indicate that gains are stable over 
periods of from I month to 4 years. Subjects as a group neither continue to improve much 
nor fall back to a significant degree, but remain at about the level of functioning they had 
achieved at the end of treatment. In summary, a review of the literature reveals that 
treatment of agoraphobia by In vivo exposure to the feared situations has produced the most 
beneficial outcomes In general.
Several workers have studied ways of optimizing the exposure approach. Group 
treatment has been found to be at least as effective as Individual work and a more efficient 
use of therapist time (Hafner & Marks, 1976; Hand, Lamontagne & Marks, 1974; and 
Teasdale, Walsh, Lancashire & Mathews, 1977). It also may be possible to Increase the 
efficiency of the In vivo exposure by combining It with another form of treatment, cognitive
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restructuring. Only two studies (Williams & Rappoport, 1983; Emmelkamp & lierch,
1982) have examined the integration of cognitive restructuring with in vivo exposure and 
then examined the treatment outcome. Both studies suggested an equivalence of treatment 
methods, however, both studies were flawed and deserve replication and extension with 
design Improvements. Despite the above two studies there Is reason to think that such a 
combined approach may enable people to utilize more effectively cognitive Interventions.
Cognitive Therapy for Phobias
The discussion which follows examines some of the theory and development of cognitive 
therapy and the evidence relating to Its therapeutic efficacy, as 1t pertains to phobias and 
phobia-related Issues in general, and as related to agoraphobia In particular.
Overview
Since the 1960s, cognitive and cognitive-behavioral Interventions have become 
popular 1n the treatment of a variety of clinical disorders. Such disorders as anxiety (e.g., 
Beck,A.T., 1976; Melchenbaum, D.H., 1972;Me1chenbaum,D.H.,etal., 1971), depression 
Ce.g., Beck, A.T., 1976; Hollon,$.D.,&Beck,A.T., 1979), assertion (e.g., Kazd1n,A.E., 
1974;L1nehan, M.M., 1979), anger (e.g., Beck, A.T., 1976; Novaco, A.E., 1974), eating 
disturbances (e.g., Kelly, A.H., & Curran, J.P., 1976; Leon, G.R., 1979), and pain (e.g., 
Spanos, N.P., & Barber, T.X., & Lang, G., 1974; Spanos, N.P., & Brazil, K., 1984; Spanos, 
N.P., Horton, C., & Chaves, J.F., 1975; Stam, H.J., McGrath, P.A., & Brooke, R.I., 1984
(a); Stam, H.J., McGrath, P.A. & Brooke, R.I., 1984 (b)) have been the subject of extensive 
experimental and clinical research. This trend toward the use of cognitive and 
cognitive-behavioral Interventions with clinical disorders Is also evident In the treatment
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of phobias, In which cognitive treatment strategies have been used occasionally either alone 
or In conjunction with behavioral exposure-based techniques.
The significance of maladaptive cognitions In the genesis of anxiety reactions and 
maintenance of anxiety disorders has been discussed by several cognitive and 
cognitive-behavioral theorists (Beck, 1976; Ellis, 1962; Melchenbaum, 1977). 
Specifically, they have proposed that catastrophic or Irrational thoughts play a critical role 
In mediating maladaptive physiological-emotional and behavioral responses.
Within a cognitive-behavioral framework, cognitions are generally viewed both as 
covert responses to certain stimulus situations and, subsequently, as the stimuli themselves 
that elicit physiological and behavioral responses. In phobic disorders, specific maladaptive 
cognitions are thought to elicit fear and anxiety, both prior to and during contact with phobic 
stimuli. Such thoughts generally center on the physiological change accompanying anxiety, 
avoidance of or escape from the phobic situation, or anticipation of a catastrophy, 1t serves 
to escalate physiological arousal, resulting in avoidance/escape behavior. These maladaptive 
cognitions are conceptualized as prim arily responsible for the maintenance of fear and 
avoidance patterns characteristic of phobic disorders.
It 1s Important to note that the proposed role of maladaptive thoughts in the fear 
process does not negate, necessarily, the etiological significance of automatic or conditioned 
fear responses within a learning theory or conditioning model or phobic disorders.
Exposure to feared situations may trigger negative self-statements based on prior learning 
experiences and past memories, which then bring on or Increase physiological activity and 
avoidance/escape behavior.
Given the hypothesized mediatlonal role of maladaptive thoughts, fear reduction Is 
thought to occur as a consequence of decreasing these self-verbalizations (Beck, 1976; 
Ellis, 1962; Goldfr1ed& Davison, 1976; Mahoney, 1974; Melchenbaum, 1977).
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Specifically, decreases In maladaptive cognitions are thought to reduce the physiological 
component of fear which, in turn, eliminates avoidance/escape behavior, since such 
behavior no longer serves its Initial purpose ( I.e., avoidance of subjective distress or 
panic).
Although numerous cognitive Interventions have been developed and utilized over the 
years, most of these treatment approxhes are based on the theorizing of Ellis (1962), Bxk 
(1976), and Melchenbaum (1977). In addition to underlying the importance of cognitive 
processes, each of these Individuals has endorsed spx lflc  prxedures for altering 
maladaptive cognitions. According to Ellis' (1962) "rational-emotive therapy,” Beck’s 
(1976) "cognitive therapy," and Melchenbaum’s "self-Instructional training" (1977) may 
all be subsumed under the category of "cognitive restructuring” since they all attempt to 
modify directly spx lflc  thoughts and beliefs believed to be mediators of arousal.
According to Ellis (1962), certain core irrational beliefs are xnceptuallzed as being 
at the root of most emotional disorders. Maladaptive cognitions consonant with these 
Irrational beliefs are sxn as responses to rea l-life  experience, and are viewed as leading to 
emotional distress. For phobias some of these beliefs are that "they must not approxh 
feared objxts or situations and that It Is horrible If they do,” " it  is awful or catastrophic 
when they don't perform well and/or are not approved of by others as they should or must 
be," "they should or must get what they want ( and should not or must not get what they don't 
want) and It Is awful or  catastrophic" If this does not happen, and that they "must not 
experience the kind of exceptionally painful ( phobic) reactions." It’s awful to f x l  that 
uncomfortably anxious. I can't stand that amount of Inconvenience" (emphases Ellis’ , Ellis,
1979, p. 162-164). Ellis proposes that pxple avoid situations because of their extreme 
assessment of the xnsequences. He tries to convince them to relabel their arousal as
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"Inconvenient" rather than "awful," that they can stand It, and that they w ill overcome the 
anxiety with practice. Ellis also emphasizes the need for In vivo exposure and discusses its 
Incorporation 1n altering cognitions.
A second approach to cognitive restructuring has been discussed by Beck ( Beck, 1976; 
Beck fk Emery, 1979). Like, Ellis, Beck maintains that certain patterns of irrational 
cognitions lead to emotional distress and "neurotic" behavior. Beck and Emery (1979) note 
that phobics often overestimate the likelihood that a situation is dangerous to them, 
frequently remind themselves of the dangers they fantasize, often imagine catastrophic 
outcomes as the ones likely to occur, attend too much to their level of arousal, assume that 
even slight arousal Justifies there appraisal of the situation as dangerous, and do not 
effectively consider coping strategies or positive outcomes. Beck and Emery (1979) 
consider these to be cognitive errors, and suggest a dual approach to dealing with these. 
Verbal interventions are used to help the person become sensitive to, question, and alter the 
self-defeating cognitive processes currently in use. In vivo work 1s conceived of as another 
way of testing (challenging) faulty beliefs and expectations and is considered to be a form of 
cognitive therapy in that its purpose is cognitive change ( rather than reconditioning).
lieichenbaum’s (1977) orientation has considerable sim ilarity to that of Beck and 
Ellis. In his approach, self-verbalization or "self-talk" Is viewed as the precipitant for a 
wide range of emotional and behavioral disorders. In the case of anxiety reactions, the aim 
of treatment Is to have clients become aware of their negative or Irrational thought patterns 
when anticipating or confronting an anxiety-producing situation, and to change these 
thoughts by substituting more adaptive, coping self-statements. Clients are encouraged to 
develop their own Idiosyncratic coping statements through a skills development approach, 
and behavioral experience often Is Incorporated Into the treatment package. This 
self-instruction approach provides some security because they have a plan of action and
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don't feel helpless, (b) guides their behavior In such a way as to make successful coping 
with task demands more likely, and (c) Interferes with anxiety engendering cognitions 
which usually occur In the situation, lieichenbaum (1977) 8lso suggests that people can 
become effective at dealing with stressful situations through "stress inoculation training," 
which Includes an educational phase during which the problem Is conceptualized and coping 
strategies worked out, a rehearsal phase during which the client practices ways of using the 
coping devices, and an applications phase in which he masters the use of coping devices by 
applying them during exposure to a variety of stressors ( lieichenbaum, 1977).
Beck and Ellis have arrived at their views largely as a result of their clinical work, 
and systematic study of the theoretical underpinnings of the systems, and of their treatment 
efficacy, have been slow In coming. Bandura's views, In contrast, have developed out of the 
behavioral research literature and rest on a solid data base. Bandura also strongly favors a 
cognitive medlatlonal model of behavior change, but argues that In most cases a 
performance-based treatment Is the best way of altering cognitions. He considers phobic 
arousal resulting from real or symbolic stimulation as occurring because of the meaning 
attached to each stimuli, rather than as a result of a classical or operant conditioning 
process. Bandura (1977) recently proposed "perceived self-efficacy" as a major organizer 
of many of peoples' cognitive and behavioral processes. He suggests that avoidance behavior, 
obsessive worrying, physiological arousal, nightmares, etc., occur In phobics because they 
perceive themselves unable to cope with some situation or stress they are threatened with. 
As they learn coping mechanisms and find themselves able to use them, all the phobic 
manifestations disappear. He suggests that the reason both exposure therapy and other 
forms of therapy are successful with phobics Is that In one way or another they Increase the 
person’s perceived self-efficacy.
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Effectiveness of Cognitive Therapy for Phobias
Cognitive restructuring procedures have proven to be successful in the treatment of 
small animal phobias (D'Zurllla, Wilson & Nelson, 1973; Melchenbaum, 1971; Wein, 
Nelson & Odom, 1975), test anxiety (Holroyd, 1976; Melchenbaum, 1972), speech anxiety 
(DiLoreto, 1971; Melchenbaum, Gilmore &Fedoravicus, 1971; Thorpe, 1975) and 
interpersonal anxiety ( Kanter & Goldfrted, 1979). Despite the fact that all of these 
investigations were analogue studies with students as subjects, at least two of them, both 
involving comparisons with systematic desensiti2ation, are worth examining in detail.
Melchenbaum, Gilmore and Fedoravicus( 1971), In a controlled outcome study, found 
that cognitive restructuring (based on Rational Emotive Therapy) was as effective as 
systematic desensitization in the treatment of speech anxiety and more effective than 
desensitlzatlon with subjects who suffer anxiety in many varied social situations as opposed 
to those subjects for whom speech anxiety was confined to formal speech situations. This 
finding is relevant to the treatment of agoraphobia Insofar as agoraphobia anxiety is also 
experienced in many varied situations as opposed to being situation-specific, defined in 
Meichenbaum's study as confined to formal speech situations.
Kanter and Goldfrled (1979), In a clinical outcome study comparing the relative 
effectiveness of rational restructuring and self-control desensitlzatlon in the reduction of 
Interpersonal anxiety, found that when compared with waiting list controls, rational 
restructuring was significantly more effective on a greater number of variables than was 
desensitlzatlon. The clearest findings emerged on the self-report measures revealing that 
rational restructuring was significantly more effective than desensitization in reducing 
state anxiety, tra it anxiety, and Irrational beliefs. There was a greater tendency for the 
cognitively-oriented treatment to result In generalization of anxiety reduction to nonsocial 
situations. This finding is similar to Meichenbaum's and both researchers' comments
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Indicate that cognitive restructuring might have greater generalIzablUty In 
reducing anxiety than systematic desensitlzatlon. If this finding Is valid, then one of the 
unique contributions of cognitive restructuring with the agoraphobic whose fear of fear 1s so 
widespread, might be In changing cognitions about anxiety which can then be generalized and 
emitted In any anxiety-eliciting situation, whether or not the situation has previously been 
labelled as phobic or nonphobic.
Effectiveness of Cognitive Therapy for Agoraphobia
1. Use of Cognitive Modification Alone
The firs t published study to examine the application of cognitive modification 
techniques for the treatment of agoraphobia was conducted by Emmelkamp et al. (1978). In 
this experiment, he compared cognitive restructuring versus flooding in vivo in a 
cross-over design with 21 agoraphobic outpatients. Each treatment condition consisted of 
five group sessions, each lasting two hours. The cognitive restructuring treatment 
comprised the following three components: (a) relabeling, i.e., helping each subject 
understand the nature of his/her responses to phobic situations, (b) pinpointing Irrational 
beliefs related to agoraphobic situations and (c) self-instructional training designed to 
train subjects to emit more adaptive self-statements. Flooding In vivo Involved remaining 
1n phobic situations until anxiety declined. Approximately 90 minutes of the 2-hour 
session was spent In exposure. Assessment consisted of a behavioral measure, self and 
observer ratings of anxiety and avoidance, and various mood and anxiety scales. After each 
group had experienced both treatments, they both showed significant Improvement on most 
measures. Exposure proved superior to cognitive restructuring on many of the behavioral, 
anxiety, and avoidance measures. Cognitive restructuring as the firs t treatment resulted In 
benefit on only one anxiety and two avoidance scales, and as the second treatment
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showed no benefit on any behavior, anxiety, or avoidance measure. The exposure treatment, 
whether given firs t or second, resulted In Improvement on almost every scale. Results of an 
assessment conducted at 1 -month follow-up were almost Identical to those Immediately 
posttreatment. I n vivo exposure was generally, and slgnlflcanty superior to cognitive 
restructuring.
Despite findings which point to the superiority of prolonged exposure in vivo over 
cognitive restructuring, Emmelkamp et al. (1978) offer an interesting Interpretation of 
these findings which emphasizes once again the role and Importance of cognitions In 
therapeutic change. They suggest that giving a form of treatment a name Is not the same as 
ellucidating the therapeutic process Involved.
Whether the treatment ’cognitive restructuring’ does actually produce a 
modification of cognitive processes Is a debatable point. On the other 
hand, the effects of prolonged exposure In vivo could at least partly be 
explained In terms of cognitive restructuring. During treatment with 
prolonged exposure In vivo clients notice, for example, that their anxiety 
diminishes after a time and that the events which they feared, such as 
fainting or having a heart attack, do not take place. This may lead them to 
transform their unproductive self-statements Into more productive ones: 
'there you are, nothing w ill go wrong with me.’ A number of clients 
reported spontaneously that their ’thoughts’ had undergone a much greater 
change during prolongkl exposure In vivo than during cognitive 
restructuring. It is possible that a more effective cognitive modification 
takes place through a procedure which Is focused directly on such a 
change. (Emmelkamp etal., 1978, p. 40)
Ellis (1979), In an article written to comment on the conclusions of the Emmelkamp 
et al. (1978) study, endorsed their cognitive Interpretations of the prolonged exposure In 
vivo treatment. In an attempt to draw lessons from Emmelkamp's study in order to Improve 
the efficacy of cognitive restructuring In treating agoraphobia, he postulated a new 
cognitive-behavioral construct which he calls discomfort anxiety (DA), and defines as
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emotional tension that results when people feel: (1 ) that their comfort (or life) Is 
threatened, (2 ) that they should or must get what they want ( and should not or must not get 
what they don't want), and (3 ) that It is awful or catastrophic ( rather than merely 
Inconvenient or disadvantageous) when they don’t  get what they supposedly must. Ellis 
claims that discomfort anxiety underlines the avoidance behavior of agoraphobics and that 1t 
exists as both a primary and a secondary disturbance. He explains 1t thusly:
Agoraphobics f irs t tend to make these cognitive demands on themselves: 'I 
must not experience any discomfort or handicap when I am 1n open spaces, 
buses, or similar situations; and it  Is terrib le If I do!' With this 
absolutlstic demand that they wrongly label themselves as being afraid of 
these situations Instead of (more accurately) as being afraid of the 
discomfort they w ill probably feel when they approach such situations. 
They are not tru ly  afraid of the open spaces or the buses, but of their own 
reactions to the spaces or the buses. Once they actually do 'become 
frightened' (actually, frlohten themselves) about the spaces or the buses, 
they then as a secondary symptom, 'fear or the underlying discomfort of 
being frightened- (E llis, 1979, p. 3)
In addition to proposing a theory of discomfort Ellis (1979) expressed some concerns 
about the methodology of Emmelkamp et al's (1978) study. One of these concerns was that 
Ellis felt that 10 hours of cognitive restructuring might not be sufficient to produce 
significant cognitive and/or behavioral change. Emmelkamp et al. (1978) In his discussion 
section acknowledged this criticism.
Emmelkamp et al. ( 1978) make some interesting comments In that they state that 
with cognitive restructuring, a transfer gap often proved to exist between practicing during 
the treatment sessions and applying the new forms of behavior In real life situations. 
Although most of the clients after some practice with cognitive restructuring, were able to 
think productively when Imagining phobic situations, they found It more difficult to make 
use of productive self-statements In real life situations.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
26.
The effect, of cognitive restructuring might be Increased If this procedure 
was combined with real life exposure In phobic situations. In the clinical 
use of rational-emotive therapy, for example, use Is often made of In vivo 
homework assignments (ElUs, 1962). To what extent a combination of 
cognitive restructuring and exposure In vivo by Itself Is, however, a 
question which requires Investigation. ( Emmelkamp et al., 1978, p. 40)
Ellis (1979) agrees wholeheartedly with Emmelkamp et al’s (1978) suggestion of 
combining 1n vivo + cognitive restructuring. In fact, Ellis (1979) comments:
Pure cognitive restructuring works relatively poorly for almost any kind 
of a phobia -  as I have always tried to make clear. For unless phobic 
individuals act against their irrational beliefs that they must not 
approach fearsome objects or situations and that 1t Is horrible 1f they so, 
can they really be said to have overcome such beliefs?
A number of other authors (D'Zur 11 la et al., 1973; Woodward & Jones, 1980; and 
Beck & Emery, 1979) also suggest that a combination of cognitive restructuring with In 
vivo techniques might prove useful.
2. Cognitive Modification with In Vivo Exposure
The firs t study which has examined the effectiveness of a combination of cognitive 
restructuring and prolonged exposure In vivo for the treatment of agoraphobia was 
conducted by Emmelkamp and Mersch (1982). In this study, which was basically a 
replication and extension of Emmelkamp et al's (1978) earlier study, three treatments 
were compared In a between group design: ( I ) cognitive restructuring (8  sessions), (2 ) 
prolonged exposure In vivo (8  sessions), and (3 ) a combination of cognitive restructuring 
(3 1/2  sessions) and prolonged exposure in vivo (4  1/2  sessions). Treatment consisted of 
eight 2-hour group sessions, held three times a week. Assessments were conducted at 
pretest, posttest, and follow-up on the following measures: (1 ) Behavioral Avoidance
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Test (BAT), (2 ) Phobic Anxiety and Avoidance Scales, (3 ) the Fear Survey Schedule 
(FSS), Internal-External Locus of Control Scale ( l-E ), Self-Rating Depression Scale 
(SDS), and Adult Self-Expression Scale CASES). At the posttest, prolonged exposure 1n 
vivo and the combined procedure (self-Instructional training plus exposure In vivo) were 
superior to cognitive restructuring on phobic anxiety and avoidance measures and on the 
behavioral measure, although the difference between exposure and cognitive restructuring 
on the latter measure was nonsignificant. At 1 -month follow-up, however, the differences 
betweeen the treatments partly disappeared, due to a continuing Improvement In the 
cognitive restructuring condition and a slight relapse In the exposure in vivo condition. 
Thus, although the short-term effects were similar to the results of the Emmelkamp et al.
(1978) study, In the long run cognitive modification alone was about equally effective. 
Self-instructional training did not appear to enhance the effects of exposure In vivo.
The significant Improvement of the cognitive restructuring condition between pretest 
and follow-up on depression, locus of control, and assertiveness Is particularly 
interesting. The Improvements found on these questionnaires suggest that cognitive 
restructuring led not only to Improvements on the target behaviors ( I.e., phobic anxiety 
and avoidance) but to generalized behavior changes. Of course, the present data do not 
permit drawing definite conclusions, but they certainly do warrant further studies Into 
the use of cognitive Interventions strategies for the treatment of agoraphobia. In their 
discussion section Emmelkamp and Mersch ( 1982) state:
Cognitive therapy conducted over a longer time Interval might prove to be 
more effective than when conducted 1n a short period. One week of cognitive 
restructuring led to clinically Insignificant results ( Emmelkamp et al.,
1978), whereas after 2 months cognitive restructuring clearly led to 
clinically meaningful Improvements In the present study.
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One can not help but speculate as to whether a longer period of cognitive restructuring 
treatment (e.g., 16 or 24 weeks) would result In more significant cognitive and behavioral 
changes In the agoraphobic. Another area of concern, which Emmelkamp and Mersch
(1982) acknowledged, was the lack of Instruments for the assessment of cognitions.
Adequate assessment of faulty cognitions 1s necessary for a better understanding of the 
therapeutic processes Involved In cognitive restructuring, exposure In vivo, and any 
combination of the aforementioned. It would have been Interesting 1f Emmelkamp and 
Mersch (1982) had attempted to assess cognitions of there different treatment groups.
Such an assessment might have proved Informative.
In another study Williams and Rappoport (1983) sought to determine whether 
cognitive therapy techniques would favourably combine with behavioral practice In helping 
overcome strong fears. Following a no-treatment baseline period, twenty agoraphobics with 
severe fears of driving received eleven hours of Individually guided practice at driving 
alone. Ten of the subjects were also given cognitive techniques to use on each approach 
attempt. Measures of approach behavior, anxiety, self-reported avoidance, self-efficacy, 
and thinking gathered at assessment points preceding and following treatment revealed that 
the only difference between the groups at any time was the greater us8 of cognitive 
strategies by "cognitive therapy" subjects following treatment. Similarly, measures of 
performance during treatment Indicated an intergroup difference only In the number of 
cognitive coping strategies employed. Despite the documented utilization of the cognitive 
techniques while driving, the combination treatment failed to show significantly greater 
Improvement compared to practice alone. However, neither treatment produced major 
behavioral gains in the study.
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Because the form of In vivo practice employed In Williams and Rappoport's (1983) 
study required that subjects reach a very low level of subjective anxiety before performing 
the next driving task In the treatment hierarchy, the cognitive Interventions could only have 
augmented outcome by helping subjects reach low anxiety quickly. However, the cognitive 
group did not differ from the non-cognltlve group 1n anxiety experienced during treatment.
It 1s possible that a cognitive intervention carried out in the context of a behavioral 
treatment that encouraged subjects to progress as quickly as they were able Irrespective of 
anxiety would be of some use In directly promoting performance efforts, and therefore 
would Increase treatment effectiveness.
One of the concerns expressed about Emmelkamp’s work ( Emmelkamp et al., 1978; 
Emmelkamp & Mersch, 1982) was the relatively short treatment time and this same 
complaint could be directed to Williams and Rappoport’s (1983) work. Eleven hours of 
treatment time might not be sufficient to produce significant cognitive change. Perhaps the 
number of sessions as well as the duration of treatments was too limited, resulting In 
restricted opportunities for subjects to learn, Integrate and practice their new coping 
skills 1n the natural environment. However, since Williams and Rappoport (1983) 
targeted their interventions to one particular aspect of agoraphobic, that Is driving fears, 
perhaps the treatment time was sufficient. Since, Williams and Rappoport (1983) have 
chosen one specific fear that Is often expressed by agoraphobics, one wonders whether the 
results of their study would be the same with another fear ( I.e., walking outside alone).
The design of this study prevents the reader from obtaining Information about the 
generalization of treatment efficacy beyond the fear of driving. Whether cognitive 
restructuring combined with In vivo exposure would be superior to In vivo exposure In
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reducing other fears, or whether an Increase 1n treatment time would prove the combined 
treatment more efficient can not be answered, but these are questions which warrant 
further Investigation.
Williams and Rappoport (1983) Included In their assessment package measures of 
self-efficacy and cognitions, This was a commendable effort that provided some useful 
information. Future use of such measures should prove valuable in lllucidating effective 
treatment strategies and theoretical proposals.
Cognitive Restructuring as a Treatment Procedure: Rationale
Cognitive restructuring refers to any therapy procedure which places primary 
emphasis on the role of cognitive behavior change In therapeutic Improvement. One of the 
fundamental therapeutic goals of cognitive therapy Is to change maladaptive expectations, 
attitudes, and beliefs that an individual holds about themself and their surroundings. It Is 
the direct focus on cognitive mediational responses that Identifies cognitive restructuring 
procedures and distinguished them from treatment procedures which focus on other 
response classes such as the physiological or the behavioral.
i. c^ finn3,pn.Mslad9PtiYeJhink,ing,P8ttern i
Some of the more common thinking patterns of agoraphobics which are maladaptive and 
which serve to perpeutate the phobic condition have been enumerated by various authors 
(e.g., Lazarus, 1971). Some of these maladaptive patterns have been briefly outlined In a 
previous section. A more detailed account of these patterns is detailed below. These patterns 
Include (a) dichotomous, or black and white thinking, (b) negative anticipation, (c)
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Irrational thinking, (d) over-generallzatlon, or absolutlstic thinking, and (e) Inaccurate 
probability.
( a) Dlchotomous. or black and white thinking, refers to thinking 
patterns which represents extreme polarities such as "I always 
panic In supermarkets" or T i l  never feel comfortable In 
supermarkets again." Prior to some attempt at cognitive 
restructuring, the Individual who thinks 1n black and white Is often 
Incapable of using qualifiers like maybe or perhaps, convinced that 
the world Is as polarized 8S he perceives It to be.
( b) Negative anticipation, refers to the "what 1fH syndrome, typical of 
agoraphobics who are Incapable of Imagining anything occurlng In 
the future but the worst possibilities.
Negative anticipation Is a particularly pathological thinking pattern which often 
becomes so pervasive that the agoraphobic Is constantly concerned with avoidance of and 
escape from all noxious stimuli. Ellis (1979) claims that while agoraphobics always 
anticipate discomfort, It Is because of their low discomfort tolerance that they seek to avoid 
the discomfort they anticipate whenever possible.
(c) Irrational thinking, refers to concepts from the Individual’s 
Irrational belief system, taken from Ellis’ rational-emotive 
therapy (RET). Ellis (1962) maintains that psychological 
problems arise from Individuals misperceptions and mistaken
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cognitions about what they perceive. These beliefs are classified as 
Irrational because they are not likely to be supported ( i.e., 
confirmed) by one's environment. Ellis (1962) holds that certain 
core Irrational ideas, which have been clinically observed are at 
the root of most emotional disturbances.
According to the theory behind cognitive restructuring the extent to which a person 
tends to label situations In accord with one or more of these Irrational beliefs w ill strongly 
determine his maladaptive emotional responses and Ineffective behavior. It should be 
stressed, however, that i t  is unlikely that individuals consciously or deliberately tell 
themselves any of these statements when they are actually In a situation. Presumably 
because of the overlearned nature of the beliefs, they become as automatic and seemingly 
Involuntary as a well learned set (Woodsworth & Scholsberg, from Goldrled & Davison, 
1976).
(d) Overoenerallzatlon (Lazarus. 1971), or absolutlsttc
thinking ( Ellis, 1979) in the agoraphobic, refers to the person 
who has had a panic attack In a supermarket, then overgeneralizes 
and begins to perceive all supermarkets as threatening In that they 
have been attributed with the power to elicit a panic attack, and 
are therefore to be avoided. This tendency to overgeneralize Is 
closely linked to the tendency or need for absolute certainty. In 
other words, all supermarkets are perceived as dangerous because
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the agoraphobic Is absolutely certain that any one of them has the 
power to trigger a panic attack.
Russell (1962) once stated "not to be absolutely certain Is, I think, one of the 
essential things In rationality" (In  Lazarus, 1971, p. 169). A cognitive r estructuring 
approach with agoraphobics must attend to both the tendency to overaeneralize and the need 
for absolute certainty In order to change one of the more salient features of the 
agoraphobtc's cognitive topography.
( e) Inaccurate Probability. In the case of agoraphobics, refers to the 
fact that they tend almost never to question the actual likelihood or 
probability of what they fear actually occurlng, but rather 
assume, based either on an Inaccurate or non-existent theory of 
probability, that what they fear w ill in fact occur 1OO/K of the 
time. Cognitive restructuring procedures must therefore attempt 
to teach agoraphobics about the nature of probability In order to 
provide them with a more realistic foundation on which to base 
their predictions.
Although these thinking patterns overlap, they have been enumerated separately In 
order to Illuminate some of their differences while at the same time emphasize the fact that 
most agoraphobics manifest all of these thinking disorders to some degree.
2. Effect of Thinking Patterns on Behavior
A final consideration In favor of a therapeutic goal involving cognitive change Is that
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of patient control or mastery. Bandura ( et al., 1980) has provided an inciteful description 
of the agoraphobic's cognitions following the panic experience:
Thoughts centered Increasingly on their vulnerability to disintegrative 
loss of control in public situations. They began to dread excursions 
outside the home because the averslve experiences recur unpredictably.
Since distress subsided in the safety of the home. It took on powerful 
security value. Once perceptions of coping efficacy were undermined, 
even mild distress In taxing situations forboded disintegrative loss of 
control. As a result, the clients general ized their phobic avoidance to 
increasing domains of functioning in which they had never suffered 
disabling experiences. ( Bandura et al., 1980, p. 63)
Meyer and Reich (1977) argue that the perceived lack of control or mastery Is a 
central manifestation of the agoraphobic's complaint, I.e., " f can’t help It." They go on to say 
that treatment procedures must directly help to alter this self-perception. Now that the 
cognitive style of agoraphobics has been described, consideration w ill be given to the Impact 
or effect of these cognitions on physiological arousal and overt behavior. At one extreme, 
cognitions are held responsible for actually maintaining the phobic syndrome; that Is, the 
fear of fear which 1s largely a cognitive process, remains pervasive even when physiological 
symptoms are reportedly under control and often when the Individual has not experienced a 
full-blown panic attack In months. Klein etal. (1978), based on their experiences with 
ontl-depressants which block panic attacks but do not affect anticipatory anxiety, argues 
that the behavioral avoidances and security rituals are caused by the secondary anticipatory 
anxiety rather than by the panic. For these Individuals It Is as Bandura et al. (1980) 
suggest: It 1s the Individual's thoughts and beliefs obout Impending danger, about the 
Potential discomfort of anxiety which w ill be too painful to bear, that continue to maintain 
the original pattern of phobic avoidance, and through a process of generalization expand the
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situations and territory avoided because of the anticipation of future danger.
Chambless and Goldstein (1980) take the assumption of cognitions being responsible 
for creating autonomic arousal to Its extreme by arguing that agoraphobics actually think 
and talk themselves Into their panic attacks: "The agoraphobic... gets so anxious about being 
anxious that the attack 1s triggered" (p. 326). They view cognitions as powerful 
determinants of both autonomic arousal and avoidance behaviors, commenting on the fact that 
the mere thought of an elevator for an agoraphobic Is enough of a reminder to stay away from 
elevators forever.
In summary, because maladaptive cognitions are (1 ) an important source of distress
i
for agoraphobics, (2 ) a salient feature of the agoraphobic syndrome, and (3 ) often viewed 
as responsible for the triggering, exacerbation, and attenuation of physiological symptoms 
and/or avoidance behaviors, It would seem both logical and necessary to administer a set of 
treatment procedures specifically designed to have a direct Impact on the agoraphobic's 
cognitive domain.
Cognitive Restructuring: Treatment Procedure
As stated above, cognitive restructuring refers to any therapy procedure which places 
a primary emphasis on the role of cognitive behavior change in therapeutic Improvement.
In Ellis' (1962) case, he assumes that an Individual’s maladaptive emotional response 
reflects his Indiscriminate and automatic labeling of a situation and he suggests that 
emotional reactions are mediated by Internal sentences. Once these Internal sentences are 
acknowledged and reported by the Individual, they then become what Is referred to in the 
cognitive-behavioral literature as self-talk,self-statements; or self-instructions. The
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self-report of Internal sentences or self-statements therefore becomes that aspect of 
cognitive anxiety which Is observable and measurable.
The cognitive restructuring procedures In this study, based prim arily on the 
principles of Ellis' (1962) rational-emotive therapy (RET), are designed to provide the 
agoraphobic with an explanatory scheme to enable him to understand the nature of his 
responses to phobic situations. Participants In both treatment groups are Instructed about 
the nature of agoraphobia: Its origins, Its onset, the development of avoidance patterns and 
the role of anxiety reduction as a relnforcer, the learning theory base and the view of 
agoraphobic symptom formation as a bad habit, and so forth. However, (n the group 
receiving cognitive restructuring the cause and effect connections between mind and body 
are Included, and It Is suggested that alleviation of cognitive distress w ill help result In the 
amelioration of agoraphobia. Through examples provided by the subjects themselves It 1s 
made clear that situations are not In themselves anxiety arousing, but anxiety is aroused as 
a result of maladaptive cognitive responses. For a complete description of the cognitive 
restructuring procedures used in this study, including rationales for each procedure, 
therapist’s instructions and Interventions, formats for each weekly 2 hour treatment 
session, and so forth, the reader is referred to the Therapist's Manuals.
In summary, cognitive restructuring procedures are explained to subjects in terms of 
the notion that one's belief system can and does directly Influence one's level of emotional 
arousal. For individuals who have been convinced that the nature of anxiety Is so automatic 
that It is beyond their control, the Idea that thoughts actually can and do trigger anxiety adds 
potency to the self-control philosophy of the treatment program, mainly that the goal of 
treatment is to become the master of one’s anxiety, the reducer of fear rather than the 
victim of it.
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Statement of Purpose 
Evidence, collected In the past 15 years, has established the effectiveness of In vivo 
behavioral practice In helping people overcome the disabling problem of agoraphobia (e.g., 
Crowe etal., 1972;Emmelkampetal., 19 7 8 ;Emmelkamp& Wessels, 1975;Gelderetal.,
1967; Gelder& Marks, 1966; Roberts, 1964;Terhune, 1949; Tucker, 1956). A number 
of authors (e.g., Beck & Emery, 1979; D'Zurtlla etal., 1973; Ellis, 1979; Woodward & 
'Jones, 1980) have suggested that cognitive therapy procedures, when combined with In vivo 
exposure, may be of value 1n promoting a more effective treatment of agoraphobia. They 
have described various kinds of thoughts that can arouse anxiety and contribute to avoidance 
behavior, including anticipations of catastrophic consequences, Irrational beliefs, 
overconcern with arousal states, hypervfgllance for threatening aspects of situations, and 
judgements of personal Inadequacy. They argue that If these cognitions can be eliminated, 
and the Individual Is exposed to the fear producing situation, anxious arousal and avoidance 
w ill diminish.
. The firs t study ( Emmelkamp et al., 1978) designed to examine the effectiveness of 
cognitive restructuring by Itself with agoraphobics, failed to suggest potential usefulness of 
cognitive strategies. However, Improvements such as Increasing the length of cognitive 
restructuring treatment, and combining It with in vivo exposure, have been proposed as 
possible means to arrive at more firm  conclusions as to the merits of cognitive 
restructuring with agoraphobics. The firs t published study ( Emmelkamp & hersch,
1982), which combined cognitive restructuring with In vivo exposure suggested that the 
combined treatment was superior In some respects to the exposure alone. This study also 
suggested that 1n the long run cognitive modification alone was about equally effective as
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exposure tn vivo. Nevertheless, these conclusions are tentative and further research Is 
necessary. A number of Improvements In the design of Emmelkamp and Mersch’s (1902) 
study have been offered, namely, Increasing the treatment time and adding cognitive 
measuring Instruments to the assessment package. In the only other study (Williams &. 
Rappoport, 1983) which has attempted to assess the viability of a combined treatment 
package, there was no suggestion of superiority of the combined approach. While Williams 
and Rappoport (1983) did attempt to assess cognitive variables, again their treatment 
period was relatively short. They also focussed their clinical Intervention procedures on 
one specific fear, so the reader Is not able to arrive at any conclusions as to the effectiveness 
of their treatment with regard to other fears that agoraphobics experience.
In conclusion, the present stud/ was designed to determine whether In vivo treatment 
of agoraphobics could be made more efficient by Incorporating cognitive modification 
techniques into the treatment. This study is, to a certain extent, a replication and extension 
of the work of Emmelkamp and Mersch (1982) and Williams and Rappoport (1983), with 
the following design Improvements:
(1 ) The clinical treatment time that the subjects experienced, 1n the 
present study, was Increased. Emmelkamp (et al., 1978),
Emmelkamp and Mersch (1982), and Williams 8nd Rappoport 
(1983) studies Involved 20 hours (10 sessions, over a 2 week 
period), 16 hours (8  sessions, over a 2 1 /2  week period), J1 
hours ( the number of sessions or the time period was not 
specific), respectively. In the present study subjects were
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Involved In a 22 session program with each weekly session lasting 
approximately 2 hours.
(2 ) The assessment package was broadened to Incorporate cognitive 
variables as well as behavior and affective ones. The following 
measures were employed to tap the cognitive realm of the subjects:
(a) Agoraphobia Cognitions Questionnaire, and (b) Body Sensations 
Questionnaire.
(3 ) Not focussing on any specific fear, as Williams and Rappoport
(1983) did, but on a wide variety of fears, symptoms and 
correlates of the agoraphobic syndrome.
Hypotheses
In general, It Is hypothesized that In vivo exposure Integrated with cognitive 
restructuring (cognitive group) w ill be superior to In vivo exposure without cognitive 
restructuring ( noncognltlve group) In treating agoraphobia. More speclflcal ly , the 
following hypotheses w ill be tested:
(1) "Panic Attack" Hypotheses
For the purposes of this study, only agoraphobics with panic attacks, have been 
considered eligible. Based on this, the following hypotheses are suggested:
Hypothesis 1 a: Subjects (£s) exposed to the cognitive and noncognltlve 
treatment conditions should demonstrate a significant reduction in 
self-reported frequency of panic attacks, and this reduction should also be 
significantly different from those not exposed to the treatment 
manipulation.
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Hypothesis 1 b: £s exposed to the cognitive treatment condition should 
demonstrate a reduction 1n self-reported frequency of panic attacks, 
which 1s significantly greater than that reported by £s exposed to the 
noncognltlve manipulation.
(2 ) "General Anxiety" Hypotheses
Since general anxiety Is an Important aspect of the agoraphobic syndrome, the 
following hypotheses are suggested:
Hypothesis 2a. £s exposed to the cognitive and noncognltlve treatment conditions 
should demonstrate a significant reduction In general anxiety as measured on the 
following scales: (1 ) State dimension of the State-Trait Anxiety Inventory (STAI), 
and (2 ) Anxiety Dimension of the Brief Symptom Inventory (AD-BSI). This 
reduction In general anxiety should be significantly different from those not exposed 
to the treatment manipulation.
Hypothesis 2b. £s exposed to the cognitive treatment condition should demonstrate a 
reduction of general anxiety, which Is significantly greater than that reported by £s 
exposed to the noncognltlve manipulation, as measured on the STAI and AD-BSI.
(3 ) :‘P hob 1c Anxiety" Hypotheses
Since phobic anxiety is an Important aspect of the agoraphobic syndrome, the following 
hypotheses are suggested:
Hypothesis 3a. &s exposed to the cognitive and noncognltlve treatment 
conditions should demonstrate a significant reduction In phobic anxiety as 
measured on the following scales: (1 ) Phobic Anxiety Dimension of the 
BSI (PAD-BSI), (2 ) Obsessive-Compulsive Dimension of the BSI 
(O-C-BSI), (3 ) Watson and Marks (1971) rating scale of phobic 
anxiety, (4 ) Agoraphobic Cognitions Questionnaire (ACQ), (e) Body 
Sensations Questionnaire (BSQ), and (6 ) self-report scale of anxiety on 
the Behavioral Avoidance Test ( BAT). This reduction In phobic anxiety 
should also be significantly different from those not exposed to the 
treatment manipulation.
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Hypothesis 3b. £s exposed to the cognitive treatment condition should 
demonstrate a reduction In phobic anxiety, which 1s significantly greater 
than that reported by &s exposed to the noncognltlve manipulation, as 
measured on the P AD-BSI, O-C-BSI, rating scale of phobic anxiety, ACQ, 
BSQ, and BAT.
(4) '’ftghayloral AYoidancaUt/PQilisssa
Since avoidance behavior is a central feature of agoraphobia, the following hypotheses 
are suggested:
Hypothesis 4a. £s exposed to the cognitive and noncognltlve treatment 
conditions should demonstrate a significant reduction in behavioral 
avoidance as measured on the following scales: (1 ) self-report of 
avoidance In six phobic situations, and (2 ) Behavior Avoidance Test 
(BAT). This reduction In avoidance behavior should also be significantly 
different from those not exposed to the treatment manipulation.
Hypothesis 4b. £s exposed to the cognitive treatment condition should 
demonstrate a reduction of behavioral avoidance, which Is significantly 
greater than that reported by £s exposed to the noncognltlve 
manipulation, as measured on a self-report scale of avoidance and BAT.
"PlPbal.PigtressmycQtheses 
Since the degree of global distress Is considered an Important component of the 
agoraphobia syndrome, the following hypotheses are suggested:
Hypothesis 5a. &s exposed to the cognitive and noncognltlve treatment 
conditions should demonstrate a significant reduction In global distress as 
measured on the following scale: Global Severity Index of the BSI 
(GSI-BSI). This reduction In global distress should also be significantly 
different from those not exposed to the treatment manipulation.
Hypothesis 5b. &s exposed to the cognitive treatment condition should 
demonstrate a reduction of global distress, which Is significantly greater 
than that reported by £s exposed to the noncognltlve manipulation, as 
measured on the GSI-BSI.
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Hypotheses 1 -5  represent the major suppositions of this study. In addition, the 
following subsidiary hypotheses w ill be tested:
(1) "Treatment Expectations" Hypothesis
Since £s’s treatment expectations have been shown to affect treatment outcome, the 
following hypothesis Is suggested:
Hypothesis 1. £s exposed to the cognitive and noncognltlve treatment 
condition w ill manifest no significant differences on treatment 
expectations, as measured on the Treatment Expectations Questionnaire.
(2) "Eear." Hypotheses
Marks and Mathews (1979) have recently developed a brief self-rating scale In 
order to standardize the assessment of phobic patients and thereby facilitate the 
comparlbillty of results between research studies and treatment centers. Since this scale 
has been used with Increasing frequency In studies examining the problem of agoraphobia, 
the following hypotheses are suggested:
Hypothesis 2a. £s exposed to the cognitive and noncognltlve treatment 
conditions should demonstrate a significant reduction 1n fear, as measured 
on the following scales of the Fear Questionnaire: (a) total phobia, and
( b) agoraphobia. This reduction in fear should also be significantly 
different from those not exposed to the treatment manipulation.
Hypothesis 2b. £s exposed to the cognitive treatment condition should 
demonstrate a reduction In fear, which is significantly greater than that 
reported by £s exposed to the noncognltlve manipulation, as measured on 
the Fear Questionnaire.
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METHOD
The purpose of the present study was to determine whether In vivo exposure 
treatment of agoraphobia could be made more efficient by Incorporating cognitive 
modification techniques Into the treatment. One experimental group received In vivo 
exposure with cognitive restructuring, and the other experimental group received In vivo 
exposure without cognitive restructuring. The waiting- list control group received neither 
In vivo exposure or cognitive restructuring. All participants underwent an Initial 
interviewing, diagnosis and screening stage before being accepted Into the study. For the 
subjects randomly assigned to the therapy groups a 22 week treatment plan followed. The 
control group subjects did not receive treatment; however, they were requested to return 
for the assessments sessions along with the subjects In the two therapy groups. These 
assessments were made before treatment began ( pretest), after the 11 th treatment session 
(Intermediate -test) and after the completion of treatment ( posttest).
Elagnostlc Criteria for Subject Selection
A broad operational definition of agoraphobia was considered desirable, In order to
allow for the inclusion of the typically wide range of agoraphobic symptoms. However, the 
definition had to be specific and explicit enough to exclude phobias which are similar (for 
example, claustrophobia and Interpersonal phobias) but not the same as agoraphobia.
-4 3 -
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Therefore, Individuals were selected for the study according to the following criteria, either 
discernible upon self-report, or as Indicated on questionnaires (I.e., the Personal Data 
Questionnaire, Appendix A).
(1 ) All subjects met the Diagnostic and Statistical Manual of Mental 
Disorders, 3rd ed(DSM-lll) criteria for the diagnosis of 
agoraphobia with panic attacks.
(2 ) The Individual was currently engaged in avoidance behavior In at 
least two of the following situations, (a) Walking alone, (b) 
shopping alone, (c) drlvlngalone, (d) passenger 1nacar,(e) 
public places (theatres, church, hairdresser, restaurant, etc.),
( f) staying at home alone. The Individuals degree of avoidant 
behavior was assessed on the personal data questionnaire (see 
question nine of this questionnaire).
(3 ) The Individual experienced phobic anxiety of an anticipatory 
nature, the fear of fear which manifested Itself both physiologically 
and cognitively. Questions on the personal data questionnaire were 
Included to assess the presence of phobic anxiety of an anticipatory 
nature (see question eight). Physiological symptoms of phobic 
anxiety were also assessed In this questionnaire (see question five 
b).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
45.
Screening Criteria for Subject Selection
On the basis of results on the interview and questionnaires Individuals were diagnosed 
as agoraphobic. They were also screened for this study according to the following additional 
criteria:
(1 ) The individual's agoraphobia was the primary problem with any 
other psychological problems being clearly secondary.
(2 ) The Individual reported that he/she was not receiving another form 
of psychotherapy, and he/she would not seek another form of 
psychotherapy during the treatment program ( see Appendix B,
Client Contract).
(3 ) The Individual was able to continue taking tranquillzlng drugs If 
alread/ prescribed.
1 4) The individual was available for the duration of treatment ( see 
Appendix B).
(5 ) The individual was 18 years of age or older at the time of the study.
(6 ) The Individual was judged to be sufficiently literate to be able to 
take full advantage of the written and oral training materials.
(7 ) Individuals signed the appropriate consent forms (see Appendix C).
Objects
Subjects were recruited from the clientele of the outpatient department at the 
foothills Hospital, Calgary, Alberta, and from announcements in local media of a program to 
treat agoraphobia (see Appendix D). After the screening process, detailed above, subjects
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were randomly assigned to either the In vivo exposure group (noncognltlve group), the In 
vivo exposure + cognitive restructuring (cognitive group), or the waiting lis t control 
group. Originally 38 subjects were accepted Into treatment and six subjects dropped out by 
the sixth session. Two subjects from the cognitive group claimed that they were unable to 
comply with scheduling requirements and were thus terminated from the study. One subject 
from the noncognltlve group claimed that the requirements of the treatment protocol were 
too difficult. Three subjects, in the waiting lis t control group, dropped out of treatment 
claiming that they were seeking alternate forms of treatment. Twelve subjects In the 
noncognltlve group, and 11 subjects 1n the cognitive group completed the treatment 
program. Nine subjects in the control group completed the assessment packages at the 
appropriate times. Demographic Information on the 32 subjects who participated 1n the 
treatment program Is presented In Table 1.
Treatment Procedures
Treatment was administered In a group format and the author served as therapist for 
both treatment groups. Treatment consisted of 22 weekly sessions lasting approximately 
two hours exh. Two therapist's manuals, (1 ) In Vivo Exposure (Noncognltlve group; 
Appendix E), and (2 ) Cognitive Restructuring + In Vivo Exposure (Cognitive group; 
Appendix F), were designed, delineating session by session the procedures used for exh 
approach and the distinguishing features of exh treatment. Both these manuals are in 
excess of 100 pages, consequently It is difficult to briefly summarize the two approxhes. 
However, a brief description of the therapy procedures and a table ( Table 2, Summary of 
Therapy Procedures) summarizing the two therapies are detailed below.
Treatment procedures for Noncognltlve Orouo (see Table 2 ). During the firs t 20
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Table 1 
Subject Demographics
Total
Population
(n -32)
&&aLscreen1nq
Mean (years) 38.7
f e l lal Status
single ( ^ )  18.8
parried (& ) 68.8
Divorced /Widowed 12.4
EUy&Uca
Mean (years completed) 11.0
N a tion of Fear
Mean (years) 8.5
^ l l M s  havlnn 
PUOLlreatment
Percentage 62.5
Non- Cognitive Waiting
Cognitive List
(n=12) (n = M ) (n=9)
41.6 37.5 36.2
25.0 11.1 22.2
66.7 81.8 55.6
8.3 11.1 22.2
10.8 11.9 10.2
8.7 8.5 8.4
58.3 63.6 66.7
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Table 2
Summary of Therapy Procedures
Sess­
ion
Noncognltlve Group (a* 12) Cognitive Group lfl-1 U
* Introduction of members.
Discussion of causes, maintenance 
symptoms of agoraphobia.
Discussion of BASIC ID.
and
Rationale for Relaxation Training.
Discussion of the necessity for homework. 
Assignment of reading homework.
Summary and questions from last session. 
Review homework.
Relaxation practice begins, with emphasis to 
practice between therapy sessions.
Continue to discuss causes and maintenance of 
agoraphobia.
Discuss other common forms of treatment. 
Assignment of reading and relaxation 
homework.
Introduction of members.
Discussion of causes, maintenance and 
symptoms (COGNITIVE SYMPTOMS 
STRESSED) of agoraphobia.
Discussion of BASIC ID.
CONCEPT OF FEAR OF FEAR 
AND CAUSE AND EFFECT 
CONNECTIONS BETWEEN MIND AND 
BODY ARE DISCUSSED.
Rationale for Relaxation Training.
BRIEF INTRODUCTION TO THE CONCEPT 
OF ANXIETY RELATED TO COGNITIONS. 
Discussion of the necessity for homework. 
Assignment of reading homework,
Summary and questions from last session. 
Review homework.
Relaxation practice begins, with emphasis to 
practice between therapy sessions.
Continue to discuss causes and maintenance of 
agoraphobia (C 0 6 N IT IV E  ASPECTS  
HI6HLIG HTED).
Discuss other common forms of treatment. 
Assignment of reading and relaxation 
homework.
Summary and questions from last session. 
Review homework.
Conduct relaxation exercise.
Discuss in vivo treatment strategy: General 
discussion.
Assignment of relaxation and reading 
homework.
Summary and questions from last session. 
Review homework.
Conduct relaxation exercise. 
INTRODUCTION TO IRRATIONAL  
THINKING MODEL (COGNITIVE  
THERAPY. RATIONAL EMOTIVE 
THERAPY). APPLICATION OF 
IRRATIONAL THINKING MODEL TO 
AGORAPHOBIA.
Assignment of relaxation and READING ON 
IRRATIONAL THINKING IN 
AGORAPHOBICS. AND TO BEGIN 
RECORDING C 0 6 N IT I0 N S .
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2 cont'd
Summary and questions from last session. 
Review homework.
Conduct relaxation exercise.
Continue discussion of In vivo exposure: 
Treatment in practice -  Step 1.
Discuss drawing up problem list. 
Assignment of problem list, reading and 
relaxation homework.
Summary and questions from last session. 
Review homework.
Conduct relaxation exercise.
Continue discussion of In vivo exposure: 
Treatment In practice -  Step 2, Step 3.
Assignment of relaxation, reading and problem 
list homework.
Summary and questions from last session. 
Review homework.
Conduct relaxation exercise.
Continue to discuss fn vivo exposure: 
Summary of treatment plan.
Discuss Individual hierarchy development.
Assignment of reading, relaxation and drawing 
up Individual hierarchy homework.
Summary and questions from last session. 
Review homework.
Conduct relaxation exercise.
Determine problem client is going to begin 
working on from personal hierarchy.
Discuss methods of coping with panic attacks.
Summary and questions from last session. 
Review relaxation and IRRATIONAL 
BELIEFS homework.
Conduct relaxation exercise.
Discuss in vivo treatment strategy: General 
discussion.
CONTINUE TO DISCUSS COGNITIVE 
THERAPY ASPECTS OF TREATMENT 
FOR A 60R A P H 0B IA : COGNITIVE 
RESTRUCTURING PROCEDURES.
Assignment of relaxation, READING, 
and COGNITIVE RESTRUCTURING,
homework.
Summary and questions from last session. 
Review homework.
Conduct relaxation exercise.
Continue discussion of In vivo exposure:. 
Treatment In practice -  Step I .
Discuss drawing up problem list.
CONTINUE DISCUSSION OF COGNITIVE 
THERAPY AND RATIONAL EMOTIVE 
THERAPY.
Assignment of relaxation. READING, 
REC0RDIN6 OF C 06N IT I0N S , and problem 
list homework.
Summary and questions from last session.
Review homework
Conduct relaxation exercise.
Continue to discuss in vivo exposure: 
Treatment in practice -  Step 2, Step 3. 
CONTINUE DISCUSSION OF COGNITIVE  
THERAPY AND RATIONAL EMOTIVE 
THERAPY.
Assignment of relaxation, READING. 
RECORDING OF COGNITIONS, and problem 
list homework.
Summary and questions from last session. 
Review homework.
Conduct relaxation exercise.
Continue to discuss in vivo exposure: 
Summary of treatment plan.
Di3cus3 Individual hlerachy development. 
CONTINUE DISCUSISION OF COGNITIVE 
THERAPY AND RATIONAL EMOTIVE 
THERAPY.
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Table 2 cont'd
10
11
Assignment of reading, relaxation and 
corrections to personal hierachy homework.
Summary and questions from last session. 
Review homework.
Summarize the purpose of relaxation 
training and its use in in vivo exposure, 
Review coping with panic attack strategies. 
Describe Individual problem treatment diaries 
and hand out appropriate forms.
Discuss other factors that interfere with 
improvement.
Group discussion of firs t group exposure. 
Assignment of reading, relaxation, filling 
out personal diaries homework.
Summary and questions from last session. 
Review homework.
Brief group discussion of upcoming exposure. 
Conduct first group exposure.
Group discussion of outing: Problem solving.
Summary and questions from last session. 
Brief group discussion of upcoming exposure. 
Conduct group exposure.
Group discussion of outing: Problem solving.
Summary and questions from last session. 
Group discussion, feedback from each client 
as to their progress and problems with 
exposure: Problem solving session.
Begin to emphasis the need to work on 
individual goals, between sessions.
Assignment of relaxation, READING. 
RECORDING OF COGNITIONS, and drawing 
up individual hierarchy homework.
Summary and questions from last session. 
Review homework.
Summarize the pur pose of relaxation 
training and its use in in vivo exposure. 
Determine problem client is going lo begin 
working on from personal hiereachy.
Discuss methods of coping with panic attacks. 
CONTINUE DISCUSSION OF COGNITIVE  
THERAPY AND RATIONAL EMOTIVE 
THERAPY.
Assignment of relaxation, READING 
RECORDING OF COGNITIONS, and
corrections to personal hierachy homework.
Summary and questions from last session. 
Review homework.
Review coping with panic attacks,
Describe Individual problem treatment diaries 
and hand out appropriate forms.
Discuss other factors that interfere with 
improvement.
Group discussion of firs t group exposure. 
Discussion of ADDITIONAL COGNITIVE  
COPING TECHNIQUES.
Assignment of READING, RECORDING OF
COGNITIONS, filling out personal diaries 
homework.
Summary and questions from last session. 
Review homework.
Brief group discussion of upcoming exposure. 
Conduct firs t group exposure.
Group discussion of outing: Problem solving, 
including COGNITIVE PROBLEM SOLVING  
STRATEGIES.
Summary and questions from last sesston. 
Group discussion, feedback from each client 
as to their progress and problems with 
exposure: Problem solving session, including 
COGNITIVE PROBLEM SOLVING  
STRATEGIES.
Begin to emphasis the need to work on 
Individual goals, between sessions.
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12 Summary and questions from last session.
13 Brief group discussion of upcoming exposure.
1*1 Conduct group exposure.
Group discussion of outing: Problem solving.
Review clients individual problem 
diaries, problem solving.
Continue to encourage practice of individual 
goals between sessions.
Summary and questions from last session. 
Group discussion, feedback from each client 
as to their progress and problems with 
exposure: Problem solving session.
Discuss individual goals clients will work 
on in the next group session.
Summary and questions from last session. 
Brief discussion of upcoming exposure. 
Conduct group exposure, with clients 
working on individual goals,
Group discussion of outing: Problem solving.
Review clients individual problem diaries, 
problem solving.
Summary and questions from last session. 
Group discussion, feedback from each client 
as to their progress and problems with 
exposure: Problem solving session.
Discuss Individual goals clients will work 
on in the next group session.
Summary and questions from last session. 
Brief group discussion of upcoming exposure. 
Conduct group exposure.
Group discussion of outing.
Review clients Individual problem diaries, 
problem solving.
Summary and questions from last session. 
Group discussion, feedback from each client 
as to their progress and problems with 
exposure: Problem solving session.
Emphasis the need for continued practice 
of exposure.
Dfscussfon of feelings about termination.
Summary and questions from last session. 
Brief group discussion of upcoming exposure. 
Conduct group exposure.
Group discussion of outinq: Problem solving 
inctudinq COGNITIVE PROBLEM SOLVING  
STRATEGIES.
Review clients individual problem 
diaries, problem solving.
Continue to encourage practice of individual 
goals between sessions.
Summary and questions from last session. 
Group discussion, feedback from each client 
as to their progress and problems with 
exposure: Problem solving session including 
COGNITIVE PROBLEM SOLVING 
STRATEGIES.
Discuss individual goals clients will work 
on in the next group session.
Summary and questions from last session. 
Brief discussion of upcoming exposure. 
Conduct group exposure, with clients 
working on individual goals.
Group discussion of outing: Problem solving, 
including COGNITIVE STRATEGIES.
Review clients individual problem diaries, 
problem solving.
Summary and questions from last session. 
Group discussion, feedback from each client 
as to their progress and problems with 
exposure: Problem solving session including 
COGNITIVE STRATEGIES.
Discuss Individual goals clients will work 
on In the next group session.
Summary and questions from last session. 
Brief group discussion of upcoming exposure. 
Conduct group exposure.
Group discussion of outing.
Review clients individual problem diaries, 
problem solving.
Summary and questions from last session. 
Group discussion, feedback from each client 
as to their progress and problems with 
exposure: Problem solving session including 
COGNITIVE STRATEGIES.
Emphasis the need for continued practice 
of exposure.
Discussion of feelings about termination.
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minutes of the firs t session, subjects briefly exchanged Information about themselves and 
their agoraphobia. The therapist spent approximately an hour discussing in an educational 
format the nature of agoraphobia, that 1s. a description of agoraphobia, symptoms of 
agoraphobia, what causes agoraphobia , and what keeps agoraphobia going. The rationale for 
tr eatment was also described. The role of anxiety in the development and maintenance of 
agoraphobia was outlined. One method of coping with anxiety, namely progressive muscular 
relaxation, was described to the patients. The firs t session concluded, as did alt the sessions, 
with a question period and the assignment of homework.
In the second session relaxation training began. This relaxation exercise, or some 
variation of It, was performed during sessions two through seven. Additional educational 
material was presented about the causes of agoraphobia. The different types of treatment 
commonly available for agoraphobia were also described. Sessions three to eight focussed 
primarily on explaining the rationale of treatment, treatment strategy and the necessity 
for in vivo exposure to the feared object or situation. A considerable amount of time was 
spent during these six sessions in group discussion about the educational material and 
other related Issues. In sessions four through eight the sublects were asked to tlevelop a 
problem lis t of their feared situations and to construct a personalized hierarchy. Sessions 
nine through 22 involved group exposure to feared situations, and group discussions of the 
subject’s experiences, difficulties and successes. Gradually the therapist faded from the
group during the group exposures and by session 16 the therapist was not present during in 
vivo exposures. However, the therapist was present at the group discussion sessions and 
following the exposure periods. By session 12 subjects were requested to begin to enter the 
feared situations on their personalized hierarchies, either as part of their homework 
assignments or during the group exposures. The final session was devoted to obtaining
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Information about individual subject’s progress and to encourage continuation of systematic 
exposure practice, after the completion of treatment.
Treatment procedures fnr Cnnnltlve Oroun ( see Table 2 ). This group received the 
same treatment as the noncognltlve group except for the addition of a cognitive 
restructuring component. The cognitive restructuring procedure 1n this study, was based 
primarily on the principles of Ellis' (1962) rational-emotive therapy ( RET). In this 
group the cause and effect connections between mind and body were Included, and It was 
suggested that alleviation of cognitive distress would help ameliorate agoraphobia symptoms. 
Through examples provided by the subjects themselves it  was made clear that situations 
were not 1n themselves anxiety arousing, but anxiety was aroused as a result of maladaptive 
cognitive responses. Cognitive restructuring procedures were explained to subjects In 
terms of the notion that one's belief system can and does directly Influence one's level of 
emotional arousal. The cognltlve-restructurlng component of the treatment was presented 
primarily In sessions one through nine, In an educational format. However these concepts 
were applied during group exposure and they were addressed In the group discussions, 
during sessions 10 through 22. For a complete description of the differences between the 
cognitive and noncognltlve groups the Interested reader Is directed to the two therapy 
manuals alluded to earlier. These manuals Include rationales for each procedure, therapist's 
Instructions and Interventions, client handouts, and formats for each weekly treatment 
session.
Treatment Procedures for Waltlnq-Llst Control. This group did not receive any 
therapeutic Intervention. However, they were asked to f i l l  In the treatment questionnaires 
and conduct the behavioral avoidance test at a preassessment Interview. They were asked to
return In 11 weeks to complete an Intermediate assessment Identical to that completed by
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cognitive and noncognltlve subjects and finally to return after 22 weeks to complete the 
postassessment, again Identical to that completed by the therapy subjects. The wa1t1ng-Hst 
control subjects were offered therapy after the completion of the postassessment.
Assessments
Assessments were performed before treatment (pretest), after the 11 th treatment 
session ( Intermediate test) and Immediately following the last treatment session ( posttest). 
The design allowed for wlthln-group treatment outcome comparisons as well as between 
group comparisons.
Instrumentation
Five dependent variables were selected for measurement to assess the comparative 
effectiveness of the treatments. They were chosen on the basis that, (1 ) they were 
Indicators of agoraphobic symptomatology, (2 ) they accurately represented the diagnostic 
criteria used In this study, and (3 ) all variables were accurately measured In order to 
detect changes due to treatment. The five dependent variables measured In the stud/ are:
(1 ) frequency of panic attacks; (2 ) general anxiety (also referred to In the literature as 
Pervasive or chronic); (3 ) phobic anxiety (also referred to In the literature as 
anticipatory or cognitive, i.e., the obsessive "what Ifs," the Irrational beliefs, and so forth;
(4 ) phobic avoidance; (5 ) global distress. These five variables are considered in more 
detail on the following pages.
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(1 ) Frequency of panic attacks. This variable was measured on a 9-polnt symptom 
scale of panic attacks which goes from 0 = "not at a ll," to 8 ■ "very much Indeed, very 
severe panic, very frequent attacks" (Watson & Marks, 1971; see Appendix G). This 
9-polnt rating scale and many others like 1t which were developed and validated by Marks 
and his associated In the 60's (Gelder & Marks, 1966; Marks, Boulougourls & Mar set,
1971) have been adapted by North American researchers and used extensively with 
agoraphobic populations. This early development of a self-report scale to measure the 
frequency of panic attacks has always been considered an Important goal 1n the treatment of 
agoraphobia.
(2 ) General anxletv. This variable was measured by two Instruments, viz., the 
State-Tralt Anxiety Inventory (STAI; Spielberger et al., 1970) and the Anxiety Dimension 
of the Brief Symptom Inventory (AD-BSI). TheSTAI Is a brief self-report measure of both 
state and tra it anxiety (see Appendix H ). The "A-state scale" consists of 20 statements that 
pertain to the subject's feelings at a particular moment In time. Half the statements concern 
the absence of such feelings (e.g., "I feel c a lm " I  feel content"). Subjects rate each 
statement (e.g., "I feel tense") on a 4-polnt scale ( "not at a ll” to "very much so"). The 
"A-tralt scale" comprises 20 statements which refer to how the subjects generally feel, 
for the purpose of this study only the "A-state scale" was scored and used In statistical 
comparisons. The STAI Is a particularly popular research Instrument and the validity and 
reliability of this instrument has been discussed by a number of author's (e.g., Spielberger 
&Gorsuch, 1966; Spielberger et al., 1972).
The second measure of general anxiety, the Anxiety Dimension of the Brief Symptom 
Inventory (AD-BSI; Derogatls, 1975) is composed of six items reflecting a set of symptoms 
ond signs that are associated clinically with high levels of manifest anxiety. General signs
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such as ner vousness and tension are Included, as are panic attacks, spells of terror or panic, 
and feelings of fearfulness. Although the BSI was administered as a direct measure of the 
fifth dependent variable, specific dimensions of It were also used as additional checks on the 
validity of the measurement of certain dependent variables, and provided additional data for 
the interpretation of results. A more detailed description of the BSI Is found In Appendix I .
(3 ) Phobic anxiety. This variable has been defined as a persistent fear response to a 
specific person, place, object, or situation, which is characterized as being Irrational and 
disproportionate to the stim uli, and which leads to avoidance or escape behavior. Phobic 
anxiety (dp. no three) Includes a measure of the Irrational content of the fear and the 
prospect of avoidance behaviors, thus distinguishing it from the general anxiety factor (dp. 
no. two) which measures non-specific arousal. It was Important to Include both types of 
anxiety In this study, and to measure them as separate dependent variables In order to 
reflect fu lly the anxiety profile of the agoraphobic population.
Phobic anxiety, was measured In six ways: (1 ) on the Phobic Anxiety Dimension of 
the BSI ( PAD-BSI). The five Items of this dimension focus on the pathognomic and 
disruptive manifestations of phobic behavior, afraid In open spaces, afraid to travel, having 
to avoid certain things, places, or x tlv tties, feeling uneasy In crowds, and feeling nervous 
when alone; (2 ) the score from the Obsessive-Compulsive Dimension of the BSI 
(O-C-BSI). This was included not only as a possible correlate of the PAD-BSI score, but 
also, because there Is often an obsessive-compulsive quality to the nature and content of 
agoraphobic thinking. The O-C-BSI focuses on thoughts, Impulses, and actions that are 
experienced as unremitting, as well as behaviors and experiences of a more general 
cognitive performance attenuation. Six Items which Include trouble remembering things, 
difficulty making decisions, your mind going blank, and so forth, comprise this dimension;
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(3) a third measure of phobic anxiety was the rating scale originally developed by Gelder 
end Harks {1966) and then later modified by Watson and Marks (1971). This Is a 9-polnt 
scale which measures both anxiety and avoidance for five ( In this study six) 
fairly specific phobic situations. Interrater reliability for the Watson and Marks scale has 
been found to be satisfactory ( Emmelkamp, 1974,1979; Emmelkamp & Ultee, 1974; 
Hafner& Marks, 1976; Hand, Lamontagne&Marks, 1974; Teasdale et al., 1977;Watson& 
Marks, 1971) (Appendix J );(4 ,5 ) The next two measures of phobic anxiety fall within 
the cognitive realm. The first of these instruments, and the fourth measure of phobic 
anxiety was Chambless’ et al. (1981) Agoraphobia Cognitions Questionnaire. The fifth 
measure of phobic anxiety was the Body Sensations Questionnaire also designed by 
Chambless’ et al (1981) (Appendix K ). According to a number of authors agoraphobia has 
been descrIbed as not only a fear of particular places and situations but also a "fear of fear" 
(Goldstein & Chambless, 1978; Weekes, 1976). According to the model proposed by 
Goldstein and Chambless (1978) this fear of fear has two Important components: 
cognitions concerning Imagined disastrous consequences of having panic attacks, and a fear of 
Interoceptive cues of arousal, particularly cues associated with the agoraphobic’s typical 
anxiety response pattern. The Agoraphobic Cognitions Questionnaire and the Bod/ Sensations 
Questionnaire are two self-report instruments, devised to measure fear components. The 
former is comprised of nine thoughts concerning disastrous consequences of panic that are 
commonly reported by agoraphobics; these are rated as to the frequency of their occurrence 
on a 1 -5 scale. The Body Sensations Questionnaire 1s made up of 17 Items concerning 
Internal responses associated with anxiety; all ot these items, which were drawn from 
interviews with agoraphobics concerning sensations that exacerbate their anxiety, are rated
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for the severity of anxiety they elicit on a 1 -5  scale; (6 ) The sixth measure of phobic 
anxiety was a self-report of anxiety during the Behavioral Avoidance Test (see Appendix L). 
At each station on the test course subjects recorded their subjective level of anxiety on an 
11 -point scale, ranging from 0 ( "Unafraid, not tense or anxious"), to 10 ( "Extremely 
afraid, very tense and anxious"). Subjects self-report of fear at each of the completed 
stations was averaged to yield an overall Index of fear arousal during the test walk.
(4 ) Phobic Avoidance. This variable was measured on two instruments. The firs t was 
the 9-polnt self-rating avoidance scale (see Appendix J ), mentioned earlier, which lists 
six commonly feared and avoided agoraphobic situations; Walking alone, shopping alone, 
driving alone, passenger in a car, public places such as theatre, church and restaurant, and 
staying home alone (Watson & Marks, 1971). The second measure of phobic avoidance was 
an actual behavior avoidance test ( BAT; see Appendix L ). Subjects were asked to walk a 
specially designed course. Subjects were informed that the purpose of the test walk was to 
obtain an objective measure of their fear. Each subject was provided a detailed map ot the 
course and Instructed to walk unaccompanied along the course alone as far as they could. 
Subjects were asked to rate their anxiety level during the behavior test on forms provided. 
The number of stations reached (0  to 10 score) served as the Index of performance on the 
test walk. The BAT was conducted before (pretest), and immediately following the last 
treatment session (posttest).
(5 ) Global Distress. This variable was measured on the Brief Symptom Inventory 
(see Appendix I ). The BSI as a total Instrument, that Is over and above Its nine primary 
symptom dimensions, yields three scores, or global Indices of distress. They are the Global 
Severity Index (GSI), the Positive Symptom Distress Index (PSDI), and the Positive 
Symptom Total ( PST). Each measure communicate In a different way In a single score the
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level or depth of an Individual’s psychopathology. The GSI represents the best single 
Indicator of the current level or depth of the disorder and should be utilized where a single 
summary measure Is required (Derogatls, 1977). For the purposes of this study the GSI 
was used as the single Indicator of global distress.
Additional Instrumentation
The Instruments used for the major hypotheses have been described above. Subsidiary 
analyses demand the following additional tests:
(1 ) To evaluate whether outcome differences among treatments might be due to 
different expectations for Improvement generated by the procedures, subjects completed a 
brief questionnaire after having received the treatment rationale and having completed a 
portion of treatment. Expectations of success and credibility of therapy procedures were 
measured by a questionnaire which contains four questions, with exh having an 11 -point 
rating scale. For example the expectation of personal success question asked the subjxt, 
"How confident are you that this treatment would be successful in reducing your fear?” , and 
9oes from 0= "not at all confident," to 10= "highly confident," reflecting the subjects 
self-reported evaluation of treatment effxts (see Appendix M ).
(2 ) Marks and Mathews (1978) have recently developed a brief one page self-rating 
scale (see Appendix N ) In order to standardize the assessment of phobic patients and 
thereby facilitate the comparability of results between research studies and treatment 
centers. The form requests patients to rate themselves on one specific main target phobia,
15 of the commonest phobias from which three phobia subscores of agoraphobia, blood 
injury, and social anxiety can be derived, five associated anxiety/depression symptoms 
found In clinical practice, and a global phobia rating. The fear questionnaire yields five 
scores: Global
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phobia, total phobia, agoraphobia, main phobia, and anxiety/depression. For this study the 
agoraphobia, and total phobia scores were used for statistical purposes. For more details on 
the Fear Questionnaire see Appendix N.
Summary of Methodology
This stud/ was designed to Investigate the relative effectiveness of two different 
methods for treating agoraphobics in groups, (1) in vivo exposure alone, and (2) 1n vivo 
exposure + cognitive restructuring. Eligibility for all participants was determined based 
on two separate sets of criteria; the first, a set of diagnostic criteria which were In accord 
with the DSM-lll's current definition of agoraphobia, and the second, a set of screening 
criteria which dealt with the Issues of age, language, and so forth. Screening procedures 
Included a personal Interview and a personal data questionnaire, for all subjects in the 
study.
The questionnaire battery consisted of several self-report measures as well as a 
behavioral avoidance test designed to be sensitive to and measure the following dependent 
variables; (1) Frequency of panlcattacks (self-report), (2) general anxiety (STAI, 
AD-BSI), (3) phobic anxiety ( PAD-BSI, O-C-BSI, rating scale of phobic anxiety, ACQ, 
BSQ, self-report scale of anxiety on the BAT), (4) avoidance behavior (self-report of 
avoidance, BAT), and (5) global distress ( BSI). The questionnaire battery was 
administered at pretest, intermediate test, and posttest. The same instruments were 
administered at the same points in time to the control subjects.
Two therapist's manuals were designed, delineating session by session the procedures 
used for each approach and the distinguishing features of each treatment. In addition to the 
procedures used for subject selection and treatment, this chapter described the Instruments 
that were used in the study.
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CHAPTER III 
PRESENTATION OF RESULTS
This study was designed to determine whether In vivo exposure treatment of 
agoraphobia could be made more efficient by incorporating cognitive restructuring Into the 
treatment. Three groups of agoraphobic subjects, a noncognltlve group ( in vivo exposure; 
11= 12), a cognitive group ( In vivo exposure + cognitive restructuring; n= 11) and a 
waiting-list control group (no treatment; a= 9) were assessed on a number of self-report 
scales and a behavioral avoidance test ( Dependent measures) to determine the comparative 
effectiveness of the treatment manipulations. Assessments were performed before 
treatment ( pretreatment), after the 11 th treatment session ( Intermediate treatment), and 
immediately following the last treatment session (posttreatment).
Analyses of Variance on Pretreatment Scores
To ascertain Initial equality of the three groups (cognitive, noncognltlve, and waiting 
Ust control) one way analyses of variance (ANOVA’s) were computed on pretreatment 
scores for all dependent measures. No significant differences emerged among the three 
9roups. These results are presented in Table 3 .
Introduction to Hypothesis Testing 
To test the hypothesis that In vivo exposure + cognitive restructuring Is more
-6 1 -
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Table 3
One Way Analyses of Variance on Pretreatment Scores for 
All Dependent Measures
DgpendentElaasuca Eiesi
"Panic Attack” Measure
Frequency of Panic Attacks 0.23
"General Anxiety” Measures
State Anx iety Score 0.16
Anxiety Dimension Score 0.0$
"Phobic Anxiety” Measures
Phobic Anxiety Dimension of BSI 0.0$
Obsessive-Compulsive Dimension 0.25
of BSI
Rating Scale of Phobic Anxiety 1.02
Agoraphobic Cognitions 1.11
Body Sensations 0.‘10
Anxiety on Behavior Avoidance Test 0.31
"Behavioral Avoidance" Measure
Rating Scale of Avoidance 0.52
Behavior Avoidance Test 0.14
"Global Distress" Measure
Global Distress Measure 0.32
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Table 3 cont’d
"Fear" Measures
Total Phobia Score 0.16
Agor aphobia Score 0.15
*  C.< .05
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effective 1n the treatment of agoraphobia than in vivo exposure alone, a three treatments 
(cognitive, noncognitive, and waiting-llst control) X three assessment sessions 
(pretreatment, intermediate treatment, and posttreatment) repeated measures ANOVA 
design was used. When only two repeated measures were used ( pretreatment and 
posttreatment) a three X two ANOVA was computed.
When there was a significant Interaction, between the Group and Sessions variable, 
there was little  Interest in tests of main effects (K irk , 1968). An analysis designed to 
Isolate the sources of the Interaction, was needed. Such an analysis can be obtained by 
computing tests of simple main effects (K irk , 1968). Computational procedures for these 
tests, for a split-plot design (one between and one within variable), are Illustrated In Kirk 
(1968; p. 263-268). Where the simple main effects analyses Indicated significant results 
, multiple comparison tests were used to delineate the specific points of differences between 
the cell means. For multiple comparisons between cell means with equal numbers of 
subjects per cell a Newman-Keuls analysis was appropriate ( K1rk, 1968). For multiple 
comparisons between cell means with unequal number of subjects per cell a Scheffe's 
procedure was utilized ( K irk , 1968). When the Interaction was not significant and there 
was a significant main effect(s), appropriate post-hoc multiple comparison tests were 
performed on the marginal means.
M$in Hypotheses
(1 ) -‘PanicAttack" Hypotheses
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Hypotheses 1a and 1b: Frequency of Panic Attack? Measure
Means and standard deviations for scores on the frequency of panic attacks measure are 
presented 1n Table 4. The mean self-reported frequency of panic attacks for each treatment 
group at pre, Intermediate, and posttreatment test session are illustrated In Figure 1.
Results of a three treatments X three repeated measures ANOVA yield no significant main 
affect for treatment group, on the frequency of panic attacks measure. However, results 
Indicated a significant main effect for assessment session, F( 2,56)= 39.20, p<.05, and a 
significant group X session Interaction, F( 4,58)= 5.37,p<.05. Results for the present 
analysis (F tests) are presented in Table 5.
Simple main effects analyses indicated that the panic attack scores for the 
noncognitive group and the cognitive group differed significantly over the three assessment 
sessions. F(2.58)= 25.87, p<.05, and F(2,58)= 21.09, p<.05, respectively. The waiting 
list control group did not differ significantly over the three assessment sessions. The 
simple main effects analyses conducted to determine whether the three treatment groups 
differed In terms of frequency of panic attacks, at each assessment session, indicated that 
there were no significant differences. However, visual Inspection of Figure 1 indicated that 
dt posttest both therapy groups showed a nonsignificant trend toward more reduction of 
self-reported frequency of panic attacks, than the control group. These results are 
presented in Table 5.
Newman-Keuls post-hoc multiple comparisons ( = .05) on the means Involved in the 
Interaction (cell means involved have equal number of subjects per cell) indicated that both 
noncognitive and cognitive groups reported significantly lower frequency of panic attack 
scores at postassessment than at preassessment or Intermediate assessment. There was
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Table 4
Means and Standard Deviations for Dependent Measures
Noncognitive Cognitive Coniml
te o d e o i. G em  Goaia Qmw
t teasure (n = 12) (n = 11) (n = 9)
^ .n 1 cAU9CK”
tl£9Sgr.£
Frequency of Panic Attacks
Pre 4.1 (2.0) 3.5 (1.2) 3.8 (2.4)
Inter 3.4 (2.1) 3.2 (1.5) 2.9 (2.5)
Post 2.0 (1.2) 1.7 (1.0) 3.1 (2.1)
General Anxiety” 
Pleasures
State Anxiety Measure
Pre 48.7 (10.9) 45.7 (8.3) 42.9 (6.7)
Inter 47 .0(11.6) 43.5 (7.7) 43.6 (6.3)
Post 40.9(11.1) 38.0 (7.4) 44.6 (6.6)
Anxiety Dimension of BSI
Pre 15.3 (5.7) 15.9 (3.7) 14.7 (5.2)
Inter 13.4 (5.4) 13.6 (3.3) 13.9 (4.6)
Post 8.9 (3.3) 8.4 (2.9) 14.7(5.3)
HEhoblc Anxiety"
Pleasures
Phobic Anxiety Dimension of BSI
Pre 10.4(5.4) 11.4(5 .3) 11.1(6.5)
Inter 9.1 (4.9) 10.0(4 .5) 10.4(6.3)
Post 6.2 (3.2) 6.9 (2.9) 9.6 (6.0)
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Table 4 cont’d
Obsessive-Compulsive Dimension 
of BSI
Pre 7.5 (5.3) 6.3 (5.2) 7.8 (5.2)
Inter 6.9 (4.8) 5.8 (4.7) 7.0 (4.5)
Post 6.3 (4.5) 5.3 (4.5) 7.3 (3.9)
Watson & Marks (1971) Rating 
Scale of Phobic Anxiety
Pre 19.3(7.2) 15.9(5.7) 20 .2 (9 .0 )
Inter 15.3 (6.2) 13.3 (5.6) 18.9 (8.7)
Post 9.0 (3.0) 8.5 (3.1) 20.4 (8.9)
Agoraphobia Cognitions Questionnaire
Pre 29.2 (9.7) 25.3 (4.4) 25.3 (5.6)
Inter 27.3 (10.5) 24 .5 (5 .4 ) 26.6 (5.3)
Post 22 .8(10.7) 20.5 (4.9) 24 .7 (5 .7 )
Bod/ Sensations Questionnaire
Pre 41.1 (13.6) 37 .7 (6 .3 ) 37.9 (7.9)
Inter 39.0 (13.6) 36 .2 (6 .8 ) 37 .2 (7 .4 )
Post 33 .4(10.6) 32.1 (7.2) 36.3 (8.0)
Anxiety on Behavior Avoidance Test
Pre 8.1 (1.6) 7.6 (1.6) 7 8 (1 .5 )
Post 5.3 (1.6) 5.5 (1.7) 7.4 (1.7)
^Behavioral Avoidance'’ 
Measures
Watson & Marks (1971) Rating 
Scale of Avoidance
Pre 17.3(7.6) 18.4(7.5) 21 .0 (9 .8 )
Inter 15.8(7.9) 15.9(7.0) 22 .4 (9 .2 )
Post 11.1(5.9) 10.1(4.3) 22 .2 (8 .9 )
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Table 4 conl'd
Behavior Avoidance Test
Pre 2.8 (2.2) 2.5 (1.7)
Post 6.8 (2.9) 7.2 (2.8)
G lobal Distress" 
Heasure
Global Distress Measure
Pre 1.7 (0.7) 1.4 (0.5)
Inter 1.5 (0.6) 1.3 (0.5)
Post 1.0 (0.4) 0.9 (0.3)
I lc eatment Expectat1onsM 
Heasure
Treatment Expectations Questionnaire
Pre 26.3 (3.7) 27.5 (2.7)
H e a r"  Measures 
Total Phobia Score
Pre 48.1 (20.9) 49.5 (23.6)
Inter 44.5 (20.7) 45.6 (22.8)
Post 37.8 (18.3) 39.5 (21.1)
Agoraphobia Score
Pre 21 .0 (7 .1 ) 19.5(10.6)
Inter 19.1 (6.7) 18.3 (10.0)
Post 14.8 (5.2) 13.9(8.2)
2.4 (2.1)
2.5 (2.3)
1.5 (0.7)
1.6 (0.7)
1.6 ( 0.6 )
53.3(17.8)
53 .8(17.9)
51.3(18.4)
21.3 (7.0)
22.1 (7.3)
22.2 (7.6)
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Table 5
Significance of Trealment, Session, Interaction, and Simple Main Effects for Dependent Measures
Source (F tests)
i^dabl£s_ Treat Session AXB A at A a l  A J i. P at B at B at
ment (B) Ere Inter Post Moncoq Cog Cont
(A)
^SOte-Attack"
Vaciabis
frequency of 
panic Attacks
0.19 39.20* 5 .37*
1 Anxletv" 
Madabies
State Anxiety 0.36 74.39* 31.20*
Anxiety Dimension 
of BSI
0.64 36.61* 9 .46*
Anxiety"
xarlahlo<^
Phobic Anxiety 
Dimension of BSI
0.35 40.58* 2.92*
Dhsesslve-Compulsive 
Dimension of BSI
0.3» 8.48* 0.97
Patlng Scale of 
Phobic Anxiety
4.27* 35.02* 15.03
Agoraphobic Cognitions 
Questionnaire
0.46 53.75* 8.09*
j*°dy Sensations 
Questionnaire
0.21 41.66* 5.43*
Anxiety on Behavior 
Avoidance Test
1.47 54.56* 0.82*
0.08 0.08 0.63 25.87* 21.09* 1.72
✓
0.38 0.18 0.49 72.64* 68.06* 3.06
0.09 0.02 2.57 23.98* 33.57* 0.46
0.04 0.07 0.47 21.42* 23.57* 2.72
0.51 0.80 5 .44* 42.80* 22.62* 2.82
0.32 0.11 0.28 42.89* 25.53* 3 .64* .
0.14 0.06 0.19 33.09* 18.49* 0.13
0.14 n.a. 2.90 41.36* 24.52* 0.65
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Table 5 cont’d
IBehavinral Avoidance'*
Variable?
Rating Scale of 3.77" 36.60* 12.88" 0.25 1.00 3 .77* 24.84*
Avoidance
Behavior Avoidance 3.35* 125.67* 27.49* 0.04 n.a. 5.95" 67.41*
Test
-fiM a l Distress-
Maciabis
Global Distress 0.95 26.16* 9 .49* 0.12 0.24 1.82 29.67*
Measure
ITreatmont Expectations'
Variably
Treatment Expectations 0.39 —
Questionnaire
0.65 59.02* 7.36* 0.06 0.23 0.54 32.70* 41.71* 2.03
0.96 48.38* 16.36* 0.06 0.24 1.23 45.91* 38.14* 1.05
* P < .05
Total Phobia Score 
Agoraphobia Score
39.03* 0.99 
98.12* 0.00
16.63* 0.00
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no significant change from preassessment to Intermediate assessment for both therapy 
groups on the frequency of panic attacks measure.
Results of Hypothesis Testing. Findings Indicated that subjects in the two therapy 
groups Improved significantly over the assessment sessions. The cognitive and noncognitive 
treatment conditions did demonstrate a significant reduction 1n self-reported frequency of 
panic attacks, however this reduction was not significantly different from those not exposed 
to the therapy manipulations. Therefore, hypothesis 1 a was only partially supported.
There was no evidence to Indicate that the cognitive treatment group demonstrated a 
reduction In self-reported frequency of panic attacks, which was significantly greater than 
that reported by subjects In the noncognitive group. Therefore, hypothesis 1 b was not 
supported.
(2 ) “GeneralAnxiety" Hypotheses
Hypotheses 2ab (1): State Anxiety Score from the State-Tralt Anxiety 
iriventorv
Means and standard deviations for scores on the state anxiety scale of the state-tralt 
anxiety Inventory are presented In Table 4 . The mean state anxiety score for each 
treatment group at pre, Intermediate, and posttreatment test session are Illustrated In 
Figure 2. Results of a three X three repeated measures ANOVA ( see Table 5) yield no 
significant main effect for group on the state anxiety score. However, results Indicated a 
significant main effect for assessment session, F(2,58) = 74.39, p< .05, and a significant 
group X session interaction, F(4,58) *  31.20, p< .05.
Simple main effects analyses Indicated that the state anxiety scores for the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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noncognitive group and the cognitive group differed significantly over the three assessment 
sessions, F(2,58) = 72.64, p< .05, andF(2,58) = 68.86, p< .05, respectively. The 
waiting list control group did not differ significantly over the three assessment sessions.
The simple main effects analyses conducted to determine whether the three treatment groups 
differed 1n terms of state anxiety, at each assessment session, Indicated that there were no 
significant differences. However, visual Inspection of Figure 2, Indicated that at posttest 
both therapy groups showed a nonsignificant trend toward more reduction of self-reported 
state anxiety, than the control group. These results are presented In Table 5 .
Newman-Keuls post-hoc multiple comparisons ( = ,05) on the means involved in the 
Interaction indicated that both noncognitive and cognitive groups reported significantly 
lower state anxiety scores at postassessment than at preassessment or Intermediate
assessment. Both therapy groups reported significantly less state anxiety at intermediate 
assessment than at preassessment.
Results of Hypothesis Testing Findings Indicated that subjects In the two therapy 
Qroups Improved significantly over the assessment sessions. The cognitive and noncognitive 
treatment conditions did demonstrate a significant reduction in self-reported state anxiety, 
however, this reduction was not significantly different from those not exposed to the therapy 
manipulations. Therefore, hypothesis 2a( 1) was only partially supported. There was no 
evidence to indicate that the cognitive treatment group demonstrated a reduction in state 
anxiety, which was significantly greater than that reported by subjects In the noncognitive 
Qnoup. Therefore, hypothesis 2b (1 ) was not supported.
idypotheses 2ab ( 7 \ .  Anxiety Dimension of B rief Svmotom Inventory
Means and standard deviations for scores on the anxiety dimension of the brief
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symptom Inventory are presented 1ri Table 4 . The mean score on the anxiety dimension for 
each treatment group at pre, Intermediate, and posttreatment test session are Illustrated 1n 
Figure 3 . Results of a three treatments X three repeated measures ANOVA ( see Table 5 ) 
revealed no significant main effect for group on the anxiety dimension of the brief symptom 
Inventory. However, results Indicated a significant main effect for assessment session, 
F(2,58) = 36.61, p< .05, and a significant group X session interaction, F(4,58) = 9.46, p 
<.05.
Simple main effects analyses Indicated that the anxiety dimension scores for the 
noncognitive group and the cognitive group differed significantly over the three assessment 
sessions, F(2,58) = 23.98, p< .05, andF(2,58) = 33.57, p< .05, respectively. The 
waiting list control group did not differ significantly over the three assessment sessions.
The simple main effects analyses conducted to determine whether the three treatment groups 
differed In terms of anxiety dimension scores, at each assessment session, indicated that 
there were no significant differences. However, visual Inspection of Figure 3, Indicated 
that at posttest both therapy groups demonstrated a nonsignificant trend toward more 
reduction of self-reported anxiety dimension scores, than the control group. These results 
are presented In Table 5.
Newman-Keuls post-hoc multiple comparisons ( = .05) on the means Involved In the 
Interaction Indicated that both noncognitive and cognitive groups reported significantly 
lower anxiety dimension scores at postassessment than at preassessment or Intermediate 
assessment. Both therapy groups reported lower anxiety dimension scores at Intermediate 
assessment than at preassessment.
Results of Hypothesis Testing. Findings indicated that subjects In the two therapy 
groups Improved significantly over the assessment sessions. The cognitive and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Mean Score on 
Anxiety 
Dimension of 
Brief Symptom 
Inventory
Non-Cognltlve O -  Cognitive
Pre
' Wailing List
1
18
16
14
12
10
8
6
4
2
0
In ter
Assessment Session
Post
FIGS. SUBJECTS’ MEAN SCORE ON ANXIETY DIMENSION OF BRIEF SYMPTOM INVENTORY AT
PRE. INTER AND POST-TREATMENT
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
77.
noncognitive treatment conditions did demonstrate a significant reduction 1n self-reported 
anxiety dimension scores, however, this reduction was not significantly different from those 
not exposed to the therapy manipulations. Therefore hypothesis 2a (2 ) was only partially 
supported. There was no evidence to Indicate that the cognitive treatment group 
demonstrated a reduction 1n anxiety dimension scores, which was significantly greater than 
that reported by subjects In the noncognitive group. Therefore, hypothesis 2b (2 ) was not 
supported.
( 3 )  "Phobic Anxiety" Hypotheses
Hypotheses 5ab (1): Phobic Anxiety Dimension of Brief Symptom 
inventory
Means and standard deviations for scores on the phobic anxiety dimension of the brief 
symptom Inventory are presented in Table 4 . The mean score on the phobic anxiety 
dimension for each treatment group at pre, Intermediate and posttreatment test session are 
Illustrated In Figure 4. Results of a three X three repeated measures ANOVA (see Table 5 ) 
yield no significant main effect for treatment group on the phobic anxiety dimension of the 
brief symptom inventory. However, results Indicated a significant main effect for 
assessment session, F(2,58) s 40.58, p< .05, and a significant group X session interaction, 
F(4,58) = 2.92, p< .05.
Simple main effects analyses Indicated that the phobic anxiety scores for the 
noncognitive group and the cognitive group differed significantly over the three assessment 
sessions, F(2,58) = 21.42, p< .05, and F(2,58) = 23.57, p< .05, respectively. The 
waiting list control group did not differ significantly over the three assessment sessions.
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The simple main effects analyses conducted to determine whether the three treatment groups 
differed in terms of phobic anxiety scores, at each assessment session, Indicated that there 
were no significant differences. However, visual inspection of Figure 4 Indicated that at 
posttest both therapy groups demonstrated a nonsignificant trend toward more reduction of 
self-reported phobic anxiety scores, than the control group. These results are presented in 
Table 5 .
Newman-Keuls post-hoc multiple comparisons ( = .05) on the means Involved in the
interaction Indicated that both noncognitive and cognitive groups reported significantly 
lower phobic anxiety dimension scores at postassessment than at preassessment or 
intermediate assessment. Both therapy groups reported lower phobic anxiety dimension 
scores at Intermediate assessment than at preassessment.
Results of Hypothesis Testing Findings Indicated that subjects 1n the two therapy 
groups Improved significantly over the assessment sessions. The cognitive and 
noncognitive groups did demonstrate a significant reduction In self-reported phobic anxiety 
, however, this reduction was not significantly different from those not exposed to the 
therapy manlpluations. Therefore, hypothesis 3a (1 ) was only partially supported. The 
cognitive group did not demonstrate a reduction in phobic dimensions scores, which was 
significantly greater than that reported by subjects In the noncognitive group. Therefore, 
hypothesis 3b (1 ) was not supported.
Hypotheses 3ab (2)-. Obsessive Compulsive Dimension of Brief Symptom Inventory
Means and standard deviations for scores on the obsessive compulsive dimension of the 
brief symptom Inventory are presented in Table 4 . The mean obsessive-compulsive score 
tor each treatment group at pre, intermediate and posttreatment test session are
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Illustrated tn Figure 5. Results of a three X three repeated measures ANOVA ( see T able 5 ) 
yield no significant main effect for treatment group on the obsessive compulsive dimension 
of the brief symptom Inventory. There was no significant group X session Interaction, 
however, results Indicated a significant main effect for assessment session, F(2,58) =
5.48, p< .05.
Newman-Keuls post-hoc multiple comparisons ( = .05) on the means Involved In the
session main effect Indicated that subjects reported significantly higher 
obsessive-compulsive scores at session one than at session three. There were no other 
significant differences.
Results of Hypothesis Testing. Hypothesis 3a ( 2 )  and 3b ( 2 )  were not supported.
Hypotheses 3ab (3): Watson and Marks (1971) Rating Scale of Phobic 
Anxiety
Means and standard deviations for scores on Watson and Marks (1971) rating scale of 
Phobic anxiety are presented In Table 4 . The mean rating scale of phobic anxiety score for 
each treatment group at pre, Intermediate and posttreatment test session are Illustrated In 
figure 6. Results of a three treatments X three repeated measures ANOVA (see Table 5 ) 
revealed a significant main effect for treatment group and a significant main effect for 
assessment session, F(2,58) = 4.27, p< .05 and F(2,58) = 35.02, p< .05, respectively. 
A significant group X session Interaction, F(4,58) = 15.03, p< .05, was also revealed.
Simple main effects analyses Indicated that the phobic anxiety scores for the 
noncognitive group and the cognitive group differed significantly over the three assessment 
sessions, F(2,58) = 42.80, p< .05, and F(2,58) = 22.62, p< .05, respectively. The 
walt1ng list control group did not differ significantly over the three assessment sessions.
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Simple main effects analysis Indicated that at postassessment the three treatment groups 
differed significantly, F(2,58) = 5.44, p< .05. These results are presented In Table 5 .
Newman-Keuls post-hoc multiple comparisons ( ■ .05) on the means Involved 1n the 
Interaction Indicated that both noncognitive and cognitive groups reported significantly 
lower scores on Watson and Marks (1971) rating scale of phobic anxiety at postassessment 
than at preassessment or Intermediate assessment. Both therapy groups reported lower 
rating scale of phobic anxiety scores at intermediate assessment than at preassessments.
Scheffe tests ( = .05; cell means Involved have unequal number of subjects per cell) 
Indicated that at postassessment the noncognitive and cognitive groups reported significantly 
lower scores than the waiting list control group. The two therapy groups did not differ 
significantly at postassessment.
Results of Hypothesis Testing. Findings Indicated that subjects In the two therapy 
groups Improved significantly over the assessment sessions. These findings also Indicated 
that the therapy groups reported lower phobic anxiety scores than the control group at 
postassessment. The cognitive and noncognitive treatment conditions did demonstrate a 
significant reduction In self-reported phobic anxiety, and this reduction was significantly 
niore than that reported by subjects in the control condition. Therefore, hypothesis 3a (3 ) 
was supported. The cognitive therapy group did not demonstrate a reduction in 
self-reported phobic anxiety greater than that reported by subjects in the noncognitive 
group. Therefore, hypothesis 3b (3 ) was not supported.
Hypotheses 3ab ( 4): Agoraphobic Cognitions Questionnaire
Means and standard deviations for scores on the agoraphobic cognitions questionnaire
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are presented 1n Table 4 . The mean score on the agoraphobic cognitions questionnaire tor 
each treatment group at pre, Intermediate, and posttreatment test session are Illustrated In 
figure 7. Results of a three treatments X three repeated measures AN0VA( see Table 5 ) 
yield no significant main effect for treatment group on the agoraphobic cognitions 
questionnaire. However, results Indicated a significant main effect for assessment session, 
F(2,58) = 53.75, p< .05, and a significant group X session Interaction, F(4,58) = 8.09,
P< .05.
Simple main effects analyses indicated that the agoraphobic cognitions scores for the 
noncognitive, cognitive and the waiting list control group differed significantly over the 
three assessment sessions, F(2,58)= 42.89, p< .05, F(2,58) = 25.53, p< .05, F(2,58) = 
3.64, p< .05, respectively. The simple main effects analyses conducted to determine 
whether the three groups differed In terms of agoraphobic cognitions scores, at each 
assessment session, Indicated that there were no significant differences. However, visual 
Inspection of Figure 7, Indicated that at posttest both therapy groups demonstrated a 
nonsignificant trend toward more reduction of self-reported agoraphobic cognition scores, 
than the control group. These results are presented In Table 5 .
Newman-Keuls post-hoc multiple comparisons ( = .05) on the means Involved In the 
Interaction indicated that both non-cognitive and cognitive groups reported significantly 
lower agoraphobic cognitions scores at postassessment than at preassessment or 
Intermediate assessment. Results for the noncognitive group Indicated that subjects 
reported significantly lower agoraphobic cognitions scores at Intermediate 
assessment than at preassessment. The cognitive group did not differ significantly between 
pre and Intermediate assessment. For the waiting list control group results Indicated that 
subjects scored significantly higher at Intermediate assessment than at preassessment or
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postassessment
Results of Hypothesis Testing. Findings Indicated that all three treatment groups 
changed significantly over the assessment sessions. The cognitive and noncognitive group? 
did demonstrate a significant reduction fn self-reported agoraphobic cognitions scores, 
however, the waiting-llst control group also showed a significant change. Both therapy 
groups showed improvement at postassessment. The control group demonstrated a 
significantly higher agoraphobic cognitions score at intermediate assessment than at the 
other two assessment sessions. None of the groups differed significantly from one another at 
each of the assessment sessions. Therefore, hypothesis 3a (4) was only partial Iv supported. 
The cognitive treatment group did not demonstrate a reduction in agoraphobic cognitions, 
which was significantly greater than that reported by subjects in the noncognitive group. 
Therefore, hypothesis 3b (4 ) was not supported.
hypotheses 3ab (5): Body ■Sensations Questionnaire
Means and standard deviations for scores on the body sensations questionnaire are 
presented in Table 4. The mean score on the bod/ sensations questionnaire for each 
treatment group at pre, Intermediate and posttreatrnent test sessions are illustrated in 
Figure 8. Results of a three treatments X three repeated measures ANOVA ( see Table 5 ) 
yield no significant main effect for treatment group on the body sensations questionnaire. 
However, results Indicated a significant main effect for asssessment session, F(2,58) =
41.66, p< .05, and a significant group X session interaction, F( 4,58) * 5.43, p< .05 
Simple main effects analyses Indicated that the body sensations scores for the 
noncognitive and cognitive groups differed significantly over the three assessment sessions, 
F(2,58) *  33.09, p< .05, andF(2,58) -  18.49, p< ,05, respectively. The
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control group did not differ significantly over the three assessment sessions. The simple 
main effects analyses conducted to determine whether the three treatment groups differed in 
terms of body sensations scores, at each assessment session, indicated that there were no 
significant differences. However, visual Inspection of Figure 8. indicated that at posttest 
both therapy groups demonstrated a nonsignificant trend toward more reduction of 
self-reported body sensation scores, than the control group. These results are pr esented in 
Table 5 .
Mewman-Keuls post-hoc multiple comparisons ( = .05) on the means Involved in the 
Interaction indicated that both the noncognitlve and cognitive groups reported significantly 
lower body sensations scores at post assessment than at preassessment or intermediate 
assessment. There was no significant change from preassessment to intermediate assessment 
for the cognitive group on the body sensations questionnaire. However, for the noncognitlve 
group the results indicated that subjects reported significantly less body sensations at 
intermediate assessment than at preassessment.
Results of Hypothesis Testing. Findings indicated that subjects in the two therapy 
groups Improved significantly over the assessment sessions. The cognitive and noncognitlve 
treatment groups did demonstrate a significant reduction 1n self-reported body sensations, 
however, this reduction was not significantly different from those not exposed to the therapy 
manipulations. Therefore, hypothesis 3a (5 ) was only partially supported. The cognitive 
treatment group did not demonstrate a reduction in frequency of body sensations scores, 
which was significantly greater than that reported by subjects in the noncognitive group. 
Therefore, hypothesis 3b (5 ) was not supported.
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Hypotheses 5ah (6): Self-Report of Anxiety ori the Behavior Avoidance 
J fist.
Means and standard deviations for scores on the self-report anxiety scale of the 
behavior avoidance test are presented 1n Table 4 . The mean self-report anxiety scor e for 
each treatment group at pre, and posttreatment test session are illustrated in Figur e 9 
Results of a three treatments X two repeated measures ANOVA ( see Table 5 ) vleld no 
significant main effect for treatment group on the self-report, of anxiety on the behavior 
avoidance test. However, results Indicated a significant main effect for assessment session, 
f (1 ,29) = 54.54, p< .05, and a significant group X session interaction, F(2,29) = 8.82,
P< .05
Simple main effects analyses Indicated that the anxiety scores for the noncognitlve and 
cognitive groups differed significantly over the two assessment sessions, F(2,58) « 41.36, 
P< .05, F(2,58)= 24.52, p< .05, respectively. Both therapy groups reported significantly 
lower anxiety on the behavior avoidance test at posttreatment than at pretreatment. The 
control group did not differ significantly over the assessment sessions. The simple main 
effects analyses conducted to determine whether the three treatment groups differed in 
terms of anxiety on the behavior avoidance test, at each assessment session, indicated that 
there were no significant differences. However, visual inspection of Figure 9, indicated that 
at posttest both therapy groups demonstrated a nonsignificant trend toward more reduction 
of self-reported anxiety on the behavior avoidance test, than the control group. These 
results are presented In Table 5 .
Results of Hypothesis Testing. Findings indicated that subjects in the two therapy 
groups Improved significantly over the two assessment sessions. The cognitive and 
noncognitlve treatment conditions did demonstrate a significant reduction In self-reported
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anxiety on the behavior avoidance test, however, this reduction was not significantlv 
different from those not exposed to the therapy manipulations Therefore, hypothesis 3a 
(6) was only partially supported. The cognitive treatment group did not. demonstrate a 
reduction in self-reported anxiety on the behavior avoidance test, which was significantly 
greater than that reported by subjects in the noncognltive group. Therefore, hypothesis 3b 
(6 ) was not supported.
( 4 )  "BehavioralAvoidance" Hypotheses
Hypotheses 4ab ( 1): Watson and Marks ( 1 9 7 1 )  Rating Scale of Avoidance
Means and standard deviations for scores on Watson and Marks (1971) rating scale of 
avoidance are presented In Table 4 . The mean score on the rating scale of avoidance for each 
tr eatment group at pre, Intermediate and posttreatment test session are illustrated in 
Figure 10. Results of a three X three repeated measures ANOVA ( see Table 3 ) revealed a 
significant main effect for treatment group on the Watson and Marks (1971) rating scale of 
avoidance, F(2,29) *  3.77, p< .05. Results also Indicated a significant main effect for 
assessment session, F (2 ,58 )« 36.80, p< .05, and a significant group X session interaction, 
F (4,58)= 12.88, p<.05.
Simple main effects analyses indicated that the avoidance scores for the noncognitlve 
and cognitive groups differed significantly over the three assessment sessions, F( 2,58) - 
24.84, p< .05, and F(2,58)= 39.03, p< .05, respectively. The waiting list control group 
did not differ significantly over the assessment sessions. Simple main effects analysis 
Indicated that at postassessment the three treatment groups differed significantly, Ft 2 ,581 
a 3.77, p< .05.
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Newman-Keuls post-hoc multiple comparisons ( *  .05) on the means Involved 1r>
the Interaction indicated that both noncognitive and cognitive groups reported significantly 
lower scores on Watson and Marks (1971) rating scale of avoidance at postassessment than 
at preassessment or Intermediate assessment. There was no significant change from 
preassessment to intermediate assessment for the noncoqnltive group on the avoidance 
measure. However, for the cognitive group the results Indicated that subjects reported
significantly less avoidance at Intermediate assessment than at preassessment.
Scheffe tests Indicated ( -  .05) that at postassessment the noncognitlve and cognitive
groups reported significantly lower scores than the waltlng-list control group. The two 
therapy groups did not differ significantly at postassessment.
Results of Hypothesis Testing Findings indicated that subjects in the two therapy 
groups improved significantly over the assessment sessions. At postassessment, the 
cognitive and noncognitlve groups reported a significant reduction in self-reported 
avoidance scores and this reduction was significantly different from the scores reported by 
the waiting list control group. Therefore, hypothesis 4a (1 ) was supported. The cognitive 
treatment group did not demonstrate a reduction in avoidance scores , which was 
significantly greater than that reported by the noncognitlve subjects. Therefore, hypothesis 
4b ( I ) was not suppor ted.
Hypotheses 4ah (2): Behavior Avoidance Test
Means and standard deviations for scores on the behavior avoidance test are presented 
In Table 4 . The mean score on the behavior avoidance test for exh treatment group at pre, 
and posttreatment test session are Illustrated In Figure 11. Results of a three X two
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repeated measure ANOVA ( see Table 5 ) yielded a significant main effect for treatment 
group, Ft 2,29)= 3.35, p< .05, a significant main effect for assessment session, Ft 1,291= 
127.67, p< .05, and a significant group X session Interaction, Ft 2,29)= 27.49, p ' 05.
Simple main effects analyses indicated that the behavior avoidance test scores for the 
noncognitlve and the cognitive groups differed significantly over the two assessment 
sessions, F(2,58)= 67.41, p< .05, and Ft 2,58)= 98.12, p< .05, respectively Both 
therapy groups reported significantly higher behavior avoidance test scores at post­
assessment than at preassessment. The control group did not differ significantly over the 
assessment sessions. Simple main effects analysis indicated that the three treatment groups 
differed significantly at postassessment, F(2,29) = 5.95, p< .05.
Scheffe tests Indicated ( = .05) that at postassessment the noncognitlve and cognitive 
groups reported significantly higher scores than the waitlng-llst control group. The two 
therapy groups did not differ significantly at postassessment.
Results of Hypothesis Testing. Findings Indicated that subjects In the two therapy 
groups Improved significantly over the two assessment sessions. At postassessment, the 
cognitive and noncognitlve groups reported a significant Increase in self-reported behavior 
avoidance test scores, and these scores were significantly higher than those reported by 
subjects In the waitlng-llst control group. Therefore, hypothesis 4a (2 ) was supported.
The two therapy groups did not differ significantly at postassessment. Therefore, hypothesis 
4b (2 ) was not supported.
(5 ) "Global Distress” Hypotheses
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Hypotheses 5a and 5b: Global Distress Measure from the Brief SvmDlom 
Inventory
Means and standard deviations for scores on the global severity Index from the brief 
symptom Inventory are presented In Table A . The mean global severity Index score for each 
treatment group at pre. Intermediate and posttreatment test session are Illustrated In 
Figure 12. Results of a three X three repeated measures ANOVA t see Table 5 ) yield no 
significant main effect for treatment group on the global distress Index measure. However, 
results Indicated a significant main effect for assessment session, F(2,58)= 26.16, p< .05, 
and a significant group X session Interaction, Ft 4,58)= 9.49, p < .05.
Simple main effects analyses Indicated that the global distress scores for the 
noncognitlve and cognitive groups differed significantly over the three assessment sessions, 
F(2,58)= 29.67, p< .05, and F(2,58)= 16.63, p< .05, respectively. The control group did 
not differ significantly over the assessment sessions. The simple main effects analyses 
conducted to determine whether the three treatment groups differed In terms of global 
distress scores, at each assessment session, indicated that there were no significant 
differences. However, visual Inspection of Figure 12, indicated that at posttest both 
therapy groups demonstrated a nonsignificant trend toward more reduction of self-reported 
global distress, than the control group. These results are presented in Table 5.
Newman-Keuls post-hoc multiple comparisons C = .05) on the means Involved In the 
Interaction Indicated that both noncognitlve and cognlttve groups reported significantly 
lower global index scores at postassessment than at pre- or Intermediate assessment. There 
was no significant change from preassessment to intermediate assessment for both therapy 
groups on the global severity Index.
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Results of Hypothesis Testing. Findings indicated that subjects in the 
two therapy groups Improved significantly over the assessment sessions. The cognitive and 
noncognitlve groups did demonstrate a significant reduction In self-reported global distress, 
however, this r eduction was not significantly different from those not exposed to the ther apy 
manipulations. Therefore, hypothesis 5a was only partially supported. T here was no 
evidence to indicate that the cognitive treatment group demonstrated a reduction in global 
distress, which was significantly greater than that reported by subjects In the noncognitlve 
group. Therefore, hypothesis 5b was not supported.
Subsidiary Hypotheses 
( D  "Treatment.Expectations"Hypothesis
Means and standard deviations for scores on the treatment expectations questionnaire 
ore presented 1n Table 4. A one way analysis of variance, two treatments (cognitive and 
noncognitlve) X pretreatment score on the treatment expectations questionnaire, was 
conducted. No significant differences emerged among the two groups. These results are 
presented in Table 5 .
Results of Hypothesis Testing, Subjects exposed to the cognitive and noncognitlve 
treatment conditions did not manifest any significant differences on the treatment 
expectations questionnaire. Therefore, subsidiary hypothesis 1 was supported.
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(2) "Fear"Hypotheses
Hypotheses ?ab ( 1): Total Phobia Score on the Marks and Mathews Fear 
Quest I on no Ire
Means and standard deviations for scores on the total phobia scale of the Marks and 
Mathews fear questionnaire are presented in Table 4 . The mean total phobia score for each 
treatment group at pre, Intermediate and posttreatment test session are illustrated in 
figure 13. Results of a three treatments X three repeated measures ANOVA (see Table 5 ) 
yield no significant main effect for treatment group on the total phobia score of the fear 
Questionnaire. However, results Indicated a significant main effect for assessment session, 
F(2,58)= 59.02, p< .05, and a significant group X session interaction, F(4,58)= 7.36, p< 
•05.
Simple main effects analyses Indicated that the total phobia scores for the noncognitlve 
and cognitive groups differed significantly over the three assessment sessions, F( 2,58)“  
32.70, p< .05, and F( 2,58)= 41.71, p< .05, respectively. The control group did not differ 
significantly over the assessment sessions. The simple main effects analyses conducted to 
determine whether the three treatment groups differed in terms of total phobia scores, at 
each assessment session, indicated that there were no significant differences. However, 
visual inspection of Figure 13, indicated that at posttest both therapy groups demonstrated 
a nonsignificant trend toward more reduction of self-reported total phobia scores, than the 
control group. These results are presented in Table 5 .
Newman-Keuls post-hoc multiple comparisons ( = .05) on the means involved In the 
Interaction Indicated that both noncognitlve and cognitive groups reported significantly 
lower total phobia scores at postassessment than at pre- or intermediate assessment. Both
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therapy gr oups r eported significantly lower total phobia scores at intermediate assessment 
than at. preassessment.
Results of Hypothesis Testing Findings indicated that subjects In the two therapy 
groups improved significantly over the assessment sessions. The cognitive and noncognitlve 
treatment conditions did demonstrate a significant reduction in total phobia score, however, 
this reduction was not significantly different from those not exposed to the therapy 
Manipulations. Therefore, subsidiary hypothesis 2a ( I)  was only partially supported. The 
cognitive group did not demonstrate a reduction in total phobia scores, which was 
significantly greater than that reported by subjects in the noncognitivo group. Therefore, 
subsidiary hypothesis 2b (1 ) was not supported.
fdyp.otheses.2ab (2); Agoraphobic Score on the harks and Mathews Fear 
Questionnaire
Means and standard deviations for scores on the agoraphobic fear scale of the Marks and 
Mathews fear questionnaire are presented In Table 4 . The mean agoraphobic fear score for 
each treatment group at pre, intermediate and posttreatment test session are illustrated in 
figure 14. Results of a three treatments X three repeated measures ANOVA (see Table 5 ) 
yield no significant main effect for treatment group on the agoraphobia score of the fear 
questionnaire. However, results indicated a significant main effect for treatment session,
F(2,58) = 48.38, p< .05, and F(4,58)= 16.36, p< .05.
Simple main effects analyses indicated that the agoraphobic fear scores for the 
noncognitlve and cognitive groups differed significantly over the three assessment sessions, 
F(2,58) = 45.91, p< .05, and F(2,58) = 38.14, p< .05, respectively. The control group 
did not differ significantly over the assessment sessions. The simple main
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effects analyses conducted to determine whether the three treatment groups differed In 
terms of agoraphobic fear scores, at each assessment session, Indicated that there were no 
significant differences, However, visual Inspection of Figure 14, Indicated that at posttest 
both therapy groups demonstrated a nonsignificant trend toward more reduction of 
self-reported agoraphobia scores, than the control group. These results are presented 1n 
Table 5.
Newman-Keuls post-hoc multiple comparisons on the means involved In the 
Interaction indicated that both the noncognitlve and cognitive groups reported significantly 
lower agoraphobic fear scores at postassessment than at pre- or Intermediate assessment. 
There was no significant change from preassessment to Intermediate assessment for the 
cognitive group on the agoraphobic fear measure. However, for the noncognitlve group the 
subjects reported significantly lower agoraphobic fear scores at Intermediate assessment 
than at preassessment.
Results of Hypothesis Testing. Findings Indicated that subjects in the therapy groups 
Improved significantly over the assessment sessions. The cognitive and noncognitlve 
treatment conditions did demonstrate a significant reduction In agoraphobia score, however, 
this reduction was not significantly different from those reported by the control group. 
Therefore, subsidiary hypothesis 2a (2 ) was only partially supported. The cognitive group 
did not demonstrate a reduction In agoraphobia score, which was significantly greater than 
that reported by subjects In the noncognitlve group. Therefore, subsidiary hypothesis 2b 
(2 ) was not supported.
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CHAPTER IV 
DISCUSSION
The purpose of this study was to determine whether In vivo exposure treatment of 
OQoraphobla could be made more efficient by incorporating cognitive modification techniques 
into the treatment. One experimental group received In vivo exposure with cognitive 
restructuring, and the other experimental group received in vivo exposure without 
cognitive restructuring. The waltlng-list control group received neither in vivo exposure 
or In vivo exposure + cognitive restructuring.
Bsdflw of Hypolhes M s sting
The results of the present Investigation clearly suggest that in vivo exposure treatment 
of agoraphobia could not be made more efficient by Incorporating cognitive restructuring 
into the treatment. Multiple measures of change yielded no significant improvement in 
phobic symptomotology for subjects in the walting-list control group. The lack of change in 
the control group contrasts with the improvement obtained In the two therapy groups. Doth 
therapy groups were accompanied by marked and significant reduction In phobic 
symptomotology as measured on the following scales (a) Watson and Marks (1971) rating 
scale of phobic anxiety ( b) Watson and Marks rating scale of avoidance, and (c) Behavior 
Avoidance Test. The two therapy groups also displayed a consistent but nonsignificant trend 
toward Improvement on a number of different measures including, (a) Frequency of panic 
attacks (see Fig. 1 ), (b) State anxiety score (see Fig. 2 ), (c) Anxiety dimension of DSI
-  104-
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(see Fig. 3 ), (d) Phobic anxiety dimension of BSI (see F1g. 4 ), (e) Agoraphobic cognitions 
guestlonnalre (see Fig. 7 ), ( f)  Bod/ sensations questionnaire (see Fig 8 ), (g) Self-report 
of anxiety on BAT (see Fig. 9 ), (h) Global distress measure from BSI (see Fig. 12 ) , ( i )  
Total phobia score from the fear questionnaire (see F1g. 13 ), and ( J) Agoraphobia score 
from the fear questionnaire (see F1g. 14 ).
Results of hypothesis testing are summarized In Table 7. Hypotheses 3a 13), 4a (1 ), 
and 4a (2 ) were fully supported. Results Indicated that there was a significant 
Improvement on the three relevant measures across sessions for both therapy groups, and 
this Improvement was significantly greater than that reported by the control group at 
Posttest. Hypotheses la, 2a (1 ), 2a (2 ), 3a (1 ), 3a (4 ), 3a (5 ), 3a (6 ), 5a, and 
subsidiary hypotheses 2a (1 ), 2a (2 ) were partially supported. Evidence suggested that on 
the ten relevant measures there was an improvement across sessions for both therapy 
Qroups, however, this Improvement was not significantly greater than that demonstrated by 
the control group. There was no support for hypotheses 3a (2 ), as results did not suggest 
that the therapy groups Improved across sessions on the obsessive compulsive dimension of 
the BSI. Hypotheses 1b, 2b (1 ), 2b (2 ), 3b (1 ), 3b (2 ), 3b (3 ), 3b (4 ), 3b (5 ). 3b
(6 ), 4b (1 ), 4b (2 ), 5b, subsidiary hypotheses 2b (1 ), 2b (2 ) failed to receive any 
support. There was no evidence to Indicate that the noncognitlve or cognitive groups 
differed significantly from one another on any of the fourteen relevant dependent measures. 
Results indicated no significant difference between the therapy groups on the treatment 
expectations questionnaire. Therefore, subsidiary hypothesis 1 was fully supported.
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Table 6
Summary of Hypothesis Testing
Hypothesis Dependent Measure Outcome
^Panlc Attack' 
Hypotheses
la*
1b
Frequency of Panic Attacks
Frequency of Panic Attacks
Significant reduction for both 
therapy groups, but no significant 
difference from control X sessions. 
Partial support for hypothesis.
Ho significant difference between 
therapy groups X sessions. No 
support for hypothesis.
G en era l Anxiety" 
Hypotheses
2a ( 1 ) *
2b (1 )
2a (2 )*
2b (2 )
State Anxiety Score
State Anxiety Score
Anxiety Dimension of BSI
Anxiety Dimension of BSI
Significant reduction for both 
therapy groups, but no significant 
difference from control X sessions. 
Partial support for hypothesis.
No significant difference between 
therapy groups X sessions. No 
support for hypothesis.
Significant reduction forboth 
therapy groups, but no significant 
difference from control X sessions. 
Partial support for hypothesis.
No significant difference between 
therapy groups X sessions. No 
support for hypothesis.
2Ehobic Anxiety” 
Hypotheses
3a (1  ) * Phobic Anxiety Dimension 
of BSI
Significant reduction for both 
therapy groups, but no significant 
difference from control X sessions. 
Partial support for hypothesis.
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Table 6 cont'd 
3b (1)
3a (2)
3b (2)
3a (3 )* *
3b (3)
3a (4 )*
3b (4 )
3a (5 )*
3b (5)
3a (6 )*
3b (6)
Phobic Anxiety Dimension 
of BSI
Obsessive-Compulsive 
Dimension of BSI
Obsessive-Compulsive 
Dimension of BSI
Watson & Marks (1971) 
Scale of Phobic Anxiety
Watson & Marks (1971) 
Scale of Phobic Anxiety
Agoraphobic Cognitions 
Questionnaire
Agoraphobic Cognitions 
Questionnaire
Body Sensations Questionnaire
Body Sensations Questionnaire
Self-Report of Anxiety on 
BAT
Self-Report of Anxiety on 
BAT
Ho significant difference between 
therapv groups X sessions No 
support for hypothesis.
No significant change for three 
treatment groups. No support for 
hypothesis.
No significant difference between 
therapy groups X sessions. No 
support for hypothesis,
Significant reduction tor both 
therapy groups, and a significant 
difference from control X sessions. 
Full suonort for hypothesis.
No significant difference between 
therapy groups X sessions. No 
support for hypothesis.
Significant reduction for both 
therapy groups, but no significant 
difference from control X sessions. 
Partial support for hypothesis.
No significant difference between 
therapy groups X sessions. No 
support for hypothesis.
Significant reduction for both 
therapy groups, but no significant 
difference from control X sessions. 
Partial support for hypothesis
No significant difference between 
therapy groups X sessions. Ho 
support for hypothesis.
Significant reduction for both 
therapy groups, but no significant 
difference from control X sessions. 
Partial support for hypothesis.
No significant difforenco between 
therapy groups X sessions. No 
support for hypothesis.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
108.
Table 6 conVd
IBfihavloral Avoidance" 
Hypotheses
4a ( i ) * *
4b ( t )
4a (2 )
4b (2 )
Watson & Marks (1971) 
Scale of Avoidance
Watson &. Marks (1971) 
Scale of Avoidance
Behavior Avoidance Test
Behavior Avoidance Test
Significant reduction for both 
therapy groups, and a significant 
difference from control X sessions. 
Full support for hypothesis.
Mo significant difference between 
therapy groups X sessions. Mo 
support for hypothesis.
Significant reduction for both 
therapy groups, and a significant 
difference from control X sessions. 
Full support for hypothesis.
No significant difference between 
therapy groups X sessions. Mo 
support for hypothesis.
jp i&al Distress* 
Hypotheses
5a*
5b
Global Distress Measure 
from BSI
Global Distress Measure 
from BSI
Significant reduction for both 
therapy groups, but no significant 
difference from control X 
sesssions. Partial support for 
hypothesis.
Mo slgnificat difference between 
therapy groups X sessions. Mo 
support for hypothesis.
- I neatment Expects- 
Hsds" Subsidiary 
Hypothesis
Treatment Expectations 
Questionnaire
No difference between therapy 
groups. Full support for 
hypothesis.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
109.
Table 6 corifd
lEgar" Subsidiary 
Hypotheses
2a (1 )* Total Phobia Score
2b (1 ) Total Phobia Score
2a (2 )*  Agoraphobic Score
2b (2 ) Agoraphobic Score
*  Partially supports hypothesis 
* *  Fully supports hypothesis
Significant reduction for both 
therapy groups, but no significant 
difference from control X sessions. 
Partial support for hypothesis.
No significant difference between 
therapy groups X sessions. No 
support for hypothesis.
Significant reduction for both 
therapy groups, but no significant 
difference from control X sessions. 
Partial support for hypothesis.
No significant difference between 
therapy groups X sessions. No 
support for hypothesis.
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Comparisons with Relevant Research
This stu<fy was, to a certain extent, a replication and extension of the work of 
Emmelkamp et al. (1978), Emmelkamp and Mersch (1982) and Williams and Rappoport 
(1983) with the following design Improvements:
(1 ) The clinical treatment time that the subjects experienced, In the 
present study, was Increased.
(2 ) The assessment package was broadened to Incorporate behavioral, affective, and 
cognitive components. One of the problems with the literature on agoraphobia Is 
the variety of different scales used by different Investigators. This variety makes 
it difficult to compare results between studies. In an effort to make this present 
study more comparable, a variety of measures have been included. However, 
this variety introduces the problem of redundancy of assessment Instruments. 
Fortunately, with the use of this variety of assessment instruments it gives one 
the opportunity to look et the correlations between a number of measures used 
regularly In agoraphobia research.
(3 ) No specific fear was focussed on.
Notwithstanding these changes, the outcome of the present stud/ failed to find 
differential treatment outcome favouring the cognitive approach. These findings are 
essentially the same as found In a number of other studies (e.g., Emmelkamp & Mersch,
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1982; Williams and Rappoport, 1983).
The firs t published study (Emmelkamp & Mersch, 1982; il= 27), which combined 
cognitive restructuring with In vivo exposure Indicated that at posttest, prolonged exposure 
in vivo and exposure 1n vivo + cognitive restructuring were equal and clearly superior to 
cognitive restructuring on phobic anxiety and avoidance measures (Watson &. Marks, 1971) 
. and on the behavioural measure (standardized behavioral avoidance test). At the 1 -month 
follow-up, however, the differences between the treatments partly disappeared because of 
continuing Improvement 1n the cognitive restructuring condition, and a slight relapse 1n the 
exposure In vivo condition. Cognitive restructuring training did not enhance the effects of 
exposure 1n vivo at any time: The combined procedure was no more effective than the 
exposure In vivo condition. This study used the same phobic anxiety and avoidance measures 
(Watson & Marks, 1971) and a similar behavioral avoidance test as used in the present 
study. The results on these scales from both studies were essentially the same.
In the next study Williams and Rappoport (1983) attempted to assess the viability of a 
combined treatment package. Agoraphobics were assigned to two conditions; (1 ) exposure 
inv1vo(a= 10) and (2 ) exposure In vivo + cognitive restructuring (a= 10). Treatment 
was directed to their driving disabilities; other fears were not dealt with. Although both 
conditions Improved on subjective anxiety, only the exposure in vivo group gained 
significant benefit from treatment on the behavioral measure. Since this study focussed on 
one specific fear the assessment instruments were for the most part different from those 
used in the present stud/. However, one instrument, the fear questionnaire ( Marks & 
Mathews, J 979) was the same, and both therapy groups showed equivalent improvement on 
this scale. Because of the differences in assessment instruments used, it is difficult to
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study are very similar to those found In the present investigation.
Based on the last two studies and the present investigation the evidence Indicates that 1n 
vivo exposure combined with cognitive restructuring procedures Is not superior to 1n vivo 
exposure alone 1n treating agoraphobics. However, subsequent to the design of the present 
study several other relevant articles (Emmelkamp et al., 1986; Last et al., 1984; 
Mavlssakalaln et al., 1983) have appeared in the literature which are worthy of closer 
examination.
Mavlssakallan et al (1983) Investigated the Impact of two different cognitive strategies 
(self-instructional training and paradoxical Intention) on exposure In vivo. Results of 
Mavlssakallan et al's study (a= 24) Indicated that at the end of treatment, paradoxical 
Intention plus exposure evidenced greater gains than did self-Instructional training plus 
exposure. However, the self-Instructional training condition continued to Improve after the 
posttest, which resulted In equivalent long-term effectiveness of the two treatments. Given 
that an exposure only group was not Included, It Is Impossible to determine whether the 
cognitive strategies enhanced the effects of exposure 1n vivo. This was an unfortunate 
omission as this study was methodologically adequate (e.g. .adequate treatment time, and 
assessment) otherwise, and would have aided In clariflng the role of a cognitive component 
In improving In vivo exposure treatment for agoraphobics.
The next study which addressed the Issue of efficacy of cognitive restructuring + In vivo 
exposure In treating agoraphobics was conducted by Last et al. (1984). The main purpose of 
this Investigation was to assess cognitive change during behavioral end cognitive-behavioral 
treatment of agoraphobia. Six agoraphobics participated In a treatment program consisting 
of 10 sessions of In vivo exposure , with half the subjects receiving an additional cognitive
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treatment component. Both treatments were administered 1n a multiple baseline design 
across subjects. The Marks and Mathews (1979) fear questionnaire and a standardized 
behavioral avoidance test very similar to the one used In the present study were two of the 
measures employed. Results on these scales, or on any other scales, showed neither 
treatment produced clear and consistent treatment outcome gains, or clear and consistent 
cognitive changes. The addition of a cognitive component to the In vivo exposure did not 
Improve treatment outcome. One could argue that 10 sessions might not be an adequate 
treatment time, and that the subjects did not have enough time to learn and Integrate their 
new cognitive skills.
The most recent study (Emmelkamp et al, 1986), examining the efficacy of adding a 
cognitive component to In vivo exposure treatment for agoraphobics, revealed that at 
posttreatment the cognitive stategles did not enhance the effects of exposure In vivo. This 
study was designed to Investigate the differential effectiveness of self-instructional 
training, rational emotive therapy and prolonged exposure In vivo. In addition to the short 
term effects after 3 weeks of treatment, possible delayed effects of treatments were assessed 
I month after treatment, during which period subjects received no further treatment. This 
was done to give subjects the opportunity to Integrate and practice their cognitive strategies 
in the natural environment. After this treatment-free period all subjects received 3 weeks 
of prolonged exposure In vivo, and were reassessed to evaluate possible Interactions between- 
cognitive strategies and exposure in vivo. In sum, results of the present study indicate that 
exposure In vivo was superior to cognitive treatment on measures for agoraphobia.
Further, there was no evidence that priming agoraphobic patients with cognitive therapy 
enhanced the overall effects of the exposure treatment. Again the fear questionnaire ( Marks 
& Mathews, 1979) and a behavioral avoidance scale similar to the one used 1n the present
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Investigation, were used 1n this stud/. On these scales there was no evidence to Indicate that 
the addition of a cognitive component to an In vivo exposure procedure Increased the efficacy 
of the treatment. This last study has a number of advantages over some of the other studies 
reviewed, namely, the treatment time of 6 weeks (approximately 60 hours) was adequate, 
and the sample size (fi= 39) was the largest of any of the studies reviewed. One problem 
with this study was the limited cognitive assessment.
A number of the dependent measures used In each of these studies were the same or very 
similar to those used 1n the present Investigation. Consistently, on these measures there 
was no Indication that In vivo exposure + cognitive restructuring was superior to In vivo 
exposure alone, In treating agoraphobia. The same results were evident for the other 
measures. In conclusion, the results of the present study suggest that cognitive strategies do 
not enhance the effects of exposure In vivo, corroborating the results of Emrnelkamp and 
Mersch (1982), Williams and Rappoport C1983), Last et al., (1984) arid Emrnelkamp et 
al., (1986).
Along with the present study, and the other studies, It seems to Indicate the limited role 
of cognitive procedures In treatment of agoraphobia. At least, for those agoraphobics defined 
by the DSM III system. There may be agoraphobics with a particular set of needs which 
would be better served by cognitive techniques.
Lack of Therapy Differences
In human experiments, changes In the dependent measures often may result from 
characteristics of the situation or Intervention that are not peculiar to the particular 
intervention. It is possible to conclude that something other than treatment might have
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obscured the differences between the two therapy groups, thus affecting the dependent 
measures obtained rendering them more equivalent than different.
In treatment research, the factors that may account for change often are especially 
difficult to Identify. However, there are at least five possible phenomena, either alone or In 
combination, which might be offered as an alternative explanation, for why despite the 
Intention that therapies be different from one another, they were in fact more equivalent 
than different, In the present investigation. These possibilities are:
(1 ) That nonspecific treatment effects such as motivation, faith In treatment, 
credibility of treatment, demand characteristics, attributes of the therapist such 
as supportiveness, enthusiasm, warmth, directiveness, encouragement of 
risk-taking, fostering of Independence,and expectations of succes were equivalent 
across therapy groups and were stronger than treatment effects;
(2 ) that a common mechanism of psychological change, referred to In current 
social learning theory literature as "perceived self-efficacy" (Bandura, 1977), 
was equally responsible for enhancing psychosxial functioning "through Its 
effects on choice behavior, effort expenditure, persistence, and self-guiding 
thought" In all subjxts (Bandura, 1980, p. 40).
(3 ) that cognitive change, a more generalized phenomenon than change specifically In 
perceived self-efficacy, was the superior xnstruct underlying change, and thus, 
differences between the therapy groups were obscured because of the overriding 
effect across groups of xgnitive change; i.e., "I am in x n tro l, I can cope; I have
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tools now" ( but differences between tools or techniques were not significant);
(4 ) that the standardized emphasis on 1n vivo exposure across therapy groups, 
including Instructions for hierarchy construction and homework assignments, 
therapist support, encouragement, and time allotted for group discussion on in 
vivo experiences, was stronger In Its equivalent Impact on all therapy groups 
than any differences In treatment. Marks’ conclusion (1978) that "exposure to 
the feared situation In reality 1s the basic mechanism shared by all successful 
therapies", might well account for the basic finding of nonsignificance between 
treatments In the present Investigation.
(5 ) that the results of the present study may not have been statistically significant 
but clinically significant. If one looks at the treatment efficacy one can see that 
within each of the experimental groups some clients Improve dramatically while 
others changed minimally. This erratic response to therapy suggests that 
significant uncontrolled variables were at work making the therapy treatments 
an effective treatment for some clients but not for others. Some of these 
uncontrolled variables have been alluded to above. This variance (error 
variance) 1s directly related to statistical significance. For a given difference 
between groups, the larger the error variance, the less likely w ill the results be 
statistically significant (Ka2d1n, 1980). This variability can disturb the 
Interpretation of findings. Because of the necessary use of statistical 
procedures the clinically significant findings can be hidden (Kazdin, 1980),
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Potentially significant clinical differences between the treatment groups as a 
result are missed.
In summary, considering the potency and speculated equivalence across groups of such 
phenomena as (1 ) nonspecific treatment effects, (2 ) perceived self-efficacy, (3 ) cognitive 
change as a superior construct which accounts for and overrides change In other domains,
(4 ) standardized emphasis on In vivo exposure, and (5 ) hidden clinical differences because 
of limitations with statistical procedures, It 1s possible that the two therapies were not 
different enough either to override the effects of these phenomena or to produce statistically 
significant differences In results between groups.
Cognitive Restructuring
An Interesting finding from the present Investigation was that the addition of a 
cognitive restructuring component to the in vivo exposure did not alter the cognitive set of 
the clients, as reported on the Agoraphobia Cognitions Questionnaire and the Body Sensations 
Questionnaire. Both therapy groups were equivalent In terms of scores on these two scales, 
at posttreatment assessment. This result Is contrary to expectations, and several 
alternative hypotheses w ill be considered for these results. One possibility Is that the 
particular therapist who conducted the cognitive Interventions was Inadequate at doing so. 
While therapist effects could not be tested directly since there was only one therapist In the 
present study. It Is noteworthy that the therapist was well acquainted with cognitive 
techniques and that he had been using them with agoraphobic clients and other disorders for 
some time prior to the execution of the present Investigation. In addition, the cognitive 
techniques used were drawn frdrrj. among those most widely advocated by exponents of
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cognitive therapy, and were presented enthusiastically and repeatedly as an Integral part of 
the behavior practice.
A second possible explanation Is that subjects learned the cognitive techniques but did 
not actually utilize them. Although this can not be directly assessed, subjects In the 
cognitive group condition Indicated to the therapist on many occasions that they were 
employing the techniques and that they found them helpful. Alternatively, It may be 
hypothesized that subjects utilized the cognitive techniques and did lessen their destructive 
cognitive set, but that the cognitive measures administered were not sensitive to these 
changes.
Although not specifically addressed In this study, it would be interesting to evaluate the 
role of cognitions In the fear process. In order to accomplish this, several Issues would 
warrant attention. First, the production of maladaptive cognitions by phobics upon 
confrontation with feared situations needs to be established. Second, If such cognitions 
typically are present their role In mediating fear, and their overall correspondence with 
fear reactions need to be assessed. Finally, the Importance of cognitive change to clinical 
outcome needs to be demonstrated. Although such findings would not Illuminate the causal 
relationship between cognitive and behavior change, such results would lend some support 
for a role of cognitions in the fear reduction process. The firs t preliminary efforts at the 
above tasks have been conducted (e.g. Williams & Rappoport, 1983; Last et al., 1984 ) but 
the work is a long way from complete. More adequate cognitive assessment means are 
necessary ( Last et a l, 1984).
The Issue for the future appears to have less to do with whether to Include cognitive 
variables as a focus for Intervention than It does with how to measure cognitive change 
accurately ( Last et a l, 1984). The measurement of cognitive variables In agoraphobia 1s 
relatively unexplored, but It Is likely to hold tremendous Implications for successful
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treatment of these difficult clients. Further research In this area Is clearly Indicated.
The results of the present Investigation suggest that a combination of cognitive 
restructuring plus 1n vivo exposure 1s not superior to, In vivo exposure by Itself, for the 
treatment of agoraphobics. Clearly, findings obtained on the efficacy of cognitive treatment 
procedures are discrepant between analog studies with fearful subjects (e.g. D'Zurilla, 
Wilson & Nelson, 1973; Kanter&Goldfried, 1979; Meichembaum, 1 9 7 1 ; Melchenbaum 
1972; Wein, Nelson & Odom, 1975 ) versus tru ly phobic clients such as in the present 
investigation. While the analog Investigations cited earlier tend to support the utility of 
cognitive restructuring with fearful populations, results from clinical Investigations show 
purely cognitive Interventions to be Inferior to a standard behavioral treatment ( in vivo 
exposure), and to be of no additional therapeutic value as Indicated In the present study or In 
several other studies (Emrnelkamp &Mersch, 1982; Emrnelkamp etal., 1986; Last et al., 
1984; Mavlssakallan etal., 1983; Williams & Rappoport, 1983) when combined with 
behavioral techniques. This discrepancy serves to underscore the difficulties often noted in 
generalizing results obtained from mildly fearful subjects to Individuals with clinically 
significant phobias. However, In view of the previously phenomenological Importance of 
cognitions In clinical phobics (e.g., Beck & Emery, 1979) this pattern of results Is 
somewhat surprising. Since Individuals with clinically relevant phobias are more likely 
than normal or mildly fearful Individuals to generate catastrophic cognitions, and have these 
thoughts mediate fear and panic, It would seem reasonable to expect cognitive Interventions 
to be most effective with these subjects.
There are several possible explanations of why cognitive Interventions have been 
shown to be ineffective with clIncJal phobias. First, regardless of the specific cognitive 
techniques utilized, all cognitive restructuring treatment share the aim of modifying or
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changing maladaptive cognitions Into more productive and adoptive thoughts. However, all 
but two of the studies reported (Last etal., 1984; Williams & Rappoport, 1983) failed to 
asssess whether maladaptive cognitive patterns were actually modified as a result of 
cognitive treatment. Thus It Is unclear whether cognitive restructuring Is ineffective 
because the modification of cognitions 1s unimportant or Irrelevant to therapeutic success, 
or rather that the cognitive restructuring utilized In these studies was ineffective in 
achieving the goal of cognitive modification. Secondly, the effects of treatments In analog 
studies might be more strongly Influenced than In clinical phobia trials by demand 
characteristics and expectancy of therapeutic gain. Thirdly, 1t seems probable that the 
Intelligence of the patients In clinical trails on the average w ill have been lower than that of 
the typical subject In analog research (students). Cognitive restructuring might well be 
more effective with Intelligent students used to thinking rationally. The degree of 
Physiological arousal In anxiety-engendering situations, too might differ considerably for 
agoraphobics and for subjects In analog studies. It Is quite possible that cognitive 
restructuring constitutes an effective form of treatment for low physiological reactors 
(such as the subjects of analog studies) although such treatment Is less effective with high 
Physiological reactors (such as agoraphobics). The limited usefulness of the addition of a 
cognitive component to In vivo behavior exposure Is In agreement with previous results
-r
( Emrnelkamp & Merch, 1982; Emrnelkamp etal., 1986; Last etal., 1984; Mavlssakallan 
etal., 1983; Williams & Rappoport, 1983). One possible conclusion to reach Is that 
whereas a cognitive approach may be successful with more cognltlvely-based disorders such 
as test anxiety ( e.g., Meichenbaum, 1972) or speech anxiety ( e.g., Thorpe, 1975), 1t Is 
simply not the treatment of choice for phobfc disorders, 1n which the behavioral component 
plays a major role and In which the physiological arousal Is so prominent (Rachman & 
Wilson, 1980).
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Hethodoloaical Issues
1. Sample -Size
The question that faces the researcher Is "How large a sample must I have?" or put In 
other words, "With how small a sample is It reasonable to proceed?" A simple coping 
strategy answer exposed by Kraemer (1981) and Kazdin (1983) Is 20: no fewer than 10 
per group. Kraemer (1981) states that this number represents a sample si2e that:
"(a) seems acceptable in the (clinical) field at this time, (b) generally 
seems reasonable In those circumstances when recruitment of subjects is difficult 
or processing of each subjects is expensive, (c) yields reasonable power for the 
magnitude of clinical effects that can be achieved in this area, and also provides a 
reasonable balance between the cost of the research project and its power, The 
larger the sample size, the greater the acceptability and power, but then the 
larger the sample size, the less feasible the completion of the project and the 
greater the cost" ( p. 311).
Typically the sample size of agoraphobic studies Is relatively small. For example, fo r. 
the studies reviewed In the Comparisons with Relevant Research section Emrnelkamp et al., 
1978, Emrnelkamp and Mersch, 1983, Emrnelkamp etal., 1986, Last etal., 1984, 
Mavalssakallan et al, 1983, Williams and Rappoport, 1983, reported sample sizes of 21, 
2 7 ,3 9 ,6 ,2 4 , and 20 respectively. The sample size of the present investigation was 32.
There are a number of reasons for the limited number of subjects in the present
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Investigation and in agoraphobia research, In general. Some of these reasons are outlined 
below:
a) In a large scale survey conducted by Doctor ( Thorpe & Burns, 1983)
95.8$ of their sample had consulted with a local doctor about their 
condition; 76.65? had also seen a psychiatrist; 16.4$ had consulted a 
religious or spiritual healer about their problem; 9.2$ had received 
treatment from a non-medical hypnotherapist; 3.5$ had consulted a 
psychologist. A range of treatment had been received: 95.81 $ had received 
medication; 28.9$ relaxation training; 28.3$ psychotherapy/psychoanalysis, 
13.5$ religious faith healing; and!0.7$ had received behavior therapy. As 
these results show, the most popular form of treatment for agoraphobics is the 
use of medication, and the least popular Is a behavior therapy approach (e.g., In 
vivo exposure). This Is a major limiting factor In the sample size of 
agoraphobic studies, which use behavior therapy. Doctor (Thorpe & Burns,
1983) also indicated that approximately 74 percent of the respondents felt 
they had not received adequate help for their agoraphobia. This disatisfaction 
with previous treatment makes subject recruitment difficult. Doctor (Thorpe 
& Burns, 1983) reports that a significant number of the agoraphobics 
despaired nearly always or often about getting better; this is perhaps not 
surprizing when It 1s considered that higher percentages had received 
treatment and felt that they had been Inadequately helped. This despair often 
prevents subjects from seeking treatment.
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b) For research purposes a selection criteria for agoraphobic subjects Is 
established. This selection criteria often eliminates potential subjects. For 
example, In the present study subjects were rejected If the primary problem 
was not agoraphobia. Several subjects were eliminated as their primary 
problem at the time of the screening Interview was seen as drug dependency
( I.e., alcoholism), rather than agoraphobia.
c) Often there Is limited access to the agoraphobia population. Access is limited by 
such factors as 1) they are currently under treatment by another professional 
or para-professional, 2) the agoraphobic's problem Is not accurately diagnosed 
by professionals or para-professlonals, 3) professionals or para-professlonals 
are not willing to refer patients, and 4) the agoraphobic and/or their 
therapist is not are aware of the existence of your treatment program. This last 
factor is a major problem In subject recruitment.
d) A behavior therapy form of treatment Is time-consuming for the therapist. 
Therefore, to complete the research project in a reasonable amount of time the 
researcher Is often willing to sacrifice power for time factors.
e) For ethical reasons 1t Is often necessary to proceed with 
treatment before one obtains the desired number of subjects.
f)  Subject attrition is a common problem with agoraphobic studies. This issue w ill
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be addressed al greater length 1n a later section.
The sample size of the present Investigation Is larger than the typical agoraphobic 
study, or at least larger than the average of those studies reviewed in the Comparisons with 
Relevant Research section. It also surpasses the minimum requirements staled by Kraemer 
(1981) and Kazdin (1983). Although it would have been preferable to have a larger sample 
size, the present size provides "reasonable power", and is adequate considering the 
difficulties outlined above.
2. Subject Attrition
The cost of high attrition or differential attrition In an experiment can be great in 
drawing conclusions about therapy outcome. Substantial attrition may threaten the internal 
validity of an experiment ( Kazdin, 1983). Although there Is no definite criterion for what 
constitutes "substantial", extreme cases are fa irly  obvious.
In the present study, one subject failed to complete the noncognitive group, two the 
cognitive group and three the waiting-list control group. The overall attrition rate was 
15.8S&. Emrnelkamp et al., 1978, Emrnelkamp end Mersch, 1983, Emrnelkamp etal.,
1986, Mavisaklan etal., 1983, and Williams and Rappoport, 1983 reported attrition 
rates of 12.5, 7.4,9.3, 8.3, and 16.7 £ , respectively. The attrition rate in the present 
Investigation was si ightly higher than that In the studies reported above. However, none of 
these studies had a control group. Attrition is typically highest in a control group and 
particularly In a waiting-list control group ( Kazdin, 1983). Overall, the attrition rate and 
the differential attrition rate, in the present investigation, were not high enough to be
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defined as substantial. Consequently, the attrition rate 1n the present investigation was not 
high enough to represent a threat to Internal validity.
3. Sensitivity of Dependent Measures
Another factor, which might have contributed to the lack of statistically significant 
differences between the treatment groups, 1s that certain dependent measures used 1n the 
present study might not have been sensitive enough to detect and/or measure differential 
treatment outcomes with an agoraphobic population. The only exploratory attempt to 
examine the relative sensitivity of different assessment instruments was conducted by 
Mavlssakallan and Barlow (1981). They Indicated that, "In vivo performance measures 
showed the best ability to discriminate between treatments, followed by self-report of the 
Intensity of the main phobia. Direct behavioral measures also showed the best ability to 
Identify change from the beglnlng to the end of a particular treatment” (p. 49).
This report Is Interesting In light of the findings of the present Investigation. The two 
therapy groups displayed a marked and significant reduction in phobic symptomotology as 
measured on the Behavior Avoidance Test. Mavtssaklan et al’s (1981 ) remarks lend 
support to the Idea that the behavioral measure was a sensitive measure of change and that 
the therapy groups were different from the control group. The behavioral measure along 
with the rating scale of phobic anxiety and avoidance might have been more sensitive to 
treatment change than the other measures used In the present stud/.
4. Types of agoraphobia
Phares (1967) presents a general critique of conventional practices in psychiatric 
diagnosis:
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1 People within the same diagnostic category are notoriously dissimilar from another,
2. Psychiatrists have never been able to agree amongst themselves as to who belongs 1n 
which category.
These complaints orglnally directed at the diagnostic system employed by psychiatrists 
can also be directed at the use of the label "agoraphobia":
1. People who are diagnosed as agoraphobia are often dissimilar from one another (e.g. 
Chambless & Goldstein, 1982)
2. Individuals working in the field of agoraphobia have had great difficulty in defining the 
term agoraphobia (e.g., Chambless & Goldstein, 1982).
People with "agoraphobia" do not have the unitary psychological condition Implied by 
the label, but suffer from a heterogeneous collection of phobias and a varied assortment of 
other psychological problems (Chambless & Goldstein, 1982). " This marked heterogeneity 
renders conventional psychodiagnostic modes of conceptualizing agoraphobia Inappropriate 
and dysfunctional for the conduct of treatment-oriented research." ( Hersen, Eisler & 
M iller, 1985, p. 110)
Several workers In the field of agoraphobia have established there own subtypes of 
agoraphobia. For example, Chambless and Goldstein (1978) have identified two types of
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agoraphobia; complex and simple. Another common subtyping Is acute and chronic 
agoraphobia (Johnson, 1985). At present there Is no empirical evidence to support, the 
existence of either of these two systems of subtyping. However, If these different subtypes 
of agoraphobia do exist then what are the Implications for the present research. Perhaps 
simple acute agoraphobics respond better to a cognitive component behavioral treatment? 
There 1s no easy way to assess this. The basic Issue however, Is that the disagreement or the 
confusion 1n proper definition of the term agoraphobia may have confounding effects on the 
results of research and may threaten the external validity of agoraphobia reseach, Including 
this present Investigation. Until there 1s some clarification of the term 'agoraphobia’ then 
this problem w ill continue to exist.
Treatment and Theoretical Implications
Several different evaluation strategies are available when examining the efficacy of a 
psychological treatment. The present Investigation utilizes a constructive treatment 
strategy ( Kazdin, 1980). This type of strategy refers to developing a treatment package by 
adding components to enhance therapy. With the constructive approach one begins wth a 
basic treatment component. In the case of the present study the basic package was In vivo 
exposure. Research Is then conducted that adds various Ingredients to the basic treatment to 
determine whether treatment effects are enhanced. The added component, In the present 
stud/, was cognitive restructuring. Essentially the constructive treatment approach 
addresses the question: What can be added to the basic treatment to make It more effective? 
The advantage of the constructive treatment approach Is that It empirically establishes a 
treatment package. The empirical development of a treatment package Is rare In the field of 
clinical psychology where treatments tend to proliferate endlessly. Most of the treatments
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that develop have no established body of empirically validated Information to argue for their 
use. Rather, proponents advance particular techniques based largely upon clinical practice, 
uncontrolled observations, and anecdotal material. Another distinguishing feature of the 
constructive treatment approach Is that It gives the greatest priority to outcome. 
Understanding the mechanisms of treatment gives way 1n priority to therapeutic outcome. 
Indeed, the constructive approach has relatively little  to say about theory and this Is the 
main disadvantage of this particular approach (Kazdin, 1980).
In terms of therapy implications, the results of the present study, have shown that a 
form of cognitive restructuring combined with 1n vivo exposure does not enhance the 
effectiveness of the in vivo component for the treatment of agoraphobia. Although the 
approach used has relatively little  to say about theory, It 1s Interesting that the results of 
the present Investigation can be reconciled by Bandura's (1977) self-efficacy theory. This 
theory holds that fear Is Indeed rooted 1n thought, but that the best way to change thought Is 
through performance-based treatments (e.g., 1n vivo exposure), which give clients 
firsthand evidence that they can function effectively. In contrast, verbal treatments such as 
cognitive therapy provide weak evidence of personal capability and are therefore less 
Influential 1n changing thought and behavior. If self-efficacy theory 1s correct, then 
agoraphobia would more effectively be treated by helping clients change what they do than by 
helping them through verbal means such as cognitive therapy , change what they think. The 
results of the present study support this position.
Implications for Future Research
The failure of this study to find differential treatment outcome favoring the 
treatment with the additional cognitive component parallels that evidenced in previous
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research (Emrnelkamp &Merch, 1982; Emrnelkamp etal., 1986; Last etal., 1984; 
Mavlssakallam etal., 1983; and Williams & Rappoport, 1983). However, neither these 
studies nor the current Investigation are complete tests of the effectiveness of the addition of 
a cognitive component to In vivo exposure treatment for agoraphobics, since neither the fu ll
-  range of cognitive techniques available (e.g., paradoxical Intention) nor the depth In which 
they may be applied (e.g., Individual therapy) was fu lly  explored. Future studies, need to be
conducted to explore these Issues.
Given the failure of cognitive treatments with agoraphobics, In the present study and 
elsewhere, some would argue against conducting any further research, however, It appears 
that several Important Issues remain to be explored, the results of which may have a 
profound Impact on our current understandng and delivery of treatment to agoraphobics.
The development and utilization of reliable and valid cognitive measures are critical to 
evaluation of the efficacy of cognitive treatments. As such, the u tility  and psychometric 
properties of more structured measures (e.g., self-efficacy ratings, attitudinal scales), 
beyond the one used in the current study, as well as specific cognitive measures in future 
investigations w ill aid In determining whether, and which cognitive therapies actually 
engender constructive cognitive change. Such studies must be conducted before cognitive . 
techniques can be dismissed as Ineffective
Even If these cognitive procedures should eventually be seen to be ineffective , 
cognitive measurement should be used to assess cognitive changes during behavioral, 
exposure-based treatment of agoraphobics. Although exposure treatments at this point in 
time seem to be the treatment of choice for agoraphobia, the process or mechanism of action 
by which exposure works remains unclear. Systematic testing of alternative hypotheses,
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Including cognitive change, may shed light on this complicated Issue and aid In Increasing the 
efficacy of present treatments.
Investigation of relationships between patient characteristics and response to 
particular treatments Is needed to enable prescriptive recommendations to be made for the 
Individual agoraphobic. For example, It would be Interesting to look at the differential effect 
of cognitive treatment with high and low physiological reactors and see the result, or i f  a 
valid cognitive Instrument becomes available 1t might be possible to divide patients Into 
those who are In need of some form of cognitive therapy and those who are not. Such 
research would enable us to derive prognostic indicators of treatment choice and subsequent 
treatment success.
Another topic of future research Is the definition of agoraphobia. Presently, research 
findings are clouded by the Inadequacy of the definition of agoraphobia and until there Is a 
more adequate one this problem w ill persist.
Results of the present Investigation suggest a high correlation between outcome 
measures, however, because of the limited sample size these results must be Interpreted 
with extreme caution. There Is a real need for researchers In the field of agoraphobia to 
examine the outcome measures they use, and eventually to agree on adequate outcome 
measures. This would allow for a more direct comparison of results between publications. 
There Is s till an urgent need to develop comprehensive questionnaires which w ill tap the 
cognitive, behavioral and physiological response systems of agoraphobics.
Emphasis In future research should be placed on determining a comprehensive range 
of problematic situations In which agoraphobics experience particular difficulties In a given 
environment. For example, many agoraphobic studies Include a behavioral test, and It Is 
assumed that this Is an adequate measure of behavioral avoidance. Without going Into the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
131.
methodological problems of behavior avoidance tests (see Kazdin, 1900 , for more detailed 
criticisms), it is assumed that if  subjects change their avoidant behavior on a behavior 
avoidance test (or to questionnaires for that matter) that there behavior 1n a natural 
setting w ill also be changed. However, this is not necessarily true (Kazdin, 1980). Thus, 
behavioral tests w ill be of little  value unless they correlate highly with the patients’ 
reactions to the problematic situations encountered In the natural environment. It is 
perhaps true, that too much research 1n the past has tended to employ statistical definitions 
of treatment effectiveness and outcome criteria which have little  demonstratable treatment 
effectiveness; as suggested earlier ‘statistical significance does not imply clinical u tility ’ , 
or 'statistical nonsignificance does not Imply clinical uselessness'. In addition to measuring 
what subjects can do 1n the real life phobic situation, 1t Is Important 1n terms of clinical 
outcome to assess the effects of treatment on subjects’ day to day activities. As Mathews et al 
(1981) point out, "A treatment that enables a patient to produce heroic performances but 
does not affect dally life 1s of limited value" ( p. 25). Thus It Is suggested that future 
research use outcome measures which are closely tied to the In vivo behaviors which the 
subject wishes to change, rather than to the behaviors the researcher wishes to see change.
As suggested earlier the results of the present study may have been confounded by 
nonspecific treatment effects such as demand characteristics, credibility of treatment, 
motivation of clients, and attributes of the therapist. It 1s clear that a fundamental problem 
of behavior research In general, Is a need to dlsentagle these confounding effects from the 
effects of the treatment procedures; most of the studies In agoraphobia, including the 
present one, have failed to rule out these differential effects (Kazdin, 1980). Future 
Investigations need to Identfy sources of non-specific treatment effects which may affect the
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various parameters of behavior and to ascertain ways in which they may be controlled.
Bandura (1977) has stressed the Importance of assessing the patient's sense of 
personal effectiveness in dealing with a phobic situation. Self-efficacy scales of the type 
used in Bandura’s (et al., 1980) experimental treatment of eleven agoraphobics would have 
been a useful addition to the present stud/. Initial attempts to use these scales 1n the present 
study were negated by the complexity of the scales and clients Inability to respond 
to them 1n a meaningful way. Efforts to clarify these scales would make them more useful 1n 
the future.
The primary aim of the present stud/ was not to test specific hypotheses concerning 
the various components of the In vivo exposure or In vivo exposure + cognitive 
restructuring treatment, but rather to compare different treatment "packages". In 
actuality each of the therapy treatments Involves many different components (e.g., group 
support, homework assignments, relaxation training, etc.). The design of the stud/ 
prevented a determination of the relative contributions of each of these different components 
to treatment outcome. Further research Is needed to evaluate the relative effects of these 
different components.
Finally, the present stud/ could be replicated with a larger number of subjects. This 
Increase In number of subjects would increase the power. This Increase In sample size 
would also allow a more adequate comparison between the different outcome measures used - 
in the study.
Summary
Multiple measures of change yielded no significant Improvement In phobic 
symptomatology for subjects In the waiting-list control group. The lack of change In the
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control group contrasts with the Improvement obtained In the two therapy groups. Doth 
therapy groups were accompanied by marked and significant reduction 1n phobic 
symptomotology as measured on the following scales (a) Watson and Marks (1971) rating 
scale of phobic anxiety, ( b) Watson and Marks rating scale of avoidance, and (c) the 
Behavior Avoidance Test. The two therapy groups also displayed a consistent but 
nonsignificant trend toward Improvement at posttest on ten of the eleven remaining 
variables. There was no evidence of differences between the two therapy groups on any of 
the dependent measures. The results of the present stud/ clearly suggest that In vivo 
exposure treatment of agoraphobia could noi be made more efficient by Incorporating 
cognitive restructuring Into the treatment.
The results of the present study essentially corroborated the findings of Emrnelkamp and 
Merch (1982), Emrnelkamp et al. (1986), Last et. al. (1984), Mavlssakallan et. al. 
(1983), and Williams and Rappoport (1983). Comparisons with relevant research, 
reasons for the lack of therapy differences, methodology concerns, theoretical Implications 
and suggestions for future research were discussed.
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Personal Data Q uestionna ire  
Purpose o f  t h is  q u e s tio n n a ire :
Q
The purpose o f  t h is  q u e s tio n n a ire  is  to  o b ta in  a comprehensive p ic tu re  
o f your background. In  s c ie n t i f ic  work, records are necessary, s ince  
they pe rm it a more thorough d e a lin g  w ith  one 's  problems. By com ple ting 
these questions as f u l l y  and as a c c u ra te ly  as p o s s ib le , you w i l l  
f a c i l i t a t e  your th e ra p e u tic  program.
I t  is  u n d e rs ta n d a b le 'th a t you m ight be concerned about what happens 
to  the  in fo rm a tio n  about you, because much o r a l l  o f  t h is  in fo rm a tio n  
1s h ig h ly  pe rsona l. A l l  reco rds are s t r i c t l y  c o n f id e n t ia l .  No o u t­
s id e r is  pe rm itte d  to  see your reco rd  w ith o u t your p e rm iss io n .
Date: ___________________________
I . General Data »
Name: __________________________   M _F__________
Address: _________________________________________________________________
Telephone: (day) ________________________  (even ing)______________________
Age: ___________ Occupation:_____________________________________________
M a r ita l S ta tu s : S in g le , M a rrie d , D ivorced , Widowed, R e-m arried, Separated
(C irc le  one)
Length o f p resen t m arriage :  _______________________
Length o f p rev ious m arriag e : ___________________________
With whom are you now l iv in g ?  _______________ ____________________________
By whom were you re fe rre d ?
I I .  Educational Data
1. L is t  the  h igh es t grade you completed in  schoo l.
2. Are you aware o f any d i f f i c u l t i e s  in  paying a t te n t io n ,  in  under­
stand ing  w r i t te n  m a te ria l o r in s t r u c t io n ,  o r in  hearing o r reading? 
I f  so, p lease e x p la in . ______________________________________________
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J I I .  Medical Data
Date o f B ir th  ____________________  Place o f  B i r t h ________ [
M other's  c o n d itio n  du ring  pregnancy (as f a r  as you know):
L is t  m ajor il ln e s s e s  du ring  ch ildhood and note co m p lica tio n s :
L is t  m ajor il ln e s s e s  d u rin g  adolescence and note co m p lica tio n s :
H eight: ______________________  W eight:______________
L is t  s u rg ic a l opera tions along w ith  age a t the tim e :
L is t  se rious acc ide n ts :
L is t  h o s p ita liz a t io n s ,  com p lica tion s  and le ng th  o f  confinem ent:
Have you had a physica l exam ination re c e n tly ?  Yes _____  No
I f  yes, b r ie f ly  s ta te  th e  re s u lts  o f th is  exam ination.
L is t  drugs you are ta k in g , t h e ir  dosages, how o fte n , and why you take  them.
Do you s u f fe r  from d ia b e te s , hypertens ion , or^ hypoglycemia?
Is  th e ir  a h is to ry  o f  d ia b e te s , hypertens ion , hypoglycemia, in  your fa m ily?
Has any member o f your fa m ily  su ffe re d  from a lcoh o lism , e p ile p sy , a nervous 
breakdown, depression, o r any o th e r form  o f mental o r emotional I lln e s s ?
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IV . Phobic Data * °
1. Give the date o f onset o f  your phobic c o n d it io n : _______
2. Where d id  your phobias! begin:
3. Exp la in  your circum stances a t the  tim e o f onse t. Note any s tre ss  o r 
in s t a b i l i t y  in  m arriage, fa m ily ,  o r occupa tion , f in a n c ia l problems, 
changes in  res idence , separa tion  from  loved ones, death o f a loved 
one, e tc . :  '_______________________________________________________
4. Did your problem s ta r t  w ith  a sudden panic a ttack?
Y e s__________  No___________
5. Do you c u r re n t ly  s u f fe r  from  panic a ttacks?
Yes _________  N o ___________
a) I f  yes, approxim ate ly how o ften?  (check one)
Once a d a y _ More than once a day _
Once a week    More than once a week
Once a m on th___   More than once a month'
Less than once a month _____
b) I f  yes, f i l l  in  Symptom Scale on the  next page.
6. How has your c o n d itio n  changed s ince  the  o r ig in a l onset? _
7. Have you had symptoms s im ila r  to  these p r io r  to  your present 
d i f f i c u l t y ?  Which ones? _____________________________________
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Symptom Scale
Some o f the  fo llo w in g  symptoms occur d u rin g  a panic a tta c k . Please 
eva lua te  them accord ing to  th e ir  e f fe c t  when you are having an a tta c k  
and in d ic a te  your answers on the  sca le  1 to  5 below. Add comnents 
i f  t h is  w i l l  he lp d escrib e  your panic a tta c k s .
1. No e f fe c t  4 . S trong e f fe c t
2. M ild  e f fe c t  5. Severe e f fe c t
3. Medium e f fe c t
1 2 3 4 5
1. F lu t te r y  stomach
2. Sweaty Palms
3. Warm a l l  over
4. Rapid o r heavy hea rtb ea t
5. Tremor o f the  hands
6. Weak o r  rubbery knees o r legs
7. Shaky in s id e  and o r ou t
8. Dry mouth
9. Lump in  th ro a t
10. T igh tness in  chest
11. H y p e rv e n tila t io n
12. S t i f f  neck
13. Headache
14. D izzy o r lig h t-h e a d e d
15. Nausea o r vom iting
16. D iarrhea
17. A fe e lin g  o f being unable to  move
18. A fe e lin g  o f having to  run  o r ge t ou t
•
•
Comments:
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8- Please ra te  the fo llo w in g  qu es tio ns :
1. A l l  o f the  tim e 4 . Once in  a w h ile
2. A g re a t deal o f the  tim e 5. Never
3. Sometimes
1 2 3 4 5
1) Are you bothered by fe e lin g s  o f  a n x ie ty  
i . e . ,  s u b je c tiv e  te n s io n  and phys ica l 
fe e lin g s  o f nervousness?
2) Do unpleasant o r nega tive  thoughts keep 
going over and over in  you r mind?
3) Do you w orry  about " lo s in g  c o n tro l"?
4) Does the  a n t ic ip a t io n  o f the  s itu a t io n s  
you fe a r  bo ther you?
5) Do you t r y  to  " f ig h t "  anx ie ty?
6) Are you bothered by a fe a r  o r dread o f 
the  "n e x t"  panic a ttack?
-
6
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Present le v e l o f fu n c tio n in g
are you able to Yes No
Yes, i f  accompanied 
by: ( in d ic a te  person)
Yes, 1f ( In d ic a te  
c o n d it io n , e .g . 
c lose  to  home, e tc . )
1. Walk alone
2. Shop alone
3a. D rive  alone 
(d r iv e r )
3b. D rive  (as 
passenger)
4a. Attend
th e a te r
4b. Attend
movies
4c. Attend
church/
synagogue
4d. Eat in  a 
re s ta u ra n t
5. Stay home 
alone -
6. Take an 
e le va to r
7. Take a bus 
or subway
8. Take a t r a in
9. Take a plane
*10.
1
Other
o
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V. O ccupational Data
Are you w orking a t present? Yes ______ No ___
I f  yes , what s o r t o f work are you doing? ____
What k inds o f  jo bs  have you he ld  in  the  past?
Does your present jo b  s a t is fy  you? Yes ______  No
I f  no, in  what ways are you d is s a t is f ie d ?  ________
Do you have occupa tiona l am b itio ns : Yes ______  No_______
I f  yes , p lease e x p la in : ________________________________________
V I. M a r ita l Data
■ ■ ! ■ ! ■ ■ ■  I ■ HUB Ml
How long d id  you know you r m arriage p a rtn e r be fo re  engagement? 
H u sb a n d 's /w ife 's  age:  H u sb a n d 's /w ife 's  o c c u p a tio n _____
Describe in  your own words th e  p e rs o n a lity  o f you r husband o r w ife :
In  what areas is  th e re  c o m p a t ib il i ty ?
In  what areas is  th e re  in c o m p a t ib il i ty ?
How many c h ild re n  have you? ______  Do any o f you r c h ild re n  presen t
sp e c ia l problems? ____________________________________________________
Give d e ta i ls  o f  any p rev ious m arriage :
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V I I . Family Data
a) Father
L iv ing  or deceased? __________ I f  deceased, g ive your age a t the
time o f h is death: ____________________________________________
I f  a liv e , g ive fa th e r 's  present age and occupation: ____________
Describe h is hea lth : __________________________________________
In what ways were you punished by your fa th e r as a ch ild?  ______
Give descrip tion  o f your fa ther's ; pe rsona lity  and h is a ttitu d e s  
toward you: ___________________________________________________
b) Mother
L iv ing  or deceased? __________  I f  deceased, g ive your age at the
time o f her death: ____________________________________________
I f  a liv e , give mother's present age and occupation: ____________
Describe her hea lth : __________________________________________
In what ways were you punished by your mother as a ch ild?  ______
Give descrip tion  of your mother's pe rsona lity  and her a ttitu d e s  
toward you: __________________________________________________
c) S ib lings
L is t  names and ages o f brothers and s is te rs :
Relationship w ith  brothers and s is te rs :
O
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Give your impression o f the home atmosphere in  which you grew up . 
describ ing the s ta te  o f c o m p a tib ility  between your parents and 
between your parents and the ch ild re n : __________________________
V I I I .  L ife  S ty le  Data
1. What are your curren t in te re s ts , hobbies and a c t iv it ie s ?
2. How do you spend most o f your le isu re  time?
3. To what extent have your d i f f ic u l t ie s  in h ib ite d  your socia l l i fe ?
4. Do you ta lk  about your cond ition  w ith  fr ie n d s  and or fam ily  members?
5. Do your phobic problems in te r fe re  w ith  the development o f close 
re la tionsh ips?  ________________________________________________
6. Has your cond ition  prevented your spouse from occupational advancement 
or your fa m ily  from m o b ility?  ____________________________________
IX. Treatment Data
1. Are you cu rre n tly  or have you in  the past received professional help 
fo r  your condition?
Yes_________  No___________
I f  yes, please descr.ibe when th is  was, what kind o f therapy, how long 
was th is  treatm ent, and how much b e n e fit d id  you derive  from th is  tre a t 
ment?
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2. Have you received medication fo r  th is  condition?
Yes __________  No_________
I f  yes, please describe when th is  was, what kind o f medication, 
how long i t  was taken fo r ,  the dosage, and how much bene fit was 
derived? _______
3. Have you tr ie d  se lf-h e lp  by reading psychology books? 
Yes __________ No '______
I f  yes, what d id  you read and did i t  help? _________
4. When, and under what circumstances, d id the word "agoraphobia" 
become meaningful to  you? ___________________________________
5. Many people w ith  agoraphobia are dependent on someone. I f  th is  
applies to  you, please expla in the nature and extent o f your 
dependency, and the a tt itu d e  o f th is  person toward your problem. 
I f  th is  is  other than your spouse give spouses a tt itu d e  a lso.
6. L is t  your sp e c ific  behavioural goals in  order o f th e ir  importance 
to  you; i . e . ,  I would l ik e  to  be able to ;
1 ) •_______________________________________________________________________
2 ) :3 )
4)
5 >
7. L is t  benefits  you hope to  obta in from therapy:
1 ) _______________________________________________________________________________
2 )
3) ~ ~
4)
5) — ~
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8. Please ind ica te  any tim e(s) which are abso lu te ly impossible fo r
you to  attend treatment sessions:
Monday:
Tuesday:
Wednesday:
Thursday:
F riday:
9. Treatment time could be shortened from 24 weeks, but th is  would
e n ta il you coming fo r  therapy fo r  more than once a week. Could
you come tw ice a week?
Yes __________  No___________
10. Do you a n tic ip a te  any scheduling d if f ic u l t ie s ?  _______________
11. As long as the time is  su ita b le , w i l l  you have tran sp o rta tion  to  
every treatment session? _______________________________________
Morning  Afternoon  Evening
Morning J Afternoon  Evening
Morning  A fte rn oo n  Evening
Morning  A fte rn o o n  Evening
Morning __ A fte rn o o n ____Evening
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APPENDIX B 
C lie n t Contract
O
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C lie n t Contract: Agoraphobia Group
Purpose: To ensure maximal attendance a t Agoraphobia Group sessions,
to  accept re s p o n s ib ility  fo r  my actions, to  accept respon­
s ib i l i t y  to  the th e ra p is t and group members, and to  increase 
the p ro b a b ility  o f compliance w ith  goals which are established 
to  a lle v ia te  agoraphobia.
Having worked extensive ly  w ith  the complex problem o f agoraphobia 
1n the past, i t  has been found to  be necessary to  implement the fo llo w in g .
I ,  ,_________ _________ _____, while  a c lie n t/p a t ie n t 1n
the treatment programme fo r  agoraphobia agree to  comply w ith  the fo llo w in g .
1) I w i l l  make every e f fo r t  to  attend as many sessions as possible 
as I recognize th a t my p a r tic ip a tio n  1n the programme is  
essentia l 1n order to  overcome the d i f f i c u l t y .
i i )  I f ,  however, I am unable to  a ttend, I w i l l  c a ll and speak to  
Mr. Steggles or leave a message w ith  the secretary fo r  him 
p r io r  to  the session in d ica tin g  my in a b i l i t y  to  p a rtic ip a te  
on th a t day.
111) I am aware th a t fa i lu r e  to  make the th e ra p is t and other group 
members aware o f my lack o f attendance 1s irrespons ib le  on my 
part and is  d is ru p tiv e  to  the group procedure. As a re s u lt ,
I accept th a t fa i lu re  on two occasions to  c a ll 1n p r io r  to  non- 
attendance w i l l  re s u lt  in  me being asked to  v o lu n ta r ily  
withdraw from the group (subject to  the decision of the th e ra p is t 
and group members).
iv )  Knowing that!group goals and homework assignments (e .g .,  reading, 
behavioural assignments),.wh1le sometimes d i f f i c u l t ,  are in  the 
best in te re s t of a lle v ia t io n  of the agoraphobia, I agree to  
put fo r th  my best e f fo r t  to  complete a l l  group and in d iv id u a lly  
assigned tasks. I f  I do not complete them, I agree to  discuss 
w ith  the group my ra tio n a le  fo r  not doing so.
Having read and understood the above, Iv w ll l  abide by the guide lines 
of th is  agreement.
Signature o f Group Member
Signature o f Therapist
Date:
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Informed Consent Form
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informed consent for agoraphobic volunteer subjects in  the research program
You are being asked to participate in a research program designed to compare acceptable 
behavioral procedures used in the treatment of agoraphobia. The treatments w ill focus on 
tinder standing and learning how to control your phobic anxiety, and acquiring the shills 
necessary to overcome vour tendency to avoid certain feared situations. It is hoped that you w ill 
benefit from the program by developing the ability to control your anxiety and to enter 
oorrentlv avoided situations.
Therapy w ill take place in groups of eight to ten individuals. Sessions, approximately 2 
hours in length, v/ill be conducted once weekly for 22 weeks. There w ill be no charge to 
Participants in this program.
The therapist w ill be available to discuss the results of the program with you. and to 
answer any questions you may have regarding treatment procedures, upon completion of the 
Program.
You are free to withdraw consent and to discontinue you participation (see Client 
Contract) in the treatment program at any time by notifying the researcher. If you understand 
and are willing to participate In this program, please sign below on the designated line.
T hank you for your cooper ation,
( Signed Consent)
iDatei (P rin t Name)
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Advertisement fo r  Agoraphobia 
Treatment-Research Program
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AGORAPHOBIA 
CAN BE. TREAIED o
Mr. S. Steggles, M.A. a Psychologist a t  the Footh il ls  
Hospita l ,  Is looking For agoraphobics to become Involved 
In a treatment-research programme (Agoraphobia is a fear 
o f  public places, a recurrence o f  anxiety experienced by 
people In common situat ions  such as walking, d r iv in g ,  
shopping, eating In  restaurants, attending meetings, 
e t c . ) .
The treatment programme w i l l  be 24 weeks In duration and 
Is of no charge to p a rt ic ip an ts .  A screening interview  
w i l l  be u t i l i z e d  to confirm an accurate diagnoses o f  
agoraphobia.
For further Information, please telephone Mr. S. Steggles,  
Dept, o f  rsychosocial Resources, Foo th i l ls  Hosp ita l .
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Therap is t's  Manual: In V1vo Exposure
o
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Due to the length of the Therapist's Manual: In Vivo Exposure ( in excess of 100 pages), 
this manual has been attached in a separate section.
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APPENDIX F
T herap is t's  Manual: Cognitive R estructuring +
In Vivo Exposure
o
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Due to the length of the Therapist's Manual: Cognitive Restructuring + In Vivo Exposure 
( 1n excess of 100 pages), this manual has been attached In a separate section.
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Frequency of Panic Attacks
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Marne
Have you suffered from acute attacks of panic, anxiety, palpitations, breathlessness, sweating or 
trembling fo r no obvious reason during the past 7 days? (Do not include persistent background tension 
or your phobias).
Using the scale below c irc le  the appropriate number.
not at 
a ll
A l i t t l e :  
mild panic, 
or a few 
attacks
to some 
extent: 
.moderate 
panic, 
several 
attacks
markedly: 
severe panic, 
or frequent 
attacks
very much 
indeed: very 
severe panic, 
or very fre ­
quent attacks
a*cr>
O
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APPENDIX H 
S ta te -T ra lt Anxiety Inventory
o
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SELF-EVALUATION QUESTIONNAIRE , 68
D e v e lo p e d  b y  C . D .  S p ie lb e rg e r, R .  L . G o rsuch  a n d  R . Lusheno
stai Fornvi x-1
N A M E _________________________________________________________  D A T E ___________
b lU E C T IO N S : A  number of statements which people have 
^sed to describe themselves are given below. Head each state* 
jfient and then blacken in the appropriate circle to the right of
statement to indicate how you feel right now, that is, a t  3 i
this moment. There are no right or wrong answers. Do not ■>. g
8Pend too much time on any one statement but give the answer 'I 3
'mich seems to describe your present feelings best. P 5
I  feel calm  _______________________     —-................... ©  ©
2. I  feel secure ...   ...__________  ........._____ ______ _   —............... ............ ............ ............ ............  ©  ©
3. I  am tense------------------------------------ ---------------------------------------------------------------  ©  ©
4* I  am reg retfu l__________________________    — ---------- ---------- ----------  ©  ©
6. I  feel a t ease______________________________________________________ .... ©  ©
6* 1 feel upset ____________________ _________________________________ ____  CTj ©
I  am presently worrying over possible misfortunes  ___   :...............  ©  ©
I  feel rested______________________________________________________I   ©  ©
I  feel anxious ------------------------------------------------- ------------------------------------------- - ©  ©
*0. I  feel comfortable  _______________________________   ...____________ _ ©  ©
I  feel self-confident ___ ______________________________ _______ _________  ©  ©
*2. I  feel nervous ---------------------- ------------------------------------------- ------------------- --------  ©  ©
*3. I  am j i t te r y _____________________________________ _____________________ ©  ©
*4* I  feel “high strung” ----------------------------------------------------------------------- ------------ - ©  ©
*5. I  am relaxed  ---------------------- ------------------------------------------ ------------------------------  ©  ©
*6. I  feel content ........................................................................................ ....................... ©  ©
I  am worried  ................................................................................................. ..............  ©  ©
*8* I  feel over-excited and “rattled” ............................................................................ ©  ©
I  feel jo y fu l______________________ _______________________ ____________  ©  ©
I  feel p leasant ............................................ .................................................................. ©  ©
CONSULTING PSYCHOLOGISTS PRESS 
577 College Avenue, Palo Alto, California 94306
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B r ie f Symptom Inventory
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BSI
Narne:.
location: 
Age; .Sex: M. . Date:.
Patient No.:.
Visit No.:__
Remarks:__
-T7tn—
.Technician. 
.Mode: S-R. .Nar.
INSTRUCTIONS
Below is a list of problems and complaints that people sometimes have. Read each one carefully, and select one of the 
lumbered descriptors that best describes HOW MUCH DISCOMFORT THAT PROBLEM HAS CAUSED YOU DURING 
.INCLUDING TODAY. Place that number in the open block to the right of the pioblem. Do
"WCICU u
'H e past__________________________________________     ___ _______
n°t skip any items, and print your number clearly. If you change your mind, erase your first number completely. Read 
example below before beginning, and if you have any questions please ask the technician.
HOW | EXAMPLEMUCH WERE YOU DISTRESSED BY: Descriptors
0 Not at all
1 A little bit
(y  Answer 2 Moderately
DArlo a -i ■— I ' I m • , •3 Quite a bit
4 Extremely
' ^°dy Aches........................ Ex. IH
Much
HOW MUCH WERE YOU DISTRESSED BY: Descriptors
0 Not at all
1 A tittle bit
2 Moderately
3 Quite a bit
4 Extremely
WERE YOU DISTRESSED BY:
Witnessor i
'*elin9 others are to blame for most of your troubles. . . . f~l
"oub|fi temembering things
‘Ninnh
P *
81,15 in heart or chest
afraid in open spaces,
9 that most people cannot be trusted
°0r appetite
* “* '0 9  lonely even when you are with people. 
ee*'n9 blocked in getting things done.............
*e|jn9 lonely.
e*lin9 blue
e®liin9 no interest in things.
9 fearful
0'Jr feelings being easily hurt ■.................................. ^
eelin9 that people are unfriendly or dislike you. . . .
eali,n9 inferior to others
Sea or upset stomach........................................................ L-J
r«e|j
ln9 that you are watched or talked about by others
°Ubf
a^Wnn
e falling asleep.
W '^ l t y  making decisions.......................................
1975 BY LEONARD R. DEROGATIS. PH.D.
□ 28.□ 29.□ 30.□ 31.□
□ 32.
□ 33.
□ 34.□ 35.□ 36.□ 37.□ 38.□ 39.□ 40.□ 41.
□ 42.
□ 43.
□ 44.
□ 45.
□ 46.
□ 47.
□ 48.
□ 49.□ 50.□ 51.□□ 52.
53.
0
Feeling afraid to travel on buses, subways, or trains .
Trouble getting your breath.................... .................
Hot or cold spells....................................................
Having to avoid certain things, places, or activities 
because they frighten you.......................................
Your mind going blank.............................................
Numbness or tingling in parts of your body..........
The idea that you should be punished for your sins
Feeling hopeless about the future...........................
Trouble concentrating.............................................
Feeling weak in parts of your body.........................
Feeling tense or keyed up ........................................
Thoughts of death or dying.....................................
Having urges to beat, injure, or harm someone . . .
Having urges to break or smash things....................
Feeling very self-conscious with others..................
Feeling uneasy In crowds........................................
Never feeling close to another person....................
Spells of terror or panic..........................................
Getting Into frequent arguments  ...................
Feeling nervous when you are left alone.. . . . . . .
Others not giving you proper credit for your 
achievements..................................................
Feeling so restless you couldn't sit still 
Feelings of worthlessness....................
Feeling that people will take advantage of you if you 
let them..........................................................................
Feelings of g u ilt ......................................................... ..
The idea that something is wrong with your mind . . .
□□□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
. □
. □
. □
. □
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B rie f Symptom Inventory
171.
The B rie f Symptom Inventory (BSI) is  essen tia lly  the b r ie f form 
of the Symptom Checklist-90-R. Consequently, the SCL-90-R deserves a 
b r ie f descrip tion. The SCL-90-R is  a 90-item se lf-re p o rt symptom 
inventory which was developed by the C lin ica l Psychometric^' Research 
U n it, and designed to p rim a rily  re f le c t current psychological symptom 
patterns of psych ia tric  and medical patients. “ A prelim inary version 
o f the scale was introduced by Derogatis and his colleagues (Derogatis, 
Lipman, & Covi, 1973) and, based on e a r ly ..c lin ic a l»experience ..and 
"psychometric analyses, was'modified a n d va lid d te d 'in  the present
i
revised form (Derogatis, R ickels, & Rock,^ 7 6 ) .  A study conducted by 
Edwards et a l . (197.8), "which.compared f iv e  major^adjustment scales fo r  
th e ir  u t i l i t y  in  assessing patien t groups, found tha t the SCL-90-R'was 
"by fa r  the most re lia b le  instrument and thus the most sensitive fo r  
assessing ind iv id u a lrpa tien t change" (Edwards et a l 1978). The 
SCL-90-R possessed almost perfect te s t-re te s t r e l ia b i l i t y  with the 
c o e ffic ie n t value of ;939 being very close to the In ternal consistency 
of .953.
As stated e a r lie r , the BSI is  the b r ie f version of the SCL-90-R.i
.I t  -'is .comprised -.of.;53 items .designed “to <ref. lectithe^psycholqgicaT^symptom 
patterns of psych ia tric .‘and medical patients. Each item is  rated on the 
■some’ f  ive-po in t'.d istress .scale (0 through *4) \as is  used w ith .the 1SCL-90-R, 
'ranging-from "not .at a l l , "  at one po ll to-'lextremely'Vat the other. ’The 
BSI, likevthe  ,SCL-90-R is  scored and interpreted in.terms of nine primary
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symptom dimensions and three global indices of d is tress. I t  is  admin-, 
istered with a time set reference given to  the patient, which in most 
cases, as in th is  study, is  seven days including today. Correlations 
between the symptom dimensions scores of the BSI and the SCL-90-R, 
based on a sample of 564 psychiatric outpatients, were very high,
ranging from .92 to .98, thus confirming the notion tha t the BSI is  a
o
va lid  measure of the symptom constructs. Since the BSI requires only 
ha lf the time of the SCL-90-R to complete, and because the assessment 
battery in  th is  study was f e l t  to be quite lengthy, the BSI rather than 
the SCL-90-R was used as a time-saving device, as protection against 
the p o s s ib ility  of tedium or fa tigue during the assessment period.
For fu rthe r information on the r e l ia b i l i t y  and v a lid ity  of the SCL-90-R 
and the BSI, the reader is  referred to  the SCL-90-R Manual (Derogatis, 
1977).
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Phobic A voidance and A n x ie ty
Name: _____________________
. Below is a rating scale. Listed are six commonly feared situations. Under the word AVOIDANCE in the spaces 
provided write the number from the rating scale below which best indicated how much you tend to avoid the 
feared situation.
AVOIDANCE SCALE-
0 8
I never 
avoid th is 
situation
I hesitate to 
enter th is  
s ituation, but 
ra re ly avoid i t
I sometimes 
avoid th is 
situation
I usually 
avoid this 
situation
I always 
avoid th is 
situation
AVOIDANCE ANXIETY
Walking alone 
Shopping alone 
Driving alone 
Passenger in  a Car
Public Places (Theater, church, reataurant, e tc.) 
Staying at Home Alone
Other _________
Now under the word ANXIETY write the number from the rating scale below which best describes how much anxiety 
you tend to experience in the feared situation.
ANXIETY SCALE °
0 1 2 . 3 4 5 6 7 8
No Medium Moderate Marked Severe Extreme
anxiety Panic Panic Panic Panic
174.
175.
APPENDIX K. 
•Agoraphobic Cognitions Questionnaire 
and 
Body Sensations Questionnaire
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Agoraphobic C ogn itions Q uestionna ire  
This q u es tio nn a ire  has two p a rts .
Below are some thoughts o r ideas th a t  may pass through your mind when 
you are nervous o r fr ig h te n e d .
1. In d ic a te  how o fte n  each thought occurs when you are nervous.
Rate from 1-5 using the  sca le  below.
1. Thought never occurs •
2. Thought ra re ly  occurs
3. Thought occurs du ring  h a lf  o f  th e  tim es I am nervous
4. Thought u s u a lly  occurs
5. Thought always occurs when I am nervous
2. C irc le  the th ree  ideas which occur most o fte n  when you are nervous.
__________  I am going to  throw  up
__________  I am going to  pass ou t
__________  I  must have a b ra in  tumor f-
__________  I w i l l  have a heart a tta c k
__________  I  w i l l  choke to  death
__________ I  am going to  act fo o lis h
__________  I  am going b lin d
__________  I w i l l  lose  c o n tro l o f  my b ladder o r bowels
__________  I  w i l l  h u rt someone
__________  I  am going to  go crazy
__________  I am going to  scream
__________  I am going to  babble o r t a lk  funny
__________  I  w i l l  be para lyzed by fe a r
__________  Other ideas not l is te d  (P lease describe  and ra te  them)
o
Name:
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
177.
Body Sensations Questionnaire
1. Below is  a l i s t  o f sp ec ific  body sensations th a t may occur when 
you are nervous or in  a feared s itu a tio n . Please mark down how 
a fra id  you are of these fe e lin g s . Use a f iv e  point scale from 
not worried to extremely frigh tened. Only ra te  sensations you 
have personally experienced.
1. Not frightened or worried by th is  sensation
2. Somewhat frightened by th is  sensation.
3. Moderately frightened by th is  sensation.
4. Very frightened by th is  sensation.
5. Extremely frightened by th is  sensation.
C irc le  the three sensations which you fin d  most d i f f i c u l t  in  your 
l i f e .  These fee lings would be the frigh ten ing  fee lings which occur 
most frequen tly .
. 1. Heart p a lp ita tio ns
2. Pressure of a heavy fe e lin g  in  chest
3. Numbnes.s in  arms or legs
4. T ing ling  in  the fin g e rt ip s
5. Numbness in  another part o f the body
6. Feeling short of breath
7. Dizziness
8. Blurred or D istorted v is ion
9. Nausea
10. Having "b u tte r f l ie s "  in  your stomach
11. Feeling a knot in  your stomach
12. Having a lump in  your th roa t
13. Wobbly or rubbery legs
14. Sweati ng
15. A dry th roa t
16. Feeling d isoriented
17. Feeling disconnected from your body:,pnly p a rtly  
present.
18. Other
(Please descibe)
Name:
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APPENDIX L 
Behavioural Avoidance Test
O
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Behavioral Avoidance Test
Location: Entrance to Stadium Shopping M all, Calgary, A lberta .
Instructions to sub ject:
Now I would l ik e  to see how fa r in to  the mall you can walk 
by you rse lf. The procedure 1s simple. Just walk along the major 
walkway fo llow ing  the ins tru c tion s  as explained here (Subject 1s 
given handout d e ta ilin g  walk rou te ). When you've walked as fa r as 
you can go, mark on your sheet the lo ca tio n , and then re tu rn  here 
to the s ta r t .  Do you have any questions so far? OK, there 1s one 
more th in g : I would l ik e  you to rate your anxiety as you reach
various points along your walk. To make your anxiety ra tin g  you w i l l  
use th is  form (Show subject the anxiety ra tin g  procedure on the form 
already provided). As you can see on the form there are various 
numbered points or landmarks where I want you to stop and qu ick ly  
rate your anxiety. For Instance, the f i r s t  landmark 1s the fountain 
over there about 25 yards ahead (Point to foun ta in ). When you reach 
the fountain you are to b r ie f ly  stop and record your anxiety ra tin g  
on the form tha t you are ca rry ing . Once you have done tha t continue 
to  walk ahead on the major walkway u n t i l  you reach poin t number 2 
which w i l l  be the Sport Store approximately 50 yards ahead. Again, 
stop and record your anxiety level on the form and proceed to 
Dairy Queen which is  the next numbered landmark. Repeat th is  same 
procedure fo r as many landmarks as you can. At any poin t 1 f you 
feel l ik e  you ca n 't go on and want to end the walk, note on your 
sheet the loca tion  and walk d ire c t ly  back to th is  s ta rt in g  po in t.
Is th a t clear? Do you have any questions? OK, you can begin now.
Questions Subjects might ask:
L ike ly  questions such as "How anxious should I get before
I stop?" or "How hard do you want me to push myself?" should be answered
w jth the fo llow ing comment: " I t 's  up to you to decide 1 f and when.
you w i l l  s top ." I f  there is  fu rth e r questioning along these lin e s , 
say "The only one who knows how much you can do 1s yo u rse lf. When you
w i l l  stop 1s le f t  completely to your own judgment."
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Handout: Instructions fo r Walk
PLEASE RATE YOUR ANXIETY AT EACH STATION ACCORDING TO THIS SCALE:
0 1 2 3 4 5 6 7 8 9  10
I------------------------------------- 1----------------------------1------------------------------1
Unafraid A fra id  Very a fra id  Extremely a fra id
not tense somewhat tense tense and very tense or
or anxious and anxious anxious anxious
o
' * ••*<* * •#*. *
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Walk rou te Landmarks A n x ie ty  Rating
Entrance to 
Hal 1
O
I
o
1. Fountain
2. Sports S tore
3. D a iry  Queen
4. U p  Top T a ilo rs
5. Falrweathers
6. I.D .A . d rugsto re
7. Hudson Bay Store
8. Enter Bookstore and 
Browse fo r  5 minutes
Enter Woodwards and 
Browse fo r  5 minutes
10. Stand 1n l in e  and buy 
L o tte ry  t ic k e t .
Name:
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APPENDIX M 
Treatment Expectations
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Treatment Expectations
On the fo llo w in g  scales you are asked to  In d ic a te  how you fe e l about 
the trea tm en t. Th is is  a ro u tin e  procedure. Remember th a t you are 
to  ra te  the trea tm ent method and not the  th e ra p is t .  The th e ra p is t 
w i l l  not see these ra t in g  scales u n t i l  the trea tm ent program is  
complete.
How lo g ic a l does th is  type o f trea tm ent seem to  you?
0 1 2 3 4 5 6 7 8 9  10
1----------------------------------------------
not a t 
a l l  lo g ic a l •
-------------------------1
very
lo g ic a l
How co n fid e n t are you th a t  
reducing your fear?
th is  trea tm ent would be successful in
0 1 2  3 4 5 6 7 8 9 10
not a t
a l l  co n fid e n t
h ig h ly
c o n fid e n t
How co n fid e n t would you be in  recommending th is  trea tm ent to  a 
f r ie n d  w ith  the same problem?
0 1 2 3 4 5 6 7 8 9 10
not a t
a l l  co n fid e n t
h ig h ly
c o n fid e n t
How successful do you fe e l 
d i f fe r e n t  fe a r o f yours?
th is  trea tm ent may be in  decreasing a
0 1 2 3 4
■l---------------------------------------------
5 6 7 8 9 10 
--------------------------1
not a t ve ry
a l l  successful successful
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APPENDIX N 
Fear Questionnaire
o
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Fear Questionnaire
Nam e............................................. Age. . . .  Sex. . .  Date ..
Choose a number {rom the scale below to show how much you would avoid each of 
the situations listed below because of fear or other unpleasant feelings. Then write 
the ^ unber you chose in the box opposite each situation.
0 1 2 3 4 5 6 7 8
Would not Slightly Definitely Markedly Always 
avoid it avoid it avoid it avoid it avoid it
1. Main phobia you want treated (describe in your own words)
    □
2. Injectionsorramorsurgery.......................................... O
3. Eating or drinkingwith other people..................    G
4. Hospitals......................................    G
5. Traveling alone by bus or coach  ...................... G
6. Walking alone in busy streets....................................G
7. Being watched or stared a t........................     G
8. Going into crowded shops.........................................G
9. Talking to people in authority  ......................................G
10. Sightofblood.............................................................G
11. Being criticized.............................................................G
12. Going alone far from home....................................  G
13. Thought of injury or illness...................'...................... G
14. Speaking or acting to an audience........... ; ...................... Q
15. Large open spaces..............................    Q
16. Going to the dentist.................................................... Q
17. Other situations (describe).....................  G
v-
leave blank -*■ O D D  Q
Ag+Bl+Soc =  Total 
2-16
Fear Questionnaire (continued)
Now choose a number from the scale below to show how much you are troubled by 
each problem listed, and write the number in the box opposite.
0 1 2 3 4 5 6 7 8
Hardly Slightly Definitely Markedly Very severely
at all troublesome troublesome troublesome troublesome
18. Feeling miserable or depressed................................ G
19. Feeling irritable or angry.........................................G
20. Feeling tense or panicky.......................................... Q
21. Upsettingthoughtscomingintoyourmind.................G
22. Feeling you or your surroundings are strange or unreal G
23. Other feelings (describe)...................................................................... G
G Total 
*
How would you rate the present state of your phobic symptoms on the scale below?
0 1 2 3 4 5  6 7 8
No phobias Slightly Definitely Markedly Very severely 
present disturbing/ disturbing/ .  disturbing/  disturbing/
not really disabling disabling disabling 
disabling
Please circle one number between 0 and 8.
186.
Fear Questionnaire
The f i r s t  score on the Fear Questionnaire, global phobia, is  
measured on a n ine-point ra tin g  scale which goes from 0= "no phobias 
present," to  8= "very severely d is tu rb in g /d isa b lin g ," the wording of 
the anchoring points re fle c tin g  both d is tress and avoidance. The second 
score, to ta l phobia, is  derived from the 15-item fear questionnaire which 
measures avoidance on a n ine-point scale from 0= "would not avoid i t , "«
to 8= "always avoid i t , "  thus y ie ld in g  a possible score range from 0 to  
120. The th ird  score, agoraphobia, one of the phobia subscores, is  
composed o f 'f iv e  sp ec ific  agoraphobic items. The main phobia score is  
derived from the subjects response on a n ine-point scale on the f i r s t  
item o f the questionnaire. .The f i f t h  and f in a l ;score, anxiety/depression,
asks subjects to  ra te  the f iv e  most common nonphobic symptoms found in
o
phobic patients on a n ine-poin t ra ting  scale which goes from 0= "hardly 
a t a l l , "  to  8= "very severely troublesome."
There is  sa tis fac to ry  evidence th a t the fear questionnaire 
re fle c ts  the c lin ic a l status .of pa tien ts . In :an.^analysis by Hallam (1977) 
using an e a r lie r  version of the fear questionnaire w ith 171 phobic patients 
treated by nurse therap ists in  London, the rap is ts ' ra tings o f dysfunction 
corresponded well w ith the c lin ic a l state o f'p a tie n ts 'a n d 're la tiv e s ' 
accounts o f them, as well as w ith  other ra tings about th e ir  adjustment 
(Ginsberg .&  Marks, 1977; Marks et a l . ,  1977).
The current version of the fear questionnaire tha t was .used in - th is  
study has been shown to be sensitive  to c lin ic a l improvement a fte r treatment; 
in  a sample of :26 phobic patients treated by exposure in  vivo*from nurse
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'the rap is ts , analysis o f variance (p <  .01) found s ig n if ic a n t Improvemeht 
in  a ll  mean scores from pre- to posttest as fo llow s: Global phobia 
ra tin g  (5.7 to  3 .1 ), to ta l phobia ra tin g  (36.5 to 26.6), agoraphobia 
(14 to  8 ), and anxiety/depression (18 to 12).
T est-re test r e l ia b i l i t y  o f the fea r questionnaire w ith  a 
c lin ic a l population has been reported fo r  a sample o f 20 phobic patients 
w ith a te s t-re te s t in te rva l o f seven days. Test-re tes t r e l ia b i l i t ie s  
fo r  global phobia, to ta l phobia, agoraphobia, and anxiety/depression, 
ranged from .79 to .89 more than adequate.
R e lia b il it ie s  and co rre la tions  o f each Ind iv idua l item w ith  
subscores were calculated to  assess the co n tribu tio n  made by each. In 
general, both r e l ia b i l i t ie s  fo r  ind iv idua l items and item/subscore 
co rre la tions  were .5 or greater except fo r  10 Items which were therefore 
removed. The subscores from the 30-item and 20-item form hajj a mean 
co rre la tio n  o f .95 w ith one another.
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APPENDIX 0 
Correlation Coefficients for Self-Report Measures
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Correlations Between Measures
Pearson product-moment correlations between dependent measures were computed In 
an effort to determine the relationship between the dependent measures under Investigation 
In this study. The correlation matrix presented In Table 7, suggests that a number of the 
measures are highly correlated.
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Correlation Coefficients for Self-Report Measures
Variable
(1) FP1
(2) STA1 
<3) ADB1
(4) PDB1
(5) OCB1
(6) SAX1
(7) ACQ1
(3) BSQ1
(9) ABAT1
(10) SAD1 
0 1 ) b a t  1
I 12) GSI1
(13)TFQ1
(14) AFQ1
(15) FP2 
(15) STA2 
( I 7) ADB2 
(15) PDB2
(19) OCB2
(20) SAX2
(21)ACQ2
(22) BSQ2
(23) SAD2
(24) GSI2
(25) TFQ2
(26) AFQ2 
27) FP3
(28) STA3
(29) ADB3
(30) PDB3 
(31JOCB3
. 32) SAX3
(33) ACQ3
(34) BSQ3
(35) ABAT3
(36) SAD3
(37)BAT3
(38)GSI3
(39)TFQ3
(40) AFQ3
(1) (2) (3) (4) (5) (6) (7) (8) (9) . (10)
.30 .54** .23 .41* .50** .44* .43* .77*** .41*
— — .43* .24 .27 .27 .63*** .45** .32 .18
— — .58** .37* .51** .37* .38* .36* .56**
— — — .53** .28 .33 .25 .10 .50**
.. — .29 .34 .45** .20 .37*
— — .. — .54** .48** .47** .83***
.. .. .. .. — .60*** .55** .42*
— — — — — — .44* .45**
— — — — — — — — - .38*
— — — — — — -- — — --
— — — mm -- — -- — -- --
— -- -- — -- — — — -- —
— — — — — — -- — — —
— — — -- — -- -- mm mm —
- — - — — — -- ' - - -- --
— -- — -- -- -- — — — —
— — - -- — — -- — — —
— - mm — — mm mm mm —
- — -- mm -- -- — - ••
- — — mm - mm - - ••
—
\
-- - — - - -- - -i - - -- — - mm ••
— -- — — mm -- ••
o ’
—
•• •• •• — — •* •• •• **
- M — - — mm -
— - — mm — — - mm -- --
“ — - — — — mm — —
— -- — - ” -- mm mm — --
- - ~ — — ■ — -- ~ mm
-- — - — — — mm — —
-- ■ — -- -- — -- - ~ — --
- — — - — — mm mm — —
" ” - ” -- mm ~ mm --
- " — — — - — — mm mm
— — — - — -- mm — „G -
— ” •• — — - mm
— — -- — — . - •• mm ••
” -- - - — - - -- mm -
” - — mm — mm •• -- mm
.. mm mm mm mm
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Variable
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
0) 
(10)
01) 
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20) 
(21) 
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
(36)
(37)
(38)
(39)
(40)
(11) (12) (13) (14) (15) (16) (17) (18) (19)
-.76*** .54** .47** .34 .94*** .30 .59*** .28 .40*-.25 .50** .27 .09 .34 .98*** .35 .28 .29-.34 .65*** .39* .27 .52** .38* .82*** .55** .36*-.11 .68*** .17 .33 .21 .24 .50** .98*** .55**-.13 .69*** .29 .25 .36* .28 .44* .56** .99***-.57** .49** .51** .54** .43* .29 .55** .27 .35-.58*** .59*** .59*** .45* .44* .68*** .44* .39* .37*-.41* .51** .48** .36* .52** .52** .57** .30 .47**-.86*** .37* .61*** .42* .77*** .34 .54** .19 .22-.51** .57** .64*** .68*** .37* .19 .61*** .49** .41*•* -.30 -.44* -.54** -.78*** -.29 -.48** -.17 -.15•• •• .49** .42* .50** .52** .62*** .71*** .69***•• — .66*** .44* .30 .49** .24 .29•• — — .34 .12 .29 CO .26
mm — — .35* .62*** .27 .35*•• •• — — — .36* .30 .30
mm mm — -- — .55** .45*
— - mm ..
*“* mm — mm .58***
mm mm mm .. mm ••
•• — — — mm mm •• mm mm
** •“ — — mm — — mm mm
— — - — mm mm mm
•* mm — mm — mm mm
•• •*“ mm - — •• mm m m
mm •* mm -- • - — mm mm mm
** mm — mm - — mm ~ 3 mm
mm mm •• — — mm mm •• mm
mm mm — - mm mm mm
mm mm — mm mm ••
mm *• “ — - mm mm •• ••
mm — -- -- — mm —■
mm •• — mm mm ... mm mm
mm *• — - mm — mm mm mm
*• — -- — mm mm * m m
mm **• — - mm mm mm
** mm •• mm •• — mm •• ^ mm
mm — — - — mm mm
** — mm - mm mm mm mm
. •• — mm mm mm mm mm m m
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Table cont'd 
Variable
(1)
(2)
(3)
«)
(5)
(6) 
(?) 
(8) 
19) 
(10) 
01) 
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20) 
(21) 
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
(36)
(37)
(38)
(39)
(40)
(20) (21) (22) (23) (24) (25) (26) (27) (28)
.35* .45** .40* .43* .51** .47** .37* .75*** .31.09 .62*** .48** .07 .44* .27 .06 .14 .06***.33 .38* .31 .47** .61*** .37* .24 .44** .35*.17 .30 .24 .49** .68*** .17 .29 .11 .20.16 .33 .49** .39* .64*** .29 .24 .28 .29.92*** .60*** .47** .79*** .43* .53** .56** .43* .33.47** .95*** .64*** .38* .53** .60*** .42* .17 .63***.40* .58** .97*** .45* .46** .47** .35* .29 .49**.45* .52** .40* .42* .32 .62*** .45* .54** .39*.78*** .45** .43* .95*** .52** .64*** .71*** .33 .25-.55** -.61*** t O * -.53** -.27 -.61*** -.59*** -56** -.35*.32 .56** .52** .54** .96*** .49** .41* ..35* .46**.50** .56** .50** .62*** .42* .99*** .66*** .27 .39*.54** .40* .43* .63*** .36* .67*** .98*** .15 .16.31 .47** .48** .36* .47** .44* .37* .77*** .33.14 .69*** .56** .12 .48** .32 .11 .19 .26.40** .47** .48** • .59*** .60*** .48** .29 .50** .36*.18 .38* .29 .50** .72*** .24 .28 .17 .27.22 .36* .51** .43* .63*** .28 .25 .27 .29"• .55** .41* .78*** .31 .53** .59*** .44* .26
mm •• .63*** .43* .52** .59*** .41* .30 .69***•• •• — .42* .47** .50** .44* .27 .54**** •• — .53** .64*** .69*** .40* .25•• mm — — .44* .37* .45* .50**
mm -- — — .69*** .31 .44*•• mm — — mm mm .25 .21** mm — — — •• • .33•• mm — — — —
"  (•" •• mm — — — — mm
•* •• — — — -- — mm
mm •• — — — .. — mm 9m
mm •• -- — -- — — mm mm
"** •• — -- - — mm mm mm
•* — -- mm mm mm mm
•* •• mm •• mm mm mm mm
mm — — mm — •• mm mm
— mm mm - •• mm mm * mm
•• •• — mm — — mm mm mm
** mm — mm mm mm mm mm
mm mm mm •• mm mm
r \
mm
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Variable
(1)
(2)
O)
(4)
(5)
(6)
(7)
(8)
0)
(10)
01)
(12)
(13)
(14)
(15)
(16)
07 )
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
(36)
(37)
(38)
(39)
(40)
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(29) (30) (31) (32) (33) (34) (35) (36) (37)
CD * • .23 .44* .22 .40* .39* .42* .33 -.57**
.17 .24 .28 -.01 .59*** .36* .11 .10 -.08
.54** .42* .35 .22 .26 .27 .06 .35 -.13
.25 .85*** .50** .08 .20 .17 -.02 .34 -.03
.28 .43* .96*** .11 .32 .49** .14 .28 -.22
.46** .22 .38* .65*** .53** .43* .25 .73*** -.39*
.26 .34 .34 .16 .09*** .49** .27 .36* -.34
.38* .19 .45* .18 .52** .91*** .34 .34 -.32
.42* .20 .29 .28 .49“ .36* .56** .35* -.64***.46** .41* .44* .60*** .36* .37* .37* .79*** -.30
-.41* -.20 -.22 -.38* -.57** -.38* -.59*** -.44* -.69***
.44* .61*** .69*** .19 .48** .50** .18 .44 -.21
.41* .24 .34 .36* .54** .42* .41* .57** -.44*
.21 .30 .26 .33 .29 .31 .24 .45“ -.31
.46** .24 .39* .18 .40* .46** .26 .42* -.56“
.26 .29 .31 .09 .67*** .46** .21 .20 -.19.63*** .45* .48** .33 .40* .49** .26 .49** -.35*
.30 .89*** .55** .13 .29 .25 .06 .39* -.13
.27 .45** .97*** .14 .35* .50** .14 .31 -.22
.50** .22 .27 .78*** .49** .37* .40* .77*** -.47**
.37* .37* .36* .30 .95*** .51“ .35* .46“ -.45**
.36* .23 .49“ .19 .59*** .92*** .36** .34 -.33
.55** .46** .49** .70*** .38* .42* .40* .89“ * -.49**
.56** .69*** .65*** .29 .47** .49“ .30 .50** -.30
.48** .28 .36* .44* .58*** .44* .48** .63*** -.52**
.31 .33 .28 .44* .33 .34 .36* .55** -.42*
.75*** .32 .36* .56** .31 .37* .63*** .49** -.70*“
.51** .38* .34 .35* .72*** .51“ .49** .41* -.48**— .51** .37* .76*** .43* .51“ .73*“ .73*** -.74***— — .47** .33 .38* .25 .31 .50** -.35*
•* — — .25 .39* .52** .26 .42* -.33•* _ — — — .36* .32 .64*** .e >**• -.69***•• mm — — — .53** .45* .50“ -.52**** •• — — — mm .48** .42* -.45**
•* — — - mm — .55** -.88*“
mm •* — — •«* — - - -.65*“
•• •• — — — — •• —
— — - •• - •• — •• mm
•• — - - - — — mm mm
— mm — — mm mm mm
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Table cont'd
Variable
(1)
(2)
O)
(4)
(5)
(6)
(7)
(8)
0)
(10)
01)
02)
(13)
04)
(15)
(16)
07)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
(36)
(37)
(38)
(39)
(40)
(38) (39) (40)
.44* .47** .34*
.23 .23 .04
.44* .36* .22
.49** .14 .22
.60*** .30 .27
.48** .55** .60***
.33 .53** .39*
.42* .48** .35*
.38* .63*** .47**
.57** .66*** .71***
-.36* -.62*** -.59***
.65*** .46** .36*
.46** .96*** .68***
.30 .63*** .87***
.42* .46** .34
.30 .29 .13
.56** .50** .32
.56** .21 .24
.59*** . .30 .27
.48** .59*** .68***
.41* .54** .43*
.45* .50** .42*
.66*** .68*** .75***
.72*** .44* .37*
.51** .98*** .73***
.39* .67*** .93***
.64*** .41* .40*
.52** .46** .34
.81*** .60*** .55**
.70*** .30 .38*
.68*** .39* .34
.67*** .56** .70***
.49** .56** .42*
.57** .48** .42*
.67*** .60*** .59***
.76*** .70*** .74***
-.67*** -.63*** -.65***
— .61*** .59***
— - .77***
— • •
P < .05 
“  P< .0 1  
“ * P < .0 0 1
• .  T ; . ' • . . . . . . .  v
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